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IV. ABSTRACT 
The naturally existing enzymes have been evolved to work efficiently in aqueous 
environment of their hosts. Very often, their activity gets dramatically lost in the presence of 
non-conventional media (e.g. ionic liquids (ILs) and organic solvents (OS)) which are often 
present in industrial processes. Therefore, it is crucial to maintain/improve the enzyme 
resistance towards non-conventional media for the efficient operation of enzymes in industrial 
process conditions. Despite of the many successful stories of improving enzyme resistance 
towards many non-conventional media by protein engineering, there have been no geneneral 
principles for guiding researchers for efficient reengineering of enzymes. The aim of this 
work was to obtain protein engineering principles for improving IL and OS resistance of 
enzymes. A systematic study including site saturation mutagenesis (SSM) library generation 
of the complete sequence of a model enyzme Bacillus subtilis LipA (BSLA) and screening in 
presence of four ILs ([BMIM][Cl], [BMIM][Br], [BMIM][I], [BMIM][TfO]) and three OS 
(DMSO, TFE, 1,4-dioxane) were performed. The generation of 181 SSM-BSLA libraries was 
carried out by two PhD fellows in close cooperation (91 SSM-BSLA libraries by Victorine 
Josiane Frauenkron Machedjou and 90 by Alexander Fulton). Overall, 18547 clones were 
generated and screened which contained all possible 3620 single mutations as confirmed by 
sequencing. The number of beneficial positions and substitutions, type of beneficial amino 
acid exchange and location of positions was investigated. To the best of our knowledge, this is 
the first study based on such a complete set of experimental data to investigate IL/OS 
resistance of an enzyme. 
In a first study (described in chapter 3), the resistance of SSM-BSLA variants towards 
four [BMIM]-based ILs (Cl
-
, Br
-
, I
-
, and TfO
-
) was investigated. The highest number of 
improved variants was obtained for [BMIM][Cl]: 69% of all positions and 13% of all 
substitutions showed improvements. For the four ILs, at 50-69% of all positions at least one 
substitution led to improvement whereas only 6-13% of all substitutions displayed increased 
resistance in all four ILs. It was also noteworthy that higher improvements from single 
substitution (>2.5-fold) were difficult to achieve by screening random mutagenesis library 
since only 0.3% of all the substitutions resulted in improvement >2.5-fold. Furthermore, 
amino acid substitutions with polar and charged amino acids were demonstrated to 
considerably enhance ILs resistance of BSLA. Among the best variants, the highest 
improvement (11.3-fold) was obtained for [BMIM][Cl] for a substitution from charged acidic 
to aromatic (Asp91Trp). Two main lessons were obtained: a) resistance improvements were 
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obtainable at 50-69% of all amino acid positions, explaining the success rate of small sized 
random mutant libraries; b) in total 6-13% of substitutions led to improved resistance. Among 
the beneficial substitutions 66-95% were substituted by chemically different amino acids (e.g. 
aromatic to polar/aliphatic/charged amino acids), indicating that mutagenesis methods 
introducing transversions should at least for lipases like BSLA be favored to improve IL 
resistance. 
In a second study (described in chapter 4), the resistance pattern of SSM-BSLA variants 
towards three OS (DMSO, TFE, and 1,4-dioxane) was investigated. For 1,4-dioxane and TFE, 
4-5% substitutions at 41% positions led to improved resistance. As observed for IL resistance 
of BSLA, improvements >2.5-fold were difficult to achieve with single point mutation, only 
0.03% and 0.17% variants were obtained for DMSO / 1,4-dioxane and TFE, respectively. In 
addition, substitutions of BSLA WT amino acid residues with charged amino acids residues 
predominantly led to improved OS resistance towards TFE and 1,4-dioxane, whereas polar 
substitutions were preferred for DMSO. 
Overall, two features for BSLA resistance in non-conventional media were observed: 1) 
resistance improvements were obtainable at >41% (in OS) and >50% (in ILs) of all amino 
acid positions of BSLA, indicating why improved enzyme variants can often be identified 
from small sized random mutant libraries (1000-2000 clones) and 2) often only few 
substitutions per amino acid positions led to improved resistance (4-13% of all substitutions) 
for OS and ILs. Among the beneficial substitutions, 66-95% and 58-95% were exchanged 
with chemically different amino acids (e.g. aromatic amino acids substituted by 
polar/aliphatic/charged amino acid) for ILs and OS, respectively. The latter indicates that 
mutagenesis methods that introduce transversions should, at least for lipases like BSLA be 
favored to generate variants with improved OS and/or IL resistance. Furthermore, the highest 
number of improved BSLA variants were obtained for [BMIM][Cl] and DMSO among the 
four ILs and the three OS, respectively. 
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1 General Introduction 
1.1 Non-conventional Media Used in Biocatalysis 
Enzymes are powerful biocatalysts, which catalyze a broad range of reactions under 
mild conditions and have the ability to increase the reaction rates by up to 10
12 
(Carrea and 
Riva, 2000). For a long time, enzymes have been considered to be active only under mild 
reaction conditions and in presence of water. Most enzymes have not been designed by nature 
to work in non-aqueous environments in which many enzymes are destabilized (Arnold, 
1988). Water plays a crucial role in the existence of life and its role in enzymatic reactions is 
indispensable for the production of all organic molecules necessary for life (Ogino and 
Ishikawa, 2001). In contrast, non-aqueous solvents can affect enzymes performance by: (1) 
disrupting the hydration shell around enzymes and stripping off essential water from them; (2) 
penetrating into the water layer to interact with enzymes via electrostatic, hydrophobic, and 
H-bond interactions and in turn altering the protein dynamics, the conformation, and/or the 
active site; and (3) interacting directly or indirectly with the substrates and products, changing 
their concentrations in the aqueous layer (Yang and Pan, 2005; Yang and Russell, 1996). 
These interactions might cause unfolding and/or aggregation, leading to inactivation of 
enzymes. Therefore, it is not unexpected that almost all studies in enzymology have been 
carried out in aqueous media, trying to obtain the highest reaction efficiency. This general 
idea has impeded the application of biotransformations in synthetic routes that commonly 
employ organic solvents (OS). Nevertheless, intrinsic properties such as high specificity and 
selectivity make enzymes attractive biocatalysts for industrial applications (Vermue and 
Tramper, 1995), especially for the synthesis of biochemical, pharmaceuticals, and chiral 
intermediates (Ogino and Ishikawa, 2001). These compounds generally display 
disadvantageous properties such as insolubility or instability in water. Therefore, applying 
non-conventional media for biocatalysis can be a promising approach to overcoming this 
problem, enabling the production of compounds that are difficult or expensive to produce by 
chemical synthesis. It has been demonstrated that biocatalysts are less sensitive to harsh 
reaction conditions than expected, retaining their activity in all sorts of non-conventional 
media (Vermue and Tramper, 1995). Non-conventional media include all reaction media 
different from pure aqueous buffers. The most prominent examples of non-conventional 
media are OS, ionic liquids, gas and solid phases, supercritical fluids (Cantone et al., 2007; 
Hari Krishna and Karanth, 2002) or deep eutectic solvents (Abbott et al., 2004; Carriazo et 
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al., 2012; Domínguez de María and Maugeri, 2011; Lehmann et al., 2012; Zhang et al., 
2012). Using enzymes in non-conventional media is tantalizing as they enable the production 
of useful chemicals which are not possible in water and their advantages range from high 
substrate specificity to higher enzyme activity and stability (Hari Krishna, 2002). Due to these 
advantages, their scientific as well as industrial applicability is gaining huge interest. Hence, 
much progress has been made in the fundamental understanding of the phenomena that 
govern enzyme properties in non-conventional media. Several research groups and 
institutions, for instance, the graduate school BioNoCo (Biocatalysis in Non-Conventional 
media) aim to engineer enzymes as ideal tools for organic chemistry and enhance their 
stability in different non-conventional media. The non-conventional media investigated in this 
thesis are ionic liquids (ILs) and organic solvents (OS), which are intensively discussed in the 
next chapters. 
1.1.1 Ionic Liquids (ILs) 
1.1.1.1 Definition and History  
Ionic liquids (ILs) are low-temperature molten salts composed of a mixture of large 
organic cations and smaller organic or inorganic anions, which remain liquid at low to 
moderate temperature (Rogers and Voth, 2007; Wasserscheid and Keim, 2000; Welton, 
1999). When in melted state at room temperature, they are also termed room temperature 
ionic liquids (RTILs). The liquidity of ILs at moderate temperature is a consequence of the 
inability of such anions and cations to pack well between each other (Keskin et al., 2007). 
Their low melting points result from the incorporation of bulky asymmetric organic cations 
into the structure, together with weakly coordinating anions (Domínguez de María, 2012), 
disturbing the efficient packing of ions in the crystal lattice (Krossing et al., 2006). In contrast 
to classical molten salts, which are usually highly viscous, high-melting, and very corrosive 
substances, ILs possess a relatively low viscosity (Wasserscheid and Keim, 2000). 
The first ionic liquid, ethanol ammonium nitrate (melting point 52-55°C), was 
discovered 1888 by Gabriel and Weimer (Gabriel and Weiner, 1888). It was first in 1914, 
when Paul Walden described the physical properties of ethylammonium nitrate 
[EtNH3][NO3] as a room temperature ionic liquid (RTIL), with a melting point of 13-14°C  
(Walden, 1914). Although this report gained less resonance at that time, it is considered to be 
the starting point of the ILs´ history. The lack of interest in ILs was due to their instability at 
room temperature. Indeed, the first ILs were found to be sensitive to water and air and these 
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findings caused a major drawback for their application in chemical processes. ILs started to 
attract interest in the 1990s, when the second generation of ILs were synthetized with weakly 
coordinating anions such as BF4, CH3CO2, or NO3 that were water and air stable (Wilkes and 
Zaworotko, 1992). In the past years, ILs have been studied intensively and have gained 
considerable attention as they have been applied as (co)solvents for a wide range of chemical 
and biochemical reactions. Consequently, more than 8000 papers, including over 900 patents 
and applications have been reported since 2007 (Rogers and Voth, 2007). Nowadays, these 
numbers have considerably increased with the endeavors devoted on IL studies. The 
development of cheaper ILs in particular increases their attractiveness for industrial 
applications. Deep eutectic solvents (DES) have emerged in early 2000s as a cost-effective 
alternative to ILs (Domínguez de María, 2012). DES contain biodegradables anions (amino 
acids, natural bases, and naturally occurring carboxylic acids), derived from renewable 
resources and are simpler to synthetize compared to ILs (Abbott et al., 2004). 
1.1.1.2 Characteristics of Ionic Liquids 
ILs generally contain bulky cations such as imidazolium, pyridinium, pyrrolidinium, 
quaternary ammonium or tetraalkylphosphonium (Figure 1-1A) and small anions (Figure 
1-1B). One major interests of applying ILs as reaction media is the possibility to fine-tune 
their physicochemical properties, allowing them to be designed for task-specific reactions. ILs 
are also referred to as designer solvents (Freemantle, 1998). The properties of ILs are mainly 
influenced by the choice of the anion counterpart (influencing chemical properties and 
reactivity) and/or the cation counterpart (controlling physical properties) (Huddleston et al., 
2001). Thus, according to the required process, solubility, viscosity, polarity, density, melting 
point, hydrophobicity, and hydrophilicity can be finely adjusted (Yang and Pan, 2005). 
Therefore, an almost infinite number of ILs can be synthesized. Some commonly employed 
IL-cations and IL-anions are illustrated in Figure 1-1. 
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B 
 
Figure 1-1: Examples of cations and anions used in ionic liquid systems. A: common used IL-cations, B: common used 
IL-anions. The anions are classified in increased order of water-miscibility. [PF6]
-: hexafluorophosphate, [NTf2]
-: 
bis(trifluoromethylsulfonyl) imide, [BF4]
-: tetraflouroborate, [TfO]-: trifluoromethanesulfonate, [CH3CO2]
-: acetate, [NO3]
- : 
nitrate, Br-: bromide, Cl-: chloride, I-: iodide. This shema was partly adapted from (Plechkova and Seddon, 2007) with the 
permission of Royal Society of Chemistry provided by Copyright Clearance Center. 
 
ILs are characterized by high density, high thermal and chemical stability, low 
viscosity, negligible vapor pressure as well as high polarity (Anderson et al., 2002; 
Huddleston et al., 2001; Kaar et al., 2003; Park and Kazlauskas, 2003; Sheldon et al., 2002). 
The high polarity of ILs is one of their most unique features, which increases their 
attractiveness for chemical and biochemical reactions (Yang and Pan, 2005). In fact, high 
polarity enables ILs to dissolve a broad range of different substances, for instance polar and 
non-polar organic, inorganic and polymeric compounds (Madeira Lau et al., 2000). Low 
vapor pressure and high thermal stability are properties that increase their usage as 
biocatalysts from an environmental point of view (Anderson et al., 2002). Additionally, the 
immiscibility of ILs with a range of solvents facilitates their recycling (Murugesan and 
Linhardt, 2005). Although ILs are used to meet the increasing demand for clean technologies 
in industrial processes, their toxicology is not yet well studied (Park and Kazlauskas, 2003) 
and further research is necessary to evaluate their sustainability. 
1,3-Dialkylimidazolium-based ILs are among the most widely used ILs. Their anions 
and cations have been found to be associated in part by electrostatic, hydrophobic interactions 
and mostly by hydrogen bonds resulting in a polymeric supramolecular structure or IL 
network (Domínguez de María, 2012; Dupont, 2004), which is similar to the three-
dimensional network of water. In this structure, one imidazolium cation is surrounded by at 
least three anions or vice versa (Figure 1-2A). However, the number of anions surrounding 
the cations (and vice-versa) can change according to the anion size and the type of N-alkyl 
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imidazolium substituents (Dupont, 2004). Introduction of molecules such as water and 
macromolecules in the IL network can modify their physicochemical properties resulting 
occasionally in the formation of polar and non-polar regions (Dupont, 2004). The mesh of ILs 
(Figure 1-2B) enables the maintenance of enzyme´s active structural conformation with the 
ability to prevent enzyme from classical thermal unfolding (Fehér et al., 2007). 
A
 
B 
 
 
Figure 1-2: Two-dimensional simplified solid-state model of the polymeric supramolecular structure of 1,3-dialkyl 
imidazolium ILs and ILs´s network. A: Two-dimensional simplified solid-state model of the polymeric supramolecular 
structure of 1,3-dialkyl imidazolium ILs illustrating the hydrogen bonds between the imidazolium cation (C) and the anions 
(A) (one cation is surrounded by three anions and vice-versa). B: Enzymes with a small amount of water are firmly trapped in 
the network of ILs. Figure A reproduced from (Dupont, 2004) under a creative common license and figure B from (Fehér et 
al., 2007) with the permission of the Biochemical Society. 
1.1.1.3 Applications of Ionic Liquids 
ILs are tunable, multi-purpose materials for a variety of applications, rather than being 
just solvents. The main fields for the application of ILs are summarized in Figure 1-3. ILs are 
used as sensors, solar cells, solid-state photocells and batteries and also as thermal fluids 
(lubricants, hydraulic fluids, and ionogels) (Rogers and Voth, 2007). Due to their unique 
properties, ILs have been intensively investigated and are gaining an astonishing interest in 
industries and particularly in academia. Several reviews (Patel et al., 2014; van Rantwijk and 
Sheldon, 2007; Wasserscheid and Keim, 2000; Yang and Pan, 2005; Zhao, 2010) deal with 
this topic, and in particular the one written by Plechkova and Seddon listed the companies 
working with ILs at an industrial level (Plechkova and Seddon, 2007). Using ILs instead of 
classical materials offers several advantages such as high conversion rates, high selectivity, 
better enzyme stability, as well as recoverability and recyclability (Moniruzzaman et al., 
2010). Additionally, ILs can reduce the risks associated with the use of volatile and highly 
flammable organic compounds (Krossing et al., 2006). In the area of protein research, ILs 
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have been used for stabilization, crystallization, solubilization, separation, extraction of 
proteins, and performance additives in enzymatic reactions (Patel et al., 2014). 
 
Figure 1-3: Overview of possible applications of ILs in different areas. This figure was adapted from (Domínguez de 
María, 2012; Patel et al., 2014; Plechkova and Seddon, 2007). 
1.1.2 Organic Solvent (OS) 
Although water is a crucial constituent of life, it is unfortunately a poor solvent for most 
synthetic reactions (Serdakowski and Dordick, 2008). Many organic compounds (enzymes 
and substrates) are insoluble in water and rather soluble in OS. OS efficiently enable an 
increased solubility of hydrophobic substrates, enhancing reaction rates and product formation 
(Vermue and Tramper, 1995; Zaks and Klibanov, 1985). Therefore, enzymatic reactions in 
the presence of OS possess a great potential for academic and industrial applications. From 
this point of view, researchers have struggled in the last decades to develop methods to 
enhance the stability of enzymes in the presence of OS. Two different solutions have been 
proposed to handle the insufficient enzyme tolerance toward OS: 1) Optimization of the 
reaction conditions to the available catalysts and 2) design of biocatalysts, able to withstand 
ideal process conditions (Luetz et al., 2008). OS are the most used non-conventional media 
and success stories of increased stability and activity as well as interesting catalytic properties 
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of enzymes in such solvents have been reported (Carrea and Riva, 2000; Klibanov, 2001; 
Staahl et al., 1991; Zaks and Klibanov, 1985). Despite that, wild type enzymes generally 
display low activity and/ or stability in presence of OS and also apt to denaturation or 
inhibition. Several advantages and disadvantages of using OS instead of water have been 
listed in Table 1-1. 
Table 1-1: Advantages and disadvantages of enzymatic reactions in presence of OS (Castro and Knubovets, 2003; 
Doukyu and Ogino, 2010; Serdakowski and Dordick, 2008; Zaks and Klibanov, 1985). 
 
 
 
 
Advantages 
 
 
 
 
 Increased solubility of most organic compounds in non-aqueous media 
 Ability to perform new reactions impossible in water because of kinetic or 
thermodynamic restrictions 
 Outstanding stability of enzymes 
 Relative easy product recovery from OS compared to water 
 Easy recovery and reuse, elimination of immobilization because of 
insolubility of enzymes in organic media 
 Suppression of water-dependent side reactions 
 Elimination of microbial contamination 
 Alteration of substrate specificity 
 
 
Disadvantages 
 Inactivation of enzymes 
 Labor and cost-intensive preparation of biocatalysts in covalently modified 
systems 
 Mass-transfer limitations for viscous solvents or heterogeneous systems  
 Necessity to control water activity for processes requiring condensation 
reactions 
 Problems with recycling biocatalysts in non-covalently modified systems 
 
Organic solvent reaction media can be divided into four groups (Figure 1-4): A) 
water/organic-solvent mixtures, B) two-phase systems (B1, B2, and B3), C) micro-aqueous 
organic-solvent mixtures and D) reversed micelles. Water/organic-solvent mixtures usually 
contain water with a small amount of water-miscible solvent. In contrast, a two-phase system 
consists in a water-immiscible OS in an aqueous buffer. Micro-aqueous organic mixtures are 
those OS in which dry enzymes are suspended and the available water is mainly located on 
the solid enzyme particles. Reversed micelles involve miniscule droplets, which are stabilized 
by a surfactant in a bulk of water-immiscible OS (Vermue and Tramper, 1995). 
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Figure 1-4: Groups of organic solvent reation media. A) water-miscible solvent, B1) two-phase system with low volume 
organic solvent and solubilized biocatylyst, B2) two-phase system with low volume organic solvent and immobilized 
biocatylyst, B3) two-phase system with high volume organic solvent and immobilized biocatylyst, C) micro-aqueous system, 
D) reverse micelles. White area represents water, small black dots represent organic solvent, big black dots represent 
biocatalyst, and white dots represent micelles. This figure was taken from (Vermue and Tramper, 1995) under a free common 
license. 
 
Within all these categories of OS, research effort in this thesis focusses on the first 
group concerning water-miscible OS. Indeed, the screening system used in this work is based 
on the lipase catalyzed hydrolysis reaction which is favored in reaction mixtures with high 
water content. In contrast, lipase catalyzed esterification reaction is favored in pure OS. It is 
noteworthy, that lipases are the first reported and most studied enzymes in OS (Gupta, 1992; 
Sharma and Kanwar, 2014; Zadlo et al., 2015; Zaks and Klibanov, 1984, 1988).  
1.1.2.1 Characteristics of OS 
Volatility, flammability, deleterious effects on health, safety and environment are few 
reasons why alternative solvents as ILs are sometimes favored to OS (Huddleston et al., 
2001). OS harbor a range of properties that should be considered for their utilization in 
synthesis reactions and processes. Hildebrandt solubility parameter (δ), dielectric constants 
(ε), dipole moments (μ), and LogP are properties that are associated with the prediction of 
enzyme activity in OS (Khmelnitsky et al., 1991; Laane et al., 1987). A high dielectric 
constant (ε) of the solvent commonly enhance the dissolution of ions while the dipole moment 
(μ) allows the determination of the solvent-solute molecules orientation (Chernyak, 2006). 
Hildebrandt solubility parameters (δ) describes the miscibility behavior of solvents (Belmares 
et al., 2004). LogP is the logarithm of the partition coefficient of the solvent in a two-phase 
system of 1-octanol and water and is used as a measure of the hydrophobicity/polarity of a 
solvent (Laane et al., 1987; Liu et al., 2009). Among these parameters, logP meets all the 
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requirements as good indicator since it is a direct measure of polarity unlike other parameters 
(δ, μ, ε), can be easily calculated, and is very sensitive for polarity differences in wide range 
(Laane et al., 1987). Thus, the polarity of OS can be classified in three categories using LogP: 
low polarity (logP < 2); moderate polarity (2 ≥ logP < 4); high polarity (logP > 4) (Laane et 
al., 1987). LogP has been reported to correlate with activity and stability of various enzymes 
at least a decreased lipase activity has been observed with decreased logP. For instance, no 
toxic effects were observed at high logP, unpredictable toxic effects were reported at 
intermediate logP and inactivation was found at low logP (Liu et al., 2009). Nonetheless, few 
examples have shown that logP does not always correlate with enzyme activity and stability. 
It seems to be applicable only for solvents of the same functionality such as polyols and 
alcohols (Khmelnitsky et al., 1991).  
1.1.2.2 Applications of OS 
One of the main advantages of applying enzymatic reactions in OS relies on the 
possibility to perform reactions which are not possible in water because of kinetic or 
thermodynamic restrictions and insolubility of most organic compounds (Arnold, 1990; 
Castro and Knubovets, 2003). New alternatives are possible and biotechnological 
applicability of enzymes is therefore increased. As a result, enzymatic reactions in OS can be 
applied for, 1) kinetic resolution of racemates in pharmaceutical and agrochemical companies, 
2) synthesis of chiral intermediates in chemistry, 3) modification of fats and oils 4) synthesis 
of sugar-based polymers, 5) gas phase biocatalysis, 6) biopolymers, 7) production of flavors 
and fragrances (Carrea and Riva, 2000; Choi and Yoo, 2012; Hari Krishna and Karanth, 2002; 
Schmid et al., 2001; Zumárraga et al., 2007a). 
1.1.3 Organic vs Ionic Liquids  
Several reports have clearly demonstrated that the catalytic mechanism observed for 
enzymatic reactions in ILs is similar to the one obtained in water and OS. Accordingly, De 
Diego and co-workers reported that stabilization of enzymes by ILs as well as by hydrophobic 
OS correlates to the preservation of their compact native structure, being associated with the 
preservation of the essential water shell (De Diego et al., 2004). As in OS, enzymes in ILs are 
presumed to require a microaqueous phase surrounding its structure (Ventura et al., 2012). 
Both affect enzyme performances in a similar manner. Although the effect of OS on enzymes 
performance has been reported to be similar to the effect of ILs, the latter however, dissolve 
and dissociate into individual anions and cations rather than being intact molecules (Yang et 
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al., 2009). Therefore, particular attention has to be paid to the effect of IL-ions on enzyme 
properties. Because of their excellent properties, better enzyme performance is sometimes 
achieved in ILs compared to OS. In Table 1-2, properties of ILs and OS are compared 
revealing the advantages and disadvantages of both non-conventional media. 
Table 1-2: Comparison between OS and ILs. This table was adapted from (Plechkova and Seddon, 2007) with the 
permission of Royal Society of Chemistry provided by Copyright Clearance Center. 
Properties OS Ionic liquids 
Number of solvents ≥1,000 ≥1,000,000 
Applicability Single function Multifunction 
Catalytic ability Rare Common and tunable 
Vapor pressure Mostly high Negligible under normal conditions 
Flammability Usually flammable Usually nonflammable 
Solvation Weakly solvating Strongly solvating 
Tunability Limited range of solvents available Virtually unlimited range (designer solvents) 
Polarity Conventional polarity concepts apply Polarity concept questionable 
Recyclability Green imperative Economic imperative 
Cost Normally cheap Typically between 2 and 100 times the cost of 
OS 
 
1.2 Protein Stability 
Proteins are linear polymer chains that consist of a combination of the 20 canonical 
amino acids. The sequence and arrangement of the amino acids is crucial since small changes 
in the order of amino acids affect the function. Proteins are essential in all aspects of cell 
function and as enzymes they catalyze biological processes under physiological conditions of 
the host organism (Illanes et al., 2012). The intact structure of a protein is essential for 
achieving a proper function. Four distinct categories of protein structure are known: primary, 
secondary, tertiary, and quaternary structure. The primary structure consists of the unique 
linear sequence of the amino acid residues in the polypeptide chain that is held together by 
covalent peptide bonds made during the process of protein biosynthesis. The secondary 
structure describes regions of periodic conformations (e.g. α-helix and β-sheet) resulting from 
hydrogen bonding along the peptide backbone. Alterations in α-helices and β-sheets can lead 
to denaturation and irreversible aggregation of proteins. Both primary and secondary 
structures of a protein contribute to its tertiary structure. The tertiary structure consists of the 
three-dimensional shape that is stabilized by hydrogen bonding, salt bridges, π-π stacking of 
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aromatic amino acids, as well as by covalent bonds (disulfide bridges) as illustrated in Figure 
1-5. The quaternary structure is an aggregation of two or more polypeptide subunits. 
 
Figure 1-5: Various types of interactions stabilizing proteins. Some examples between residue chains are shown. R= 
amino acid side chain, yellow represents electrostatic interactions, red represents hydrogen bonds and grey represents van der 
Waals interactions. This figure was reproduced from Essential Cell Biology, 4th Edition by Alberts et al. with the permission 
of Garland Science/Taylor & Francis LLC. 
1.2.1 Strategies for Stabilization of Enzymes  
Utilization of proteins in industrial processes requires high stability under process 
conditions. Indeed, enzymatic reactions in industries are sometimes performed with novel 
substrates or under extreme conditions of salt content, temperature, pH, or in the presence of 
inhibiting or denaturing chemicals (Brissos et al., 2008; Eijsink et al., 2005). Under such non 
physiological conditions, the native structure of proteins is destroyed and followed by the loss 
of its biological activity, which is closely connected with their native, three-dimensional (3D) 
structure. This influences the stability and strongly limits the biotechnological applicability of 
enzymes. In fact, enhanced stability has been reported to be a prerequisite for altering 
enzymatic activity (Bommarius et al., 2006).  
Protein stability can be defined as the preservation of the unique chemical and 3D 
structure of a polypeptide chain under aqueous conditions. The quantification of the stability 
can be achieved by breaking the native structure of a protein (Jaenicke, 1991). Denaturation 
or deactivation induces irreversible protein aggregation, which was proposed by Vagenende 
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and co-workers as a major manifestation of instability affecting protein functionality in vivo 
and in vitro (Vagenende et al., 2009). Protein stability results from a balance between 
destabilizing and stabilizing forces. The destabilizing forces are mainly due to the large 
increase in entropy of unfolding, and the stabilizing forces are provided by several types of 
non-covalent interactions. Disruption of any of these interactions may shift the balance and 
destabilize the protein (Wang, 1999). The thermodynamical definition of protein stability 
gives the difference in Gibbs free energy, ΔG, between the folded and the unfolded states. The 
unique factors affecting stability in this case are the relative free energies of the folded (Gf) 
and the unfolded (Gu) states. A larger and more positive ΔGu results in a higher stability of the 
protein (Pace, 1990). Since the information for the folding is coded in the amino acid 
sequence and folding is the primary function of the nascent polypeptide chain, biologically 
active proteins have to be properly folded. Proteins fold to minimize their free energy, leading 
to well-packed hydrophobic interiors and hydrophilic exteriors. Hydrophobic forces are major 
driving forces during the folding process (Dill, 1990). Maximizing function leads to active 
site clefts where charged and polar groups are secluded from water and where hydrophobic 
pockets are exposed to solvent (Sadana, 1987; Shoichet et al., 1995). Initially, it was 
demonstrated that folded conformations of proteins occur spontaneously from their linear 
chain in the appropriate environment, in most cases in milliseconds or less (Kubelka et al., 
2004). Isolation of new enzymes, medium engineering and enzyme engineering have been 
used as strategies to improve enzyme stability in non-aqueous solutions (Carrea and Riva, 
2000; Illanes et al., 2012; Stepankova et al., 2013). Few methods of these strategies are listed 
as well as their advantages and disadvantages are summarized in Table 1-3. 
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Table 1-3: Advantages and disadvantages of stabilization strategies. This table was adapted from (Stepankova et al., 2013) with the permission of American Chemical Society provided by 
Copyright Clearance Center. 
Strategy Advantages Disadvantages 
 Intrinsically stable 
enzyme 
 applicability in a variety of harsh environments  laborious and time-consuming screening, possibly 
problematic recombinant expression, 
 risk of altered stability and activity of enzymes produced 
in different hosts 
 immobilization  biocatalyst reuse, continuous mode of operation, in situ product 
recovery facilitated, 
 definition of biocatalyst microenvironment, enhanced  reaction 
rates, high volumetric productivities, 
 generally applicable procedures, enzyme activity and 
enantioselectivity can be tailored 
 mostly empirical, high cost, mass transfer limitations, loss 
of enzyme activity, loss of the enzyme due to leakage,  
 operational restraints, requirement for additional material 
and equipment, 
 immobility of enzyme molecules inside carriers, particle 
erosion 
 chemical 
modification 
 increased solubility of the enzyme in OS,  
 decreased substrate diffusion limitations, nontoxic solvents, 
 fast and simple procedure, knowledge of the enzyme structure not 
necessary, not limited to natural amino acids 
 differences between various batches, 
 enzyme needs to be modified each time 
 genetic 
modification 
 enzymes tailored for a target application, 
 “green” technology, no additional additives required 
 time-consuming, high cost, risk of improper protein 
folding, 
 detailed knowledge of protein structure often required 
 propanol-rinsed 
enzyme preparation 
 drying of the enzyme without denaturation  only a few reported examples,  
 risk of enzyme deactivation 
 ionic liquid 
coating 
 reduction of ionic liquid consumption, biocatalyst reuse, 
 ionic liquid properties tailored for target application 
 only a few reported examples, uncertain toxicity  
 high price of ionic liquids, risk of enzyme deactivation 
 additives  simple procedure, enhancement of the enzyme flexibility,  
 wide choice of additives available 
 complicated separation of additives from the product, 
 incompatibility with the reaction system 
 microemulsions  the enzyme is present in the aqueous phase,  
 increased solubility of substrates 
 risk of enzyme inactivation by the surfactant or  
 large interface between the two phases 
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Protein stability is affected differently by ILs and OS. Given the industrial significance 
of enzymes, unravelling the molecular basis for protein stability has been the focus of 
numerous studies. Therefore, structural features relevant for improvement of protein stability 
were summarized including surface regions, the hydrophobic core, access tunnels, binding 
pockets, the interface of the enzyme’s subunits disulfide bridges, surface charges, and isolated 
charges (Stepankova et al., 2013). The integrity of a protein structure is determined by 
intramolecular interactions (salt bridges, hydrogen bonds, and hydrophobic interactions) and 
its interactions with the surrounding solutes and solvents (Burley and Petsko, 1988; Dill, 
1990; Pace et al., 1996; Prabhu and Sharp, 2006). 
1.2.2 Factors Influencing Enzyme Activity and Stability/Resistance in Ionic 
Liquids (ILs) 
Due to their structure and diversity, ILs are able to participate in most types of 
interactions (hydrogen bonding, dipolar, ionic or charge-charge) (Anderson et al., 2002). 
Nevertheless, hydrogen bonding has been reported to be the most important factor that affects 
the interactions between enzymes and ILs. Therefore, this also has an impact on protein 
activity and stability as well as on maintenance of its native structure (Anderson et al., 2002; 
Huddleston et al., 2001; Kaar et al., 2003; Lou et al., 2006). 
Effects on activity, stability, and selectivity observed in ILs have been reported to 
correlate with several factors, such as anion nucleophilicity, hydrogen-bond basicity, 
excipients, impurities, pH, the overall enzyme–substrate–medium relationship (Fehér et al., 
2007) as well as IL polarity characterized by Reichart´s polarity (Park and Kazlauskas, 2003). 
Better stability was observed in solvents with higher polarity as they increase the solubility of 
polar substrates, resulting in faster reactions and changes in selectivity (Fehér et al., 2007). 
Nucleophilicity (defined as the ability of a nucleophile to accept an electrophilic C atom) and 
hydrogen bonding (defined as the ability of a base to accept an electrophilic H atom) are 
usually used to demonstrate the foremost importance of the IL-anion on enzyme properties 
(Anderson et al., 2002; Huddleston et al., 2001; Kaar et al., 2003; Lou et al., 2006; Yang and 
Pan, 2005). Hydrogen bond capacity increases with basicity, which also increases with 
nucleophilicity. A higher nucleophilicity leads to higher H-bond basicity, destabilizing the 
enzyme further. Moreover, decreased enzyme activity and stability have been demonstrated to 
correlate with increasing nucleophilicity (Sheldon et al., 2002; Zhao, 2010). It is noteworthy 
that ILs containing strong nucleophilic anions were revealed to interact with positively 
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charged amino acids of enzymes, enabling the breakage of internal hydrogen bonds or the 
formation of new hydrogen bonds that perturb the structure (Kaar et al., 2003; Lou et al., 
2006). Hydrophobicity/hydrophilicity have also been reported to influence the catalytic 
performance of enzymes (Yu et al., 2014). Hydrophobic ILs generally display low 
nucleophilicity/H-bond basicity, whereas hydrophilic ILs possess strong H-bond 
basicity/nucleophilicity. While hydrophobic ILs displayed stabilizing effects on enzymes, 
pure hydrophilic ones were reported to lower the activity or even deactivate enzymes (De Los 
Ríos et al., 2007). Indeed, ILs containing hydrophobic anions are inferred to change the 
secondary structure of enzymes resulting in enhanced interactions between substrate and 
active site (Dang et al., 2007). This structural change was observed by the stabilization of 
Candida antarctica lipase B (CALB) in hydrophobic ILs and was attributed to the evolution 
of α-helix to β-sheet secondary structure of the enzyme, resulting in a more compact enzyme 
conformation able to exhibit catalytic activity (De Diego et al., 2005). In addition, the authors 
assigned the increase in β-sheet content to the loss of hydrogen-bonding interactions between 
water molecules and α-helices. In contrast, ILs with hydrophilic anions have been reported to 
establish strong interactions via hydrogen bonding with enzymes causing enzyme deactivation 
(Ventura et al., 2012). Most hydrophilic ILs are reported to remove the crucial enzyme bound 
water molecules, which maintain enzyme structure and function (Moniruzzaman et al., 2010). 
However, addition of water to hydrophilic ILs can reduce the negative impact of ILs on the 
enzyme and can stabilize or even activate an enzyme when an appropriate amount of the 
mixture is used (Yu et al., 2014). Although some hydrophilic ILs are able to solubilize 
enzymes through weak hydrogen bonding interactions, most of them cause conformational 
changes in enzymes leading to deactivation (Yu et al., 2014). 
The Hofmeister series is commonly used to show the specific ions effects: inorganic 
salts and ions displayed different patterns of precipitating proteins according to a recurring 
sequence called the Hofmeister series (Hofmeister, 1888; Yang, 2009). The effect of ILs on 
enzyme properties (activity, stability, enantioselectivity) has also been interpreted in some 
cases based on the Hofmeister series (Constantinescu et al., 2007; Yang, 2009; Yang et al., 
2009; Zhao et al., 2006), according to the kosmotropic (structure-maker) and chaotropic 
(structure-breaker) properties of the ILs. However, several studies are not in accordance with 
this theory, which sometimes better correlates with the IL-cations rather than IL-anions. 
Impurities in ILs such as traces of water, residual solvents, halides, acids, unreacted starting 
materials, or metal salts considerably affect the enzyme performance (Seddon et al., 2009; 
Wasserscheid and Keim, 2000) and also have to be taken into consideration. Several attempts 
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to accurately predict enzymes stability in ILs have been made by studying enzyme classes 
such as hydrolases, and particularly lipases in ILs (De Diego et al., 2005; Madeira Lau et al., 
2000; Ventura et al., 2012). However, there is still a significant knowledge gap in 
understanding the chemistry of the interactions between enzymes and ILs. 
1.2.3 Factors Influencing Enzyme Activity and Stability/Resistance in OS  
Water activity, pH control, substrate-product solvation, enzyme form (e.g lyophilisate, 
immobilisate) and nature of the solvent are parameters, which can dramatically affect enzyme 
activity in OS (Carrea and Riva, 2000). Water activity plays a crucial role in the behavior of 
enzymes in non-conventional media as it acts as lubricant to enhance the conformational 
mobility of enzymes. In fact, water presence around and within an enzyme promotes its 
flexibility, which enables better substrate binding (Yang and Russell, 1996; Zaks and 
Klibanov, 1988). Structure and function of enzymes are also affected by the pH of the 
essential water layer around enzymes. The pH of a solution determines in which state amino 
acids are, due to the ionization/protonation of their characteristic groups (-COOH and -NH2) 
(Tomé et al., 2009). The protonation state of the different groups of an enzyme influence 
enzyme activity in aqueous solution as well as in OS. However, protonation states in OS 
cannot be as easily controlled as in water (Carrea and Riva, 2000). “Organic phase buffers” 
have been proposed to surmount the effect of pre-adjustment of pH in aqueous media before 
drying. Such buffers allow control of activity by adjusting pH/and or the ionizable state of 
groups on the enzyme molecules (Blackwood et al., 1994). Enzyme activity and specificity 
can also be influenced by varying the partition of substrates and products between the bulk 
organic phase and the microaqueous phase around the active site (Halling, 1994).  
Adding small to moderate concentrations of a water-miscible solvent has been shown 
to slightly affect enzymes properties resulting in an increase activity (Dordick, 1992). 
However, inhibitory effects on the enzyme have also been observed at higher concentrations 
(Vermue and Tramper, 1995). Reduced substrate binding and catalytic turnover are observed 
when non-conventional forces that maintain the active enzyme conformation are disrupted 
(Dordick, 1992). Additionally, higher conformational stability followed by denaturation can 
be observed when the water content of an organic solvent exceeds a certain concentration 
(total inactivation of enzymes mostly occurs at 60-70% v/v organic solvent) (Stepankova et 
al., 2013). An explanation for these findings is hypothesized to be the crucial role of water in 
enzymatic reactions. As already mentioned, enzymes are surrounded by a water layer, which 
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can be disrupted by the addition of OS. Removal of this water dramatically deforms the 
catalytically active enzyme conformation leading to enzyme inactivation (Natarajan, 1991; 
Zaks and Klibanov, 1985). As long as the water monolayer surrounding the enzyme remains 
intact, OS can replace the rest water without affecting its activity (Natarajan, 1991). Based on 
their results, Klibanov and Zaks assumed that the main factor in the effect of OS on enzymes 
is the interactions of the enzyme with the bound water and not with itself (Zaks and Klibanov, 
1985). The authors showed in case of the porcine pancreatic lipase that the water molecules 
were bound to the enzyme and could not be removed even by hydrophilic solvents (Zaks and 
Klibanov, 1985). This state is comparable to a nearly anhydrous organic medium, since the 
absolute water amount present in this monolayer is minimal (Natarajan, 1991). 
Avoiding inactivation of enzymes in OS is a crucial issue, which can be easily solved 
by a proper selection of the organic solvent (Natarajan, 1991). In the ideal case, the enzyme 
should be thermodynamically stable as well as catalytically active in the selected organic 
solvent (Natarajan, 1991). Depending on the polarity, solvents can modify the enzyme 
conformation, and thereby influence enzyme properties (Carrea and Riva, 2000) as enzymes 
behave differently in polar and non-polar OS. For instance, deformation of the enzyme 
surface by the solvent penetration effect was shown to induce a decreased enzyme stability in 
hydrophilic solvents (Gorman and Dordick, 1992; Yang et al., 2004) but not in hydrophobic 
ones. Decreased enzyme activity was reported to increase with solvent polarity reflecting the 
tendency of OS to strip water molecules from the enzyme surface (Yang et al., 2004). 
Although polar solvents offer a better reaction medium for numerous synthetic applications, 
they are unfortunately strong denaturants and rapidly cause enzyme deactivation (Martinez et 
al., 1992). Therefore, hydrophobic water miscible OS are preferentially used for enzymatic 
reactions. In contrast to hydrophilic OS, hydrophobic OS are unable to strip the essential 
water away from the enzymes thus avoiding inactivation (Klibanov, 2001; Serdakowski and 
Dordick, 2008). Only for those enzymes, in which the water is bound so tightly that they 
cannot be replaced by hydrophilic solvents, enzyme activity can be retained in hydrophilic OS 
(Natarajan, 1991). 
1.3 Protein Engineering 
Protein engineering has been used to obtain enhanced protein stability in OS and ionic 
liquids. Numerous solvent-resistant enzymes have been achieved through protein engineering 
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(Figure 1-6) and a good summary is available in the supplementary part of a publication 
reviewed by Stepankova and co-workers (Stepankova et al., 2013). 
 
 
Figure 1-6: Examples of solvent-resistant enzymes achieved by protein engineering. This figure was partly adapted from 
(Stepankova et al., 2013) with the permission of American Chemical Society provided by Copyright Clearance 
Center.*: First report in this work (chapter 3). 
Native enzyme properties are difficult to maintain under harsh reactions conditions 
(high pH, high temperature, presence of OS or ionic liquids), which usually destabilize and/or 
deactivate enzymes. Therefore, an approach, which can alter proteins to adapt them or even to 
enhance their properties in non-physiological conditions, is necessary. Protein engineering is a 
powerful approach based on genetic modification, which enables the generation of tailor-
made enzymes meeting the requirements of enzymes for application in industrial processes. 
Lipases for instance, have been intensively studied for biotechnological applications (Hasan et 
al., 2006). However, despite its good solvent stability, the wild type enzyme is not evolved for 
industrial processes since it generally fails to function under other non-physiological 
conditions. Protein engineering can be used to increase suitability of enzymes for large-scale 
Chapter 1: General Introduction 
 
20 
 
industrial applications through rational design, semi-rational design or directed evolution. 
Table 1-4 compares the approaches used in protein engineering. 
Table 1-4: Classification of protein engineering methods. This table was adapted from (Stepankova et al., 2013) with the 
permission of American Chemical Society provided by Copyright Clearance Center.  
Methods Prerequisites Techniques Descriptions 
Directed 
evolution 
Gene template 
A functional assay for selection 
or screening of improved variants 
 
Random 
mutagenesis 
 
 
 
 
Recombination 
techniques 
 
 
 
 
Saturation 
mutagenesis 
Mutations are randomly generated 
alongside the whole gene with a 
preferred mutation rate; however, 
statistically only one nucleotide in a 
codon can be changed per round 
 
Fragments from different variants of the 
gene are combined into a novel DNA 
molecule; beneficial mutations can be 
combined, while deleterious 
mutationsone are eliminated 
 
A degenerate oligonucleotide, which is 
randomized at a specific position , is 
incorporated within the coding sequence 
(e.g. at the hot spot identified by random 
mutagenesis) 
Rational 
design 
Knowledge of enzyme structure 
or a homology model,  
knowledge of structure-function 
relationships, computational design 
Site-directed 
mutagenesis 
Mutations are predicted computationally 
using enzymes structures, homology 
models, or sequence comparisons; a 
desired mutant is prepared using mutant 
synthetic oligonucleotides, which carry 
with the desired mutation at certain point 
Semi-rational 
design 
Knowledge of enzyme structure or a 
homology model, knowledge of structure-
function relationships, computational 
design. Functional assay for selection or 
screening of improved variants or direct 
characterization of a number of mutants 
Saturation 
mutagenesis 
A degenerate oligonucleotide 
randomized at a specific position is 
incorporated within the coding sequence 
according to computational design 
 
1.3.1 Rational Design 
Rational design is an information-intensive protein engineering approach that is based 
on in-depth knowledge of the enzyme structure and structure-function relationship. When 
enzyme’s crystal structure is not available, the structure of a homologous enzyme can be 
alternatively used to identify important residues. Computational biology plays a crucial role in 
the identification of such residues. Site-Directed Mutagenesis (SDM) is then subsequently 
applied to introduce site specific mutations in the selected positions to improve the targeted 
properties. Thus, small libraries are generated and the screening effort is reduced. Properties 
such as activity and selectivity are easily targeted by rational design as summarized in Table 
1-5 for engineering of of lipases. 
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Table 1-5: Examples of lipases engineered by rational design. EG = Ethylenglycol, SDM: site directed mutagenesis, 
epPCR: error-prone polymerase chain reaction, RMSD: root-mean-square deviation. 
Organism of 
origin 
Improved 
properties 
Methods Mutations References 
 
 
 
Candida 
Antarctica 
 
1.5-1.8-fold longer 
half-life in 80% 
methanol 
Rational design; 
lowering RMSD of the 
four solvent-affected 
sites, redesign using 
RosettaDesign 
algorithm 
4 mutations harboring 
hydrophilic or charged 
residues on the surface 
(Park et 
al., 2013) 
1.3-1.5-fold longer 
half-life in 80% 
DMSO 
Rational design  
5 mutants designed 
using 
Insight 2 
3 mutations (polar and 
charged  residues at the 
surface) increasing H-
bond interactions between 
surface side-chains and 
water molecules 
(Park et 
al., 2012) 
 Increased 
thermostability  
(4.5-fold higher half-
life at 50°C) 
Molecular dynamics 
(MD) 
simulation and SDM 
1 double mutation 
allowing new 
hydrophobic interactions 
and formation of a salt 
bridge and hydrogen bond  
(Le et al., 
2012) 
Bacillus pumilus Enhanced 
thermostability and 
increased kcat (4-
fold) 
SDM 1 mutation producing 
local conformation 
changes that possibly 
change the flexibility and 
mobility of amino acids 
(Bustos-
Jaimes et 
al., 2010) 
Pseudomonas 
aeruginosa LST-03 
Half-lives >100 days 
for 25% n-heptane, 
n-hexane, n-octane, 
n-decane, 
cyclohexane, 
toluene, and EG 
Rational design – 
SDM on mutants 
obtained in a previous 
study by epPCR 
(Kawata and Ogino, 
2009) 
4-9 mutations 
contributing to the 
formation of new 
salt bridges, new 
hydrogen 
bonds, filling the 
hydrophobic core and 
increasing pI of the side 
chains 
(Kawata 
and Ogino, 
2010) 
Rhizomucor miehei Increased 
thermostability in 
neat n-heptane 
Rational design - 
introduction of 
disulfide bonds by 
SDM 
2 substitutions forming 
disulfide bond 
(Han et al., 
2009) 
Geobacillus 
stearothermophilus 
Improved 
thermostability, 
2-fold improved 
methanolysis yield 
and 66-fold 
improved stability in 
methanol  
Structure-guide 
consensus 
1 mutation facilitating a 
closed lid conformation 
(Dror et 
al., 2014) 
 
1.3.2 Directed Evolution 
Directed evolution, which mimics Darwinian evolution in a test tube, is a powerful 
technique for altering the protein properties according to the one’s needs (Shivange et al., 
2009; Wong et al., 2006a). To achieve this goal, large mutant libraries are generated and 
desired mutants are identified via high-throughput screening (see section 1.4). Directed 
evolution enables improvement and understanding of important biocatalyst properties such as 
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activity towards non-natural substrates, resistance towards OS, tolerance towards molar 
concentrations of substrate and products, as well as pH and temperature stability (Wong et al., 
2007a). The advantage of directed evolution over rational protein design is that it does not 
require knowledge of the 3D structure of enzymes or the relationship among structure, 
sequence, and mechanism (Schmidt et al., 2004). Basic conditions for a successful campaign 
of directed evolution are an adequate mutation strategy for the improvement of the protein, 
the functional expression of the protein in a suitable microbial host as well, as a fast and 
reliable screening assay system for identification of improved enzyme variants (Bornscheuer 
et al., 1999). The process of directed evolution is usually repeated in iterative cycles of 
random mutagenesis and screening until the desired properties of the enzyme is reached. 
Schwaneberg and co-workers reviewed random mutagenesis methods, focused library 
generation methods and computational tools to achieve high-quality mutants (Wong et al., 
2006a, 2007b). They also proposed the KISS principle (Keep It Simple and Smart) as the best 
guideline to design a directed evolution campaign. This principle consists in 1) finding an 
appropriate point for directed evolution, 2) choosing a screening system and 3) selecting a 
strategy for the diversity generation at the gene level (Wong et al., 2006a). 
Error-prone PCR (epPCR) and Sequence Saturation Mutagenesis (SeSaM) are examples 
of techniques used to introduce random mutations into DNA. Due to its versatility and 
simplicity, epPCR is one of the most successful used random mutagenesis methods (Wong et 
al., 2004a). It is a fast and robust method using either unbalanced dNTPs or varying 
concentrations of Mn2+ and allowing mutant library generation with a limited diversity (Tee 
and Schwaneberg, 2007). However, owing to the degeneracy of the genetic code and the 
biased mutational spectra of DNA polymerases, epPCR is not truly random (Cline and 
Hogrefe, 2000) and has the disadvantage to favor transitions (C vs. T or G vs. A) leading to 
conservative amino acid exchanges (Wong et al., 2004a, 2005, 2008). Therefore, site 
saturation mutagenesis (SSM) is often additionally applied in directed evolution experiments 
at mutated positions identified via epPCR to generate subsequent mutations, which explore 
more diverse sequence space. In this way, further improved variants can be yielded by SSM 
(Wong et al., 2007a) enabling generation of substitutions, that would likely never have been 
found by routine procedures, such as epPCR (Kretz et al., 2004). An upgraded random 
mutagenesis method is SeSaM having the advantage to overcome limitations deriving from 
biased polymerases. SeSaM can target the sequence at every single nucleotide and regulate 
the mutational spectra through a universal base (Wong et al., 2004a, 2005). DNA Shuffling 
(Stemmer, 1994) and StEP (Zhao et al., 1998) are recombinant methods, which enable 
Chapter 1: General Introduction 
 
23 
 
accumulation of beneficial mutations in a separate gene and removal of deleterious ones. 
Directed evolution has been successfully used to improve some lipase properties (Table 1-6). 
Table 1-6: Examples of lipases engineered by directed evolution. epPCR: error-prone polymerase chain reaction; SSM: 
site-saturation mutagenesis. 
Organism of 
origin 
Improved properties Methods Mutations References 
Candida 
antarctica 
20-fold increase in half-
life at 70 °C 
epPCR 
 
2 mutations in hydrophobic 
sequence  with additive effects (1 in 
α-helix of the substrate-binding 
pocket) disrupting the hydrophobic 
stretch or decreasing the 
hydrophobicity 
(Zhang et 
al., 2003) 
P. aeruginosa 1.7-2-fold increase in 
amidase activity 
epPCR 3 mutations located near to the 
calcium binding site (α-helix8 and 
loops near to the surface no 
interactions with the catalytic triad 
and the oxyanion hole), cumulative 
effect in a double mutant 
(Fujii et al., 
2005) 
Geobacillus sp. 
NTU 03 
79.4-fold higher activity 
at 55°C; 
6.3–79-fold enhanced 
thermoactivity 
ep PCR 
and 
SSM 
1-5 mutations located on the lid of 
α6-helix increasing the 
hydrophobicity and electrostatic 
properties of the lid 
(Shih and 
Pan, 2011) 
Pseudomonas 
aeruginosa LST-
03 
3, 9, 5 and 11 times; 
longer half-life in 25% 
DMSO, cyclohexane, n-
octane, 
and  n-decane 
epPCR 1-6 mutations hindering 
penetration of organic 
solvents into the protein 
molecule, neutral/polar 
residues changed to basic 
residues 
(Kawata and 
Ogino, 
2009, 2010) 
Pycnoporus 
cinnabarinus 
144-fold enhanced 
thermostability and 20-
fold kcat/Km 
epPCR 1 acidic mutation resulting in 
extensive H-bond 
(Sharma et 
al., 2012) 
Geobacillus 
stearothermo- 
philus 
23-fold-improved stability 
in methanol  
epPCR 1 mutation facilitating a closed lid 
conformation 
(Dror et al., 
2014) 
 
1.3.3 Semi-rational Design 
Semi-rational design is an approach combining directed evolution and rational design 
to generate small, functionally enriched mutant libraries using rationally preselected target 
sites and limited amino acid diversity (Stepankova et al., 2013). To achieve this, semi-rational 
design uses information on protein sequence, structure and function, as well as computational 
predictive algorithms (Lutz, 2010). Semi-rational approaches include computer-based 
methods (Chica et al., 2005) as well as efficient experimental methods such as OmniChange 
(Dennig et al., 2011), Combinatorial Active-site Saturation Test (CAST) (Reetz et al., 2005), 
Gene Site Saturation Mutagenesis (GSSM) (Gray et al., 2001; Kretz et al., 2004), Structure-
based COmbinatorial Protein Engineering (SCOPE) (O’Maille et al., 2002), and Iterative 
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Saturation Mutagenesis (ISM) (Reetz and Carballeira, 2007). Among these methods, GSSM 
also referred as complete or Site Saturation Mutagenesis (SSM) is most widely applied. SSM 
allows the focused exploration of defined segments of the vast protein sequence space (Kille 
et al., 2013; Romero and Arnold, 2009) and offers the advantage to deeply study (Fowler and 
Fields, 2014) the effect on each single mutation on the protein. With other random 
mutagenesis methods, mutations are randomly targeted leading to loss of possibly important 
mutations. The main challenge in the generation of site saturation libraries is to overcome 
limitations due to the redundancy of the genetic code. A small high quality mutant library can 
easily allow the identification of hotspots, with a reduced screening effort (Quin and Schmidt-
Dannert, 2011). Therefore, strategies have been developed to reduce the size of the library 
using mutagenic primers. The commonly used ones are NNN (64 codons) (Wong et al., 
2006a), NDT (12 codons), NNK (32 codons) (Reetz et al., 2008); and NNS (32 codons) 
(Funke et al., 2005) covering all 20 canonical amino acids, with exception of NDT covering 
only 12 amino acids. N represents all 4 bases (A, C, T, G); K represents only two bases (G 
and T) as well as S (G and C), and D represents 3 bases (A, G, T). Compared to rational 
design and directed evolution, semi-rational design of lipases is not well studied. Examples of 
applying semi-rational approach to improve few lipases properties are illustrated in Table 1-7. 
Table 1-7: Examples of lipases engineered by semi-rational design. ACN: acetonitrile; DMF: dimethyl formamide; 
DMSO: dimethyl sulfoxide: ISM: iterative saturation mutagenesis. 
Organism 
of rigin 
Improved properties Methods Mutations References 
 
Bacillus 
subtilis  
Enhanced tolerance in 
50% organic co-solvents 
(ACN; DMF, DMSO)  
Semi-rational design of 
thermostability; B-FIT 
method with ISM at 6 
positions 
5 mutations 
stabilizing flexible 
surface loops 
(Reetz et 
al., 2006, 
2010) 
8 times higher catalytic 
turnover  in 60% DMSO 
Semi-rational design- 
saturation mutagenesis of 91 
residues in loops 
Cumulative effect in 
a mutant with 6 
mutations improving 
surface polarity 
(Yedavalli 
and Rao, 
2013) 
 
1.4 Protein Engineering for Improving IL and OS Resistance 
Oxidoreductases (e.g. laccase (Liu et al., 2013), formate dehydrogenase (Carter et al., 
2014)) and hydrolases (e.g. celullase (Chen et al., 2013; Lehmann et al., 2014; Pottkämper et 
al., 2009) were reported to have been successfully reengineered by protein engineering for 
improved IL resistance/tolerance. Very few reports (only six reports to the best of our 
knowledge) on improving IL resistance of enzymes are described (Carter et al., 2014; Chen et 
al., 2013; Lehmann et al., 2014; Liu et al., 2013; Nordwald et al., 2014b; Pottkämper et al., 
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2009). In contrast, organic solvent tolerance of numerous enzymes have been improved by 
protein engineering (Carrea and Riva, 2000; Klibanov, 2001; Stepankova et al., 2013) mostly 
by using directed evolution (Chen and Arnold, 1991, 1993; Dror et al., 2014; Kawata and 
Ogino, 2009; Kumar et al., 2006; Seng Wong et al., 2004; Song and Rhee, 2001; Takahashi et 
al., 2005; Zumárraga et al., 2007a, 2007b). Few cases for enhanced organic solvent stability 
by rational design have been reported (Dror et al., 2014; Kawata and Ogino, 2010; Martinez 
et al., 1992; Park et al., 2012, 2013; Takagi et al., 2000) and semi-rational design yielded in 
few cases organic solvent tolerant variants (Reetz et al., 2006, 2010; Yedavalli and Rao, 
2013). Despite first success stories on improving IL and organic solvent resistance, there is 
still lack of basic knowledge indispensable to understanding and improving enzyme towards 
ILs and OS. General design principles to guide protein engineering campaigns have still not 
been discovered and are therefore, deeply investigated in chapter 3 (ILs) and chapter 4 (OS) 
of this thesis. 
1.5 High-throughput Screening 
Directed evolution allows the generation of large mutant libraries consisting of 
innumerable protein variants. However, its success depends heavily on the efficiency of the 
screening strategy employed for the identification of target enzymes with desired properties. 
Therefore, the main challenge of a successful directed evolution experiment after generation 
of diversity is to develop a reliable, accurate, highly sensitive, and robust high throughput 
screening (HTS) assay (Yang and Withers, 2009; Zhang et al., 1999). The screening system 
has to be developed and optimized for each specific enzyme and reaction (Aharoni et al., 
2005). Various screening methods have been employed in protein evolution: solid phase 
screening, display technologies, and liquid screening systems (Wong et al., 2006a). Common 
methods for screening enzymes are based on microtiter plate or agar plate assays, which 
typically require the screening of up to 10
6
 variants using robotic automation (Leemhuis et al., 
2009; Yang and Withers, 2009). Solid phase screening on agar plates, filter papers or 
membranes are also often used (Lin and Cornish, 2002). Display technologies such as mRNA, 
ribosome, or phage-display can be applied to screen huge protein libraries (He and Khan, 
2005). Fluorescence-activated cell sorting (FACS) allows the analysis of multiple fluorescent 
parameters of individual particles (cells, microbeads, or emulsions) at rates of approximately 
10
7
 cells per hour, and isolate those with the targeted properties (Yang and Withers, 2009). 
FACS enables direct analysis of single cells or proteins and, thus, gain (ultra)high throughput 
by avoiding the transfer of individuals (Brakmann, 2001). Table 1-8 summarizes throughput, 
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principles and main advantages and disadvantages of various screening platforms. The most 
used assays in microtiter format are often spectroscopic assays based on chromogenic or 
fluorogenic substrates that have functional groups bearing a highly acidic phenol or aniline 
leaving group (Cohen et al., 2001). Widely used examples are nitrophenyl and umbelliferyl 
esters. 
Table 1-8: Summary of throughput, principles; and main advantages and disadvantages of screening technologies and 
formats. GC: gas chromatography, LS-MS: liquid chromatography–mass spectrometry, NMR: nuclear magnetic resonance, 
HPLC: high performance liquid chromatography. This table is taken from (Tee and Schwaneberg, 2007). 
Strategies Throughput Principles Main advantages Main disadvantages 
GC/LC-MS 
NMR, 
HPLC 
10
2 
- 10
4 Increased throughput of 
“classical” analytic 
methods;  
often adapted to 
sampling in 96-well 
plate format 
Enantioselective 
analytics 
Significant investments in 
equipment and comparably 
high running costs; low 
throughput 
Microtiter 
plate 
10
3 
- 10
5 Colorimetric or 
fluorometric reaction 
performed for each 
individual clone in each 
well of a microtiter plate 
Quantitative information 
derived for individual 
variant; accurate 
High expenses;  
medium throughput; 
laborious 
Solid phase 10
4 
- 10
6 Screening on a solid 
surface (agar plates, 
filter papers, 
membranes) 
High throughput; 
low costs 
Comparably low accuracy;  
often used as pre-screen for 
qualitative/semi-
quantification of activity 
Flow 
cytometry 
> 10
7 Sorting of individual 
cells based on the 
generated fluorescence 
Ultra High throughput; 
cells are directly isolated 
after screening (no 
replica required) 
Mode of detection limited 
to fluorescence; comparably 
low accuracy due to dye 
diffusion and variation in 
catalyst expression per cell 
Phage/cell 
display 
> 10
7 Proteins are displayed on 
the phage/cell surface 
providing phenotype and 
genotype linkage 
Ultra High throughput; 
powerful for improving 
protein affinities 
No general use as many 
enzymes cannot be 
displayed in active form;  
limited applicability for 
improving enzyme activity 
 
1.6 Lipases 
Lipases (triacylglycerol acylhydrolases, EC 3.1.1.3) belong to the enzyme family of 
hydrolases, which are the most important and studied enzyme class for biotechnological 
applications so far (Jaeger and Eggert, 2002). First reports on the lypolitic activity of lipases 
originate from the microbiologist Eijkmann around 1901 (Hasan et al., 2006). Since then, the 
number of available lipases has considerably increased, making them one of the most 
important groups of biotechnological relevant enzymes, with immense industrial applications. 
Lipase-catalyzed reactions are required in several industries for the production of important 
intermediates. Their ability to efficiently work in neat OS is an advantage exploited in 
industrial processes, as lipase-catalyzed reactions involve the use of water insoluble substrates 
Chapter 1: General Introduction 
 
27 
 
and products (Ogino and Ishikawa, 2001). Lipases find commercial and biotechnological 
applications in the production of food and dairy products, textiles, biodiesel, detergents, 
enantiopure pharmaceuticals, perfumes flavor enhancers and more. Lipases catalyze with high 
regio- and/or enantioselectivity the hydrolysis of triacylglycerols (Figure 1-7) under aqueous 
conditions whereby fatty acid and glycerol are released. They also have the unique ability to 
carry out the reverse reaction in OS, leading to esterification, alcoholysis and acidolysis 
(Gupta et al., 2004). 
 
Figure 1-7: Hydrolysis and synthesis of a triacylglycerol on the carboxyl ester bond. The forward reaction is a 
hydrolysis and the reverse reaction is an esterification.  
Lipase reactions usually take place at the lipid–water interface in a phenomenon 
known as interphase activation. This means that the rate of a lipase catalyzed reaction 
drastically increases, as soon as the critical micellar concentration (CMC) of the substrate is 
exceeded and an interface between the hydrophobic substrate and the aqueous environment is 
formed (Sarda and Desnuelle, 1958). High catalytic activity is detected only in the presence of 
a hydrophobic phase dispersed in an organic solvent or water. This property was used in 1958 
by Sarda and Desnuelle to classify and distinguish lipases from esterases, which display rather 
a classic Michaelis-Menten kinetic. The structural reason for this phenomenon was identified 
some years later, with the elucidation of the first 3D structures of two lipases showing the 
presence of a mobile α-helical domain termed “lid” covering the entrance to the active site 
cavity (Brady et al., 1990; Winkler et al., 1990). This lid is amphiphilic, meaning that it 
possesses hydrophobic amino acid residues on the inside and hydrophilic amino acid residues 
facing the aqueous phase. The reorientation of the lid takes place at the water – lipid interface 
(Verger, 1997). Due to the hydrophobic interactions between the outside of the lid and the 
lipophilic organic solvent, the lid moves enabling the interphase activation (Louwrier et al., 
1996). The active center is then consequently exposed and the substrate can enter the binding 
pocket (Verger, 1997). 
Some years later, lipases were described as having the ability to hydrolyze long chain 
fatty acids without an interphase activation or possessing a lid (van Pouderoyen et al., 2001). 
3 H2O
+
lipase
Triacylglycerol Glycerol Fatty acid
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Based on these observations, a new definition of lipases relative to their substrate spectrum 
was suggested (Verger, 1997) and is still the mostly used criteria to distinguish lipases from 
esterases. According to this criterion, the natural substrates of lipases are long chain 
triacylglycerols with low or no solubility in water whereas esterases prefer short chain fatty 
acids as substrate. In OS, lipases exhibit very good stability and remain enzymatically active. 
Additionally, some lipases display a remarkable chemo- and stereoselectivity and do not 
require cofactors. The availability of crystal structures of many lipases is a further attractive 
criterion facilitating the design of rational engineering strategies (Jaeger and Reetz, 1998). 
Although lipases are ubiquitously produced in the nature (plants, animals, bacteria and fungi), 
microbial lipases are more attractive for industrial purposes (Akbulut et al., 2013; Jaeger and 
Eggert, 2002; Saxena et al., 1999). One of the main reasons is their ability to operate in 
extreme environments, the wide diversity of their properties, and the substrate specificity 
(Patameswaran et al., 2010). This specificity allows reduction and complete elimination of 
unwanted side products that are normally formed in chemically catalyzed reactions (Ahmed et 
al., 2009). Subsequently, microbial lipases are good targets for genetic manipulations and 
possess promiscuous catalytic activity. High product yields and rapid growth (independent of 
seasonal fluctuations ) of microbial lipases is achieved on inexpensive cultivation media 
(Hasan et al., 2006). Some important lipase-producing bacterial genera include Bacillus, 
Pseudomonas, Burkholderia, Thermomyces and Staphylococcus (Gupta et al., 2004). 
Bacterial lipases are generally secreted in extracellular medium and are significantly 
influenced by factors, such as temperature, pH, inorganic salts, nitrogen and carbon sources 
(Gupta et al., 2004; Jaeger et al., 1994) for example the lipase A (LipA) from Bacillus subilis 
(BSLA), which was employed as model enzyme in this thesis. Based on the general 
conclusion that lipases remain enzymatically active in certain non-conventional media, much 
progress has been made in the fundamental understanding of the phenomena that governs this 
property. 
1.6.1 The Alpha/Beta Hydrolase Fold of Lipases  
Since the first elucidation of the crystal structure of two eukaryotic lipases around 1990 
many other lipase structures have been solved allowing a better understanding of the 
relationship between protein structure and its catalytic activity. A common characteristic of all 
lipases is the canonical α/β-hydrolase fold (Figure 1-8:A), which is also found in esterases, 
proteases and haloperoxidases. It constitutes a central β-sheet surrounded by six α-helices (αA 
to αF). The β-sheet consists of seven parallel (β1 and β3-β8) and an antiparallel (β2) strand. 
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The strands β3 to β8 are connected to each other by flexible loops and alternate with the six 
α-helices that arrange themselves on both sides of the folded sheet (Figure 1-8A). An 
exception to this model is found in the lipase A and B from Bacillus subtilis (BSL). The 
structure of these lipases comprises a six-stranded β-sheet, flanked by 5 α-helices that are 
arranged asymmetrically around the sheets (two on the one side, three on the other side). A 
comparison between the secondary structure elements of BSL and the canonical / 
hydrolase fold leads to the conclusion that BSL can be regarded as a minimal / hydrolase 
fold enzyme (Figure 1-8B) lacking a lid domain (van Pouderoyen et al., 2001). Aside from 
BSL, two other / hydrolase fold enzymes (from Fusarium solani (Longhi and Cambillau, 
1999) and Penicillium purpurogenum (Ghosh et al., 1999)) are known to lack lid domains. 
The small size of BSL is due to the absence of the two β strands (β1 and β2) of the canonical 
fold and the replacement of the αD helix by a small 310 helix in the crystal structure of BSL. 
 
Figure 1-8: General folding model of the α/β hydrolase. A: The canonic α/β hydrolase fold; B: Bacillus subtilis lipase 
(BSL). The position of the catalytic triad is marked with bold points. This figure was taken from (van Pouderoyen et al., 
2001) with the permission of Elsevier provided by Copyright Clearance Center. 
1.6.2 The Catalytic Mechanism of Lipases 
The catalytic triad of lipases is composed of Ser, Asp/Glu, His and also of a highly- 
conserved consensus sequence (Gly-x-Ser-x-Gly) around the active site serine (Jaeger et al., 
1999). The nucleophile residue (serine) is located behind the β5-strand, the acidic residue 
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(aspartate/glutamate) usually behind the β7-strand, and the histidine residue behind the β8-
strand as illustrated in Figure 1-8: (van Pouderoyen et al., 2001). These residues are 
responsible for the substrate binding and are found on the C-terminal end of the β-sheet 
(Nardini and Dijkstra, 1999). The structure of this catalytic triad is similar to the one observed 
in serine proteases, although it differs in the α/β hydrolase arrangement as follows: 
nucleophile, acid and histidine (Ollis et al., 1992). 
The reaction mechanism of lipases consists of an acylation (Figure 1-9A/B) and a 
deacylation step (Figure 1-9C/D). The catalytic cycle is initiated with the binding of the 
substrate to the catalytic center of the free enzyme (Kamal et al., 2012). The transfer of a 
proton occurs during a nucleophilic attack of the serine residue, via the oxygen atom of the 
hydroxyl group on the activated carbonyl carbon of the susceptible lipid ester bond (Figure 
1-9A). This proton transfer is considerably affected by the catalytic acid. This acidic residue 
is responsible for the correct orientation of the histidine by interaction with the imidazole ring, 
which partially neutralizes the generated charge (Jaeger et al., 1999). A tetrahedral 
intermediate, which is energetically and structurally most similar to the transient state is 
formed (Figure 1-9B). This is characterized by a negative charge on the carbonyl oxygen 
atom of the scissile ester bond and the four atoms bonded to the carbonyl group arranged as a 
tetrahedron. The stabilization of the formed intermediate occurs by the formation of hydrogen 
bonds between the negatively charged carbonyl oxygen atom and the amide function of the 
oxyanion hole (Jaeger et al., 1999). 
The next reaction step also called deacylation is characterized by the hydrolysis of the 
covalent intermediate by a water molecule. The active site histidine activates the water 
molecule by drawing a proton from it (Figure 1-9C) and the resulting OH
-
 ion attacks the 
carbonyl carbon atom of the acyl group, which is covalently attached to the serine (Figure 
1-9D). Once more, a transient negatively charged tetrahedral intermediate is formed and 
stabilized in the same way as the first tetrahedral intermediate. As soon as the proton at the 
histidine is transferred to the catalytic serine, the acyl group separates from the active serine. 
Consequently, a second reaction product is liberated by release of a fatty acid molecule 
(hydrolysis) or fatty acid ester (alcoholysis), which in turn drives the regeneration of the 
catalytic triad to its original state (free enzyme) able to enter a new reaction cycle (Jaeger et 
al., 1999). 
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Figure 1-9: Catalytic mechanism of lipases. Ser, His and Asp represent the catalytic active amino acids. A: nucleophile 
attack, B: transient tetrahedral intermediate, C: covalent intermediate (acyl enzyme), D second transient tetrahedral 
intermediate. This figure was taken from (Jaeger et al., 1999) under a free common licence. 
 
1.6.3 Lipases from Bacillus subtilis (BSL) 
Bacillus subtilis is a Gram-positive, aerobic, endospore-forming bacterium that 
produces and excretes lipases (lipA and lipB) and several other extracellular enzymes (van 
Pouderoyen et al., 2001). Bacillus subtilis is widespread in nature and is besides the Gram-
negative Escherichia coli, one of the best studied microorganisms (Juhas et al., 2014; Westers 
et al., 2004). Additionally, it is a non-pathogenic microorganism without lipopolysaccharide 
(LPS)-layer and classified as GRAS (generally regarded as safe) organism (Singh et al., 
2009). The extracellular lipolytic activity of B. subtilis was first observed around 1979 
(Kennedy and Lennarz, 1979). However, intensive molecular research did not start more than 
one decade later (1992) with the cloning and sequencing of a lipase gene, lipA (Dartois et al., 
1992). Afterwards, this lipase was recombinantly expressed, purified and characterized 
(Lesuisse et al., 1993). A second gene lipB was later identified as being 68% identical to lipA 
(Eggert et al., 2000) followed by its cloning, recombinant expression, purification and 
characterization. B. subtilis lipases have several biotechnologically interesting characteristics. 
They are the smallest lipases known with molecular masses of 19.4 kDa or 19.5 kDa and 
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chain lengths of only 181 and 182 amino acids, respectively. As previously mentioned, B. 
subtilis lipases possesses in contrast to most other lipases, no lid and do not show any 
activation in the presence of an oil-water interface. The catalytic serine is located on the 
surface (Figure 1-10: ) and freely accessible to solvents. In addition, both enzymes do not 
contain cysteine residues and are stable without disulfide bridges (Franken et al., 2011; 
Nthangeni et al., 2001). 
 
 
 
Figure 1-10: Crystal structure of Bacillus subtilis LipA (BSLA). PDB ID: 16WP, catalytic triad residues are highlighted: 
Ser77 (pink), His156 (green) and Asp133 (yellow). N: N-terminal and C: C-terminal. Yasara was used for visualization. 
Based on sequence similarities, differences in the conserved domains or motifs, and in 
the biological properties, bacterial lipolytic enzymes are classified into eight families 
(families I – VIII) (Arpigny and Jaeger, 1999). True lipases are grouped in family I, the 
largest group containing six subfamilies. Bacillus lipases have been placed in subfamilies 4 
and 5, in which alanine replaces the first glycine residue in the conserved G-X-S-X-G 
pentapeptide around the active site serine residue. Subfamily I4 consists only of five 
members: LipA and LipB from B. subtilis, a lipase from Bacillus pumilis, Bacillus circulans 
and Bacillus licheniformis which all share altogether 74-80% sequence identity (Arpigny and 
Jaeger, 1999; Bustos-Jaimes et al., 2010). This high sequence identity denotes a common fold 
for the whole family with the advantage that mutational effects observed in one member of 
the subfamily could possibly be reproduced in one of their member (Bustos-Jaimes et al., 
2010). Common characteristics of all enzymes of this subfamily are: monomeric, mature 
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forms with 181 amino acid residues and molecular masses close to 19.5 kDa (Bustos-Jaimes 
et al., 2010). 
The crystal structure of B. subtilis lipase A displays a globular protein with dimension 35 
Å x 36 Å x 42 Å (Figure 1-10). BSLA is considered as a “minimal”α/β hydrolase, whose 
catalytic triad consists of the amino acids Ser77, Asp133 and His156. The residues Ser 77 and 
His156 were reported to be directly involved in catalytic reaction, where they act as 
nucleophilic attacking groups and general acid-base catalytic elements, respectively. Asp133 
behaves as activator of His156 and assists in stabilization of positive charges developed on 
His156 during the reaction (Kamal et al., 2012). The backbone amide groups of residues Ile12 
and Met78 form the oxyanion hole, which is required for stabilization of the transient 
intermediate (van Pouderoyen et al., 2001). BSLA has an unusually high pI value of 9.9 
(Lesuisse et al., 1993) and consists of approximately 34% of hydrophobic amino acids. It 
shows maximum stability at pH 12. LipA is very tolerant to basic pH and has its optimum 
enzymatic activity at pH 10 (van Pouderoyen et al., 2001). Lipases generally prefer substrates, 
which are insoluble in aqueous solutions. Non-aqueous solutions such as OS or organic-
aqueous two phase media are advantageous for many lipase catalyzed reactions. Like LipA, 
LipB has the ability to hydrolyze short- and long-chain glycerol esters, showing highest 
activity with C8 fatty acid chains. However, LipB does not show activity in the presence of 
the typical lipase substrate triolein in contrast to LipA. Therefore, LipA is regarded as a true 
lipase, while LipB is an esterase (Eggert et al., 2000). 
 
1.7 Aim and Objectives 
The aim of the project was to systematically investigate and identify single amino acid 
substitutions and positions that contribute to the IL and organic solvent resistance of a model 
hydrolase, and to elucidate the underlying molecular principles governing this resistance. For 
this purpose, site saturation mutagenesis (SSM) libraries targeting the complete sequence of a 
Bacillus subtilis lipase A (BSLA) were generated and screened in presence of four ionic 
liquids and three OS. In depth analysis of the generated data set allowed for the first time to 
compare the resistance of BSLA evolution in in ionic liquids and OS. In addition, each used 
non-conventional media was ranked with regard to suitability of use with BSLA´s resistance. 
This project comprises the following steps: 
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 Generation of site saturation mutagenesis libraries targeting the first 91 BSLA amino 
acid positions. 
 Selection of four ionic liquids and three OS and setting up screening system in 
microtiter plate format in presence of the selected ILs and OS. 
 Screening of the SSM-BSLA libraries (1-181) in presence of the selected ILs and OS.  
 Systematic analysis of screening results in the following aspects: the number of 
positions and subtitutions leading to improvement and locations of the variants 
influencing BSLA resistance in ILs and in OS. 
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2  Optimization of Screening System in MTP Format 
2.1 Experimental Section 
2.1.1 Chemicals and Reagents 
All chemicals were of analytical grade or higher and were purchased from Sigma 
Aldrich (Steinheim, Germany), AppliChem (Darmstadt, Germany), Fluka (Neu-Ulm, 
Germany), and Carl Roth (Karlsruhe, Germany). All ionic liquids were synthetized by 
Io.Li.Tec (Ionic Liquids Technologies, Heilbronn, Germany). Enzymes and dNTPs were 
obtained from New England Biolabs (Frankfurt, Germany) and Sigma Aldrich (Steinheim, 
Germany). The HPLC-purified oligonucleotides applied for mutagenesis were obtained from 
GATC (Konstanz; Germany) and Eurofins MWG Operon (Ebersberg, Germany). The used 
oligonucleotides are summarized in Table 7-1 and Table 7-2. 
2.1.2 Media, Buffers and Additives 
All components for microbial cultivation media were sterilized by autoclaving at 
120 °C for 20 min and were either stored at room temperature or frozen as 1 mL aliquots at 
-20 °C until further use. The media additives and the antibiotics were prepared as 1000x stock 
by dissolving individual components in ddH2O followed by sterilization via filtration through 
a 0.2 μm sterile PVDF (polyvinylidene difluoride) filter (Carl Roth, Karlsruhe, Germany) and 
stored at -20 °C if not stated otherwise. Media additives were used in 1:1000 dilution in all 
media. Trace element solution was stored at 4 °C. 
Lysogeny Broth (LB medium): It contained 10 g/L peptone, 5 g/L yeast extract, 10 g/L 
NaCl; pH 7.5 adjusted with 1 M HCl or NaOH. Agar plates were prepared by adding Agar-
agar (15 g/L) additionally to the medium. The medium was supplemented with ampicillin to 
enable selection of resistant E. coli colonies after transformation with a vector carrying the 
ampicillin resistance gene.  
Super Optimal Broth with Catabolite Repression (SOC medium): It contained 20 g/L 
tryptone, 2 g/L NaCl, 5 g/L yeast extract and 2.5 g/L KCl. After autoclaving, the media was 
supplemented with separately sterilized solutions to achieve a final concentration of 10 mM 
MgCl2, 10 mM MgSO4 and 20 mM glucose. 
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Modified Auto-Induction Medium (termed as MAIM in the present work) (Studier, 
2005). LB-medium was used as pre-culture medium. This modified auto-induction medium 
consisted of three components, which were separately autoclaved before mixing under sterile 
conditions. 1. Medium component: consists of 12 g casein hydrolysate; 24 g yeast extract 
(better expression was obtained with the yeast extract from Merck); 5 g glycerol, fill up to 
800 mL with ddH2O; 2. Buffer component: consisted of 90 mL of 1 M Kpi (Potassium 
phosphate inorganic) buffer pH 7.0; (K2HPO4/KH2PO4); 3. Induction component consisted 
of 10 mL glucose (50 g/L), 100 mL lactose α-monohydrate (20 g/L). 
ZYP Medium (Studier, 2005): The pre-cultures were incubated in ZYP-505 medium 
containing 50 mL 20xNPS (66 g/L (NH4)2SO4, 136 g/L KH2PO4 and 142 g/L Na2HPO4), 
20 mL 50x505 (250 g/L glycerol and 25 g/L glucose dissolved in ddH2O) and 2 mL MgSO4 
(1 M) and filled to 1 L with ZY medium (10 g/L tryptone and 5 g/L yeast extract). The main-
cultures were grown in ZYP-5052 medium containing 50 mL 20xNPS, 20 mL 50x5052 
(100 g/L α-lactose, 250 g/L glycerol and 25 g/L glucose dissolved in ddH2O and 2 mL 
MgSO4 (1 M), filled to 1 L with ZY medium. 
LS-medium (Studier, 2005): It consisted in two media: 1) LSG-medium was used for pre-
cultures and consisted in: 20 mL 50xL, 20 mL succinate (1 M), 12.5 mL glucose (40% w/v); 
0.2 mL trace elements (1000x) and 2 mL MgSO4 (1 M). Fill to 1 L with ddH2O. 2) LS-5052 
medium was used for main-cultures and contained: 20 mL 50xL, 20 mL succinate (1 M), 
12.5 mL glucose (40% w/v); 0.2 mL trace elements (1000x) and 2 mL MgSO4 (1 M), filled to 
1 L with ddH2O. 
Trace Element Solution: consisted in 0.5 g/L CaCl2
*
2H2O, 0.18 g/L ZnSO4
*
7H2O, 0.1 g/L 
MnSO4
*
H2O, 20.1 g/L, Na2-EDTA, 16.7 g/L FeCl3
*
6H2O, 0.16 g/L CuSO4
*
5H2O dissolved in 
ddH2O. 
Ampicillin: 100 mg/mL antibiotic stock solutions were prepared with ddH2O and diluted to a 
final concentration of 100 µg/mL in microbiological cultivation media.  
Sørensen-Phosphate buffer: It was prepared through 17:1 mixture of solution A (50 mM 
Na2HPO4*2H2O) and solution B (50 mM K2HPO4) and pH was adjusted to 8.0 with HCl. 
Triethanolamine (TEA) buffer: 50 mM TEA buffer was prepared with ddH2O and the pH 
adjusted to 7.4 with 37% (v/v) HCl. 
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Potassium Phosphate (inorganic) Buffer (KPi-buffer): 50 mM KPi (pH 7.2) buffer was 
prepared using stock solutions of 1 M K2HPO4 and 1 M KH2PO4 and stored at room 
temperature until further use. 
Tris(hydroxymethyl)aminomethane Buffer (Tris/HCl buffer): 6.05 g/L Tris were 
dissolved in ddH2O water to prepare a 50 mM solution and pH values were adjusted to pH 7.5 
and 8.0 by titration with 37% (v/v) HCl. 
3-(N-morpholino)propansulfonic Acid Buffer (MOPS buffer): 10.47 g/L acid free MOPS 
were dissolved in ddH2O water to prepare a 50 mM solution and pH 7.2 was adjusted with 
10 M NaOH. 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic Acid Buffer (HEPES buffer): 11.92 g/L 
acid free HEPES were dissolved in ddH2O water to prepare a 50 mM solution and pH 7.09 
was adjusted with 10 M NaOH. 
2.1.3 Strains and Plasmids 
The strains E. coli DH5α and E. coli BL21-Gold (DE3) (Agilent Technologies; Santa 
Clara, USA) were used as hosts for DNA manipulation and recombinant protein expression, 
respectively (Table 2-1). The vector used in this work was pET22(b)+ (Novagen/Merck; 
Darmstadt, Germany) and is represented in Figure 7-1. Plasmid purification was performed 
employing the kit “NucleoSpin Plasmid kit” from Macherey-Nagel (Düren, Germany) 
according to the supplier’s recommendations, and DNA concentrations were quantified using 
the A260nm with a NanoDrop photometer (NanoDrop Technologies, Germany). 
 
Table 2-1: Strains and plasmid. 
Strains Genotypes/ description Origin 
E. coli DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rk
-
, mk
+
) phoA supE44 thi-1 gyrA96 relA1 λ- 
Agilent 
Technologies 
E. coli BL21-Gold (DE3) F
-
 dcm
+ 
Hte ompT hsdS(rB
-
 mB
-
) gal λ (DE3) endA Tetr a Agilent 
Technologies  
pET-22b(+) Expression vector, Amp
R
 Novagen  
Amp
R
: ampicillin resistance, Tet
R
: tetracyclin resistance. 
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2.1.4 Microbiological Methods 
2.1.4.1 Preparation of Electrocompetent Cells E. coli BL21-Gold (DE3) 
Electro competent E. coli cells were prepared by inoculation of a single colony of 
E. coli BL21-Gold (DE3) from a fresh agar plate containing 10 mL LB media followed by 
incubation (37 °C, overnight, 250 rpm) in a rotary shaker Certomat S2 (Sartorius, Göttingen, 
Germany). Two 500 mL flasks containing each 200 mL pre-warmed (37 °C) LB-medium 
were inoculated with the pre-cultures (1:200) and cultured (37 °C, 250 rpm) until an OD600 
of 0.5-0.6 was measured (BioPhotometer Plus, Eppendorf, Hamburg, Germany). The cultures 
were rapidly transferred to an ice-water bath for 10-15 min and swirled occasionally to ensure 
fast cooling. For optimal transformation efficiency, the centrifuge bottles were cooled in an 
ice-water bath and all following steps were performed at 4 °C or on ice under sterile 
conditions. After cooling, the cells were transferred into the ice cold centrifuge bottles and 
harvested by centrifugation (4 °C, 3000 rpm, 10 min) in a Eppendorf 5804R/5810R centrifuge 
(Eppendorf AG, Hamburg, Germany). The cell pellets were resuspended in 250 mL ice cold 
pure water and centrifuged (4 °C, 3000 rpm, 10 min). This step was repeated once and the 
obtained cell pellets were further resuspended in 200 mL ice cold 10 % w/v glycerol. After 
harvesting (4 °C, 3000 rpm, 10 min), the cells were resuspended in 500 µL ice cold 10% w/v 
glycerol, aliquoted (50 μL/tube) in sterile pre-cooled Eppendorf tubes, frozen in a bath of 
liquid nitrogen and stored at -80 °C. Before use, the transformation efficiency of each new 
stock was verified by transforming cells with 1 ng pUC19 plasmid DNA. Transformation 
efficiency of up to 1 x 107 cfu μg-1 pUC19 was achieved. 
2.1.4.2 Preparation of Chemically Competent E. coli DH5α 
Chemically competent E. coli cells were prepared using a modified standard protocol 
(Hanahan et al., 1991). To obtain better efficiency, aliquots from cryostock were used to 
spread agar plates and to obtain single clones. One single colony was picked from the agar 
plate and used for inoculation of 3 mL LB media, which was then incubated (37 °C, 16 h, 
250 rpm) in a rotary shaker Certomat S2 (Sartorius, Göttingen, Germany). Main culture was 
obtained by inoculation of 200 mL LB medium with 1 mL pre-culture in 1 L flask followed 
by incubation on a shaker (37 °C, 250 rpm) until an OD600 of 0.4 was measured 
(BioPhotometer Plus, Eppendorf, Hamburg, Germany). The culture was cooled on ice and 
subsequently harvested (4 °C, 4000 rpm, 10 min) in a Eppendorf 5804R/5810R centrifuge 
(Eppendorf AG, Hamburg, Germany). All following steps were carried on ice and under 
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sterile conditions. The cell pellet was resuspended in 15 mL filter sterilized ice cold TFB-1-
solution (30 mM potassium acetate, 50 mM manganese chloride, 100 mM rubidium chloride, 
10 mM calcium chloride, 15% w/v glycerol in ddH2O water) and incubated for 10 min on ice. 
The resuspended cells were centrifuged (4 °C, 3000 rpm, 10 min) and the obtained cell pellet 
was further resuspended in 2 mL filter sterilized ice cold TFB-2 solution (10 mM MOPS, 
75 mM calcium chloride, 10 mM rubidium chloride, 15% w/v glycerol in ddH2O). Competent 
cells were aliquoted (50 μL/tube) in sterile and pre-cooled Eppendorf tubes, frozen in a bath 
of liquid nitrogen and stored at -80 °C. Before use, the transformation efficiency of each new 
stock was verified by transforming cells with 1 ng pUC19 plasmid DNA. Transformation 
efficiency of up to 1 x 107 cfu μg-1 pUC19 was obtained. 
2.1.5 Molecular Biology Methods 
2.1.5.1 Cloning 
The template for all PCRs (pET22b(+)-BSLA WT) illustrated in Figure 7-2 was kindly 
provided by the research group of Prof. Jaeger (Research Center Juelich; Germany) that 
performed the cloning of Bacillus subtilis lipase A (BSLA) in a pET22b(+) vector (Figure 
7-1) (Novagen; Darmstadt, Germany) in a previous work (Eggert, 2001). The pET system 
from Novagen is a powerful system for the cloning and expression of recombinant proteins in 
E. coli, in which the coding sequence for the desired protein is placed in a plasmid under 
control of a T7 promoter. Expression is most commonly induced by Isopropyl-β-D-
thiogalactoside (IPTG) addition to the bacterial culture or using an auto-induction medium. 
The presence of the pelB signal sequence in pET22b(+) allows for protein secretion and 
directs proteins to the periplasmic space. From there, BSLA is unspecifically released into the 
culture medium. 
2.1.5.2 Site Saturation Mutagenesis 
Site saturation mutagenesis (SSM) (Barettino et al., 1994) libraries targeting the first 
91 amino acids of the BSLA sequence were generated using degenerated NNS (N=A/T/G/C 
and S=C/G) oligonucleotide primers encoding all 20 amino acids with 32 distinct codons 
(Table 7-1 and Table 7-2). A modified QuikChange PCR protocol (Wang and Malcolm, 1999) 
using pET22b(+)-BSLA as template was applied. Thermal cycler (Mastercyler gradient; 
Eppendorf, Hamburg, Germany) and thinwall PCR tubes (Multi-ultra tubes, 0.2 mL; Carl 
Roth, Germany) were used in all PCRs. The PCR mixture contained sterile water, 0.2 mM 
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dNTPs, 1x Phusion HF buffer, 17-20 ng/µL template DNA and 1 U of Phusion DNA 
polymerase (New England Biolabs, Frankfurt, Germany) in a total volume of 50 µL. For each 
targeted amino acid position, the reaction mixture was split into two tubes and 10 µM of 
forwards or reverse primers were respectively added in the corresponding tube. The first step 
of the reaction was performed using the following PCR program: 98 °C for 30 s, 1 cycle; 
98 °C, 10 s / 55 °C, 30  s / 72 °C, 130 s, 3 cycles). For the second PCR step, forward and 
reverse reaction products were mixed together. Following program was employed to obtain 
the expected products: 98 °C for 30 s, 1 cycle; 98 °C,10 s / 55 °C, 30 s / 72 °C, 130 s, 15 
cycles; 72 °C for 10 min, 1 cycle). The PCR products were verified by agarose gel 
electrophoreses before further use. 
The SSM for the last 90 BSLA amino acid positions were performed in the frame of a 
BioNoCo project cooperation by Alexander Fulton (Institute for Molecular Enzyme 
Technology (IMET), Research Center Juelich (FZJ), research group of Prof. Jaeger) (Fulton et 
al., 2015). 
2.1.5.3 Agarose Gel Electrophoresis 
DNA quality control was performed by agarose gel electrophoresis as described by 
Sambrook and Russell (Sambrook and Russell, 2001) using a 1.0% (w/v) agarose gel. The gel 
was prepared by heating agarose powder after dissolution in 1X TAE-buffer (TAE-buffer 
(50X): 2 M Tris, 1 M glacial acetic acid, 50 mM EDTA dissolved in ddH2O water pH 8.0) 
and stored at 65 °C. The gels were cast after pre-mixture with Roti-Safe GelStain (Carl Roth, 
Karlsruhe, Germany) and used after solidification at room temperature. DNA samples (3 µL) 
were mixed with 0.5 µL 6x loading dye (10 mM Tris-HCl, pH 7.6; 0.03% (w/v) bromophenol 
blue, 0.03% (w/v) xylene cyanol, 60% (w/v) glycerol; 60 mM EDTA) and loaded along with 
a DNA ladder (GeneRuler 1 kb DNA Ladder, Fermentas, St. Leon-Rot, Germany) for 40 min 
at 110 V. DNA samples were visualized on agarose gels in an UV illuminator (Gel 
documentation U: Genius, Syngene, Cambridge, England) connected with a gel scanning 
system. In case of successful PCR, the methylated template DNA was hydrolyzed by DpnI 
restriction enzyme (40 U; 37 °C, 16 h) and stored (at 4 or -20 °C) for further use. 
2.1.5.4 Transformation of DNA into Electrocompetent E. coli BL21-Gold (DE3) 
Electroporation was used for the transformation of DpnI digested PCR products into 
electro competent E. coli BL21-Gold (DE3) cells. Electroporation is a procedure in which 
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electric pulses of intensity in kilovolts per centimeter and of duration in microseconds to 
milliseconds induce a temporary loss of the semipermeability of cell membranes, resulting in 
ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, 
and DNA (Tsong, 1991). The presence of salts in PCR products can inhibit the transfer of the 
voltage and therefore reduce the efficiency of the transformation. To avoid that, PCR samples 
were purified by PCR drop dialysis on small membranes (MF Millipore membrane 0.025 μm 
diameter, Merck KGaA, Darmstadt, Germany) following the manufacturer´s instructions. 
Each purified sample (5 µL) was added to a tube containing 50 µL electro competent cells 
which were previously thawed on ice and the mixture was incubated on ice for 5 min. The 
competent cells were electroporated at 1700 V using electroporator 2510 (1 mm electrode 
distance, Eppendorf AG, Hamburg, Germany). Subsequently, 450 µL SOC medium were 
directly added to the transformed cells and the tubes were incubated (45 min, 37 °C, 250 rpm) 
for cell regeneration. The regenerated cells were spread on LBAmp agar plates following by 
incubation overnight at 37 °C. 
2.1.5.5 Generation of BSLA Mutant Libraries  
Single colonies obtained after transformation of the PCR products from 91 SSM were 
picked from LBAmp agar plates to MTP for master plates preparation. For each SSM library, 
92 BSLA clones were picked to 150 µL LBAmp medium in 96-well microtiter plate (MTP) 
(flat-bottomed, polystyrene plates, Greiner Bio-One GmbH, Frickenhausen, Germany). In 
addition, three BSLA WT clones and one empty vector clone (EV) were used as control in the 
same MTP (Figure 2-1). The cultures were incubated at 37 °C (70% humidity, 900 rpm) for 
16 h in an Infors microtiter plate shaker (Infors GmbH, Eisenach, Germany). Subsequently, 
the plates were stored as master plates at -80 °C after addition of 50 µL of 50% (w/v) sterile 
glycerol to each well. 
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Figure 2-1: Scheme for MTP arrangement of generated SSM libraries. White colored wells contain SSM-BSLA variants, 
blue colored wells contain the WT (positive control, for SSM-BSLA 1-91: A1; D6 and H12; for SSM-BSLA 92-181: A12, 
D7 and H1) and red colored wells contain the EV (negative control, E7 for SSM-BSLA 1-91 and D6 for SSM-BSLA 92-
181). 
2.1.5.6 Quality Control of Generated Libraries 
To ensure high diversity in the generated 91 SSM libraries (amino acid position 1-91 
in this work) as well as the 90 SSM libraries (amino acid position 92-181) generated in 
another study (Fulton et al., 2015), quality control was carried out by sending all libraries for 
sequencing. The libraries were replicated (replicator, EnzyScreen BV, Leiden, Netherlands) 
from the corresponding master plates and cultured (37 °C, 70% humidity, 900 rpm, 16 h) in 
an Infors microtiter plate shaker (Infors GmbH, Eisenach, Germany). Each 10 µL culture/well 
was used to inoculate a LBAmp agar MTP (150 µL/well LBAmp agar medium with 13 g/L agar) 
using a multi-channel pipette (Eppendorf AG, Hamburg, Germany). The agar MTPs were 
incubated overnight (37 °C, 16 h) and after sterile sealing with lids, they were sent for 
sequencing (Eurofins MWG Operon, Ebersberg, Germany). 
2.1.6 Site Directed Mutagenesis  
Site directed mutagenesis (SDM) was performed after results analysis of sequenced 
SSM libraries to generate missing substitutions. The same protocol as described for SSM 
(2.1.5.2) was applied to generate the missing clones however, using SDM primers (Table 
7-2). The efficiency of the SDM was verified on agarose gel and the products were digested 
(2.1.5.3) and stored (4 °C or -20 °C) for further use. 
2.1.6.1 Chemical Transformation in E. coli DH5α 
Transformation of SDM products was performed using chemically competent E. coli 
DH5α cells. DNA (5 µL) was added to 50 μL (on ice) thawed competent E. coli cells 
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followed by 30 min incubation on ice. DNA uptake by E. coli cells was achieved by heat-
shock treatment in a water bath (42 °C, 45 s), followed by incubation 2 min on ice. Cell 
regeneration was achieved by addition of 900 μL SOC medium followed by incubation 
(37 °C, 45 min and 250 rpm). The regenerated cells were spread on LBAmp agar plates and the 
agar plates were incubated overnight at 37 °C. The obtained clones were cultured (45 min, 
37 °C, 250 rpm) in 3 mL LBAmp medium and plasmid extraction and purification was 
performed using the NucleoSpin Plasmid kit from Macherey Nagel (Düren, Germany) 
following the supplier´s instructions. DNA Concentrations were determined with the 
NanoDrop spectrophotometer 1000 (Thermo Scientific, Wilmington, USA). The purified 
DNA samples were sent for sequencing (Eurofins MWG Operon, Ebersberg, Germany) and 
by confirmation of the point mutations, the samples were transformed into E. coli BL21-Gold 
(DE3) (2.1.5.4) and proceeded as described before (2.1.5.5) however, with a different 
repartition of the variants in MTPs (Figure 2-2). 
 
Figure 2-2: Scheme for MTP arrangement of generated SDM libraries. White colored wells contain SDM-BSLA 
variants, blue colored wells contain the WT (positive control: A1; A2, A12, D6, D7, H1, and H12) and red colored wells 
contain the EV (negative control, A1, E6, and H2). 
2.1.6.2 Selection of BSLA Expression Medium in pET22b(+) 
BSLA wild type clones were used to investigate the optimal medium for BSLA 
expression. Therefore, three different auto-induction media (ZYP-5052, LS-5052, and MAIM, 
see 2.1.2) were selected and used for flask expression. The strain E. coli BL21-Gold (DE3)/ 
pET22b(+)-BSLA WT was first cultivated in 5 mL pre-culture media (see 2.1.2) inoculated 
with an aliquot from the cryostocks and cultivated overnight at 37 °C in a rotary shaker 
Certomat S2 (Sartorius, Göttingen, Germany). A strain with the empty vector was used as 
negative control. Main cultures were grown in 300 mL flask after inoculation of 50 mL auto-
induction media containing lactose as inducer with each 1 mL pre-culture. Samples were 
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harvested after incubation (37 °C, 12 h, 250 rpm) by centrifugation (Eppendorf 5804R/5810R, 
4 °C, 4000 rpm, 20 min) and the supernatants were diluted (1:2) and used for activity 
measurements with pNPP (p-nitrophenyl palmitate) as substrate (Gupta et al., 2002). BSLA 
activities in the three auto-induction media were compared and the best medium was selected 
for BSLA expression of the generated SSM and SDM libraries. 
2.1.6.3 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis  
Protein samples were evaluated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) as described previously (Sambrook and Russell, 2001). 
12% SDS-PAGE were obtained by casting stacking gel over the resolving gel. The resolving 
gel (for 2 gels) consisted in 4.2 mL ddH2O, 3 mL acrylamide mix (30% v/v), 2.5 mL Tris 
(1.5 M, pH 8.8), 50 μL SDS (10% w/v), 0.1 mL ammonium persulfate (APS; 10% w/v) and 
4 μL TEMED. The stacking gel (for 2 gels) contained 1.44 mL ddH2O, 0.26 mL acrylamide 
mix (30% v/v), 0.25 mL Tris (0.5 M, pH 6.8), 20 μL 10% w/v SDS, 20 μL 10% w/v APS and 
2 μL TEMED. Samples were collected after expression and prepared by incubating 20 μL of 
protein sample with 6 μL 4xSDS-PAGE loading buffer in a thermostat (Eppendorf, Hamburg, 
Germany) for entire denaturation of peptides (95 °C, 10 min). Each 5 µL sample as well as a 
pre-stained reference protein ladder (10-170 kDa, Fermentas, St. Leon-Rot, Germany) was 
loaded on the SDS-PAGE gel. The protein fractions were separated by gel electrophoresis in 
1 X SDS-buffer (0.3%  w/v Tris, 1.5% w/v glycine, 0.1% w/v SDS in ddH2O) at 30 mA for 
75 min using a Mini-Protean Tetra Cell system (Bio-Rad, München, Germany). For 
visualization of protein bands, the gels were stained in Coomassie Brilliant Blue solution 
(0.25% v/v coomasie, 45.5% v/v methanol, 9.2% v/v acetic acid) for 20 min followed by de-
staining in 10% (v/v) acetic acid solution overnight. 
2.1.6.4 Cultivation and Expression in 96-well Plates  
For expression of the generated variants, each master plate was thawed, replicated into 
a new 96-well MTP (flat-bottomed, polystyrene plates; Greiner Bio-One GmbH, 
Frickenhausen, Germany) containing LBAmp medium (150 µL per well) using a replicator 
(EnzyScreen BV, Leiden, Netherlands), then covered with a plastic lid and cultivated for 24 h 
(37 °C, 70% humidity, 900 rpm). Afterwards, the pre-cultures were replicated into new 
96-well MTPs (V-bottomed, polystyrene plates; Greiner Bio-One GmbH, Frickenhausen, 
Germany) containing a modified auto-induction medium (Studier, 2005) (2.1.2) supplemented 
with ampicillin (150 µL per well). The expression was stopped after 16 h (900 rpm, 37 °C, 
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70% humidity) and the OD600 values were measured. BSLA is released into the culture 
supernatant when the vector pET22b(+) is employed in E. coli BL21-Gold (DE3) due to the 
pelB-signal sequence of the vector which enables the translocation of the lipase in the 
periplasma as previously described (Funke et al., 2005; Reetz et al., 2007; Yedavalli and Rao, 
2013). The supernatant was therefore, harvested by centrifugation (Eppendorf 5804R/5810R, 
4 °C, 4000 rpm, 20 min) and used for activity measurements. 
2.1.7 Biochemical Methods 
2.1.7.1 Selection of Substrates for BSLA in MTP Based Screening System 
Although BSLA is described to exhibit maximum activity towards substrates with C8 
chain length, the C16 substrate p-nitrophenyl palmitate (pNPP) is widely used for lipase 
activity detection. In addition to pNPP, the C8 substrate p-nitrophenyl caprylate (pNPC) and 
the C4 p-nitrophenyl butyrate (pNPB) were selected to be characterized. Detection of lipase 
activity for the wild type clones was performed with a modified protocol of Winkler and 
Stuckmann (Winkler and Stuckmann, 1979) using a spectrophotometric assay. The substrate 
solution (8 mM, in isopropanol) was mixed (in ratio 1:18) with Sørensen phosphate buffer 
with pH 8 (2.1.2), supplemented with 5 mM NaDOC (sodium desoxycholic acid) and 
1 mg/mL gum arabic to 0.4 mM final concentration. Afterwards, 180 µL of the substrate 
emulsion were added to 20 µL of the supernatant. Absorbance at 410 nm was recorded in an 
endpoint measurement using a MTP reader (Tecan infinite
®
 M200Pro Austria GmbH, 
Männedorf, Switzerland) after 10 min incubation at room temperature on a Bench top shaker 
Certomat (Sartorius, Göttingen, Germany).  
2.1.7.2 Selection of Buffer 
Different buffers (2.1.2) were used to investigate the stability of BSLA in presence of 
co-solvents. Kpi (50 mM; pH 7.2), MOPS (50 mM, pH 7.2), Tris-HCl (50 mM, pH 7.5), Tris-
HCl (50 mM, pH 8.0), HEPES (50 mM, pH 7.1), and TEA (50 mM, pH 7.4). Reactions were 
carried out in glass test tubes (Sigma Aldrich, Steinheim, Germany) by incubating 500 µL co-
solvent (50% v/v in the incubation mixture before adding the substrate solution) with 400 µL 
buffer and 100 µL supernatant. DMSO (dimethyl sulfoxide), TFE (2,2,2,-trifluoroethanol) and 
[BMIM][Cl] (1-Butyl-3-methylimidazolium chloride) were the co-solvents used in this part. 
The mixtures were incubated (2 h, 1000 rpm, RT) in glass test tubes on a Bench top shaker 
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Certomat (Sartorius, Göttingen, Germany). Afterwards, 1000 µL of the selected substrate was 
added to the incubation mixture and pH shifts were measured. 
2.1.7.3 pNPB Assay in MTP for BSLA Activity Measurement 
Microtiter plates (96-well) were used for the screening of lipase activity based on the 
degradation of esters of chromogenic phenols. The activity is most generally determined 
spectrophotometrically using a p-nitrophenyl ester as substrate. This method is based on the 
quantification of the level of released p-nitrophenolate (λmax 400 to 410 nm) followed by 
hydrolysis of the substrate by lipase (Figure 2-3). In this work, p-nitrophenyl butyrate (pNPB) 
was selected as substrate to detect the activity in the generated BSLA libraries (Shirai et al., 
1982). The standard deviation of the assay (2.1.7.4) was determined by the addition of 90 µL 
of assay buffer or co-solvent to 10 µL of supernatant and 100 µL of the freshly prepared 
substrate solution (0.5 mM pNPB final concentration instead of 0.4 mM used for all three 
substrates in (2.1.7.1)), 10% (v/v) acetonitrile and 90% (v/v) TEA buffer (pKa 7.76, pH 7.4, 
50 mM)). Afterwards, the release of p-nitrophenol was recorded (410 nm, RT, 8 min) each 
20 sec on a MTP reader (Tecan infinite
®
 M200Pro Austria GmbH, Männedorf, Switzerland).  
 
Figure 2-3: Schematic overview of an assay based lipase hydrolysis reaction. p-Nitrophenyl butyrate (pNPB) was used as 
substrate. The formation of p-nitrophenolate is detected by the intensity of the yellow colorat 410 nm. 
 
To determine the p-nitrophenol production by BSLA during the assay and the linear 
range of the assay, a calibration curve was prepared using different concentrations (0-4 mM) 
of a p-nitrophenol standard solution. 
2.1.7.4 Standard Deviation of pNPB Assay in Buffer 
After optimization of all factors (expression medium, substrate and buffer) necessary 
for screening of SSM-BSLA libraries, the standard deviation of pNPB assay was determined. 
Therefore, a 96-well MTP containing only BSLA WT and another 96-well MTP containing 
p-nitrophenyl butyrate (pNPB)
H2O+
BSLA
+ H+
butyratep-nitrophenolate
+
H+
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only EV were cultured and assayed as mentioned above (2.1.6.4) and 90 µL assay buffer was 
added to each 10 µL supernatant followed by activity measurement (2.1.7.3). 
2.1.7.5 Selection of Non-conventional Media  
For an ideal investigation of enzymatic reactions in OS, several factors should be 
investigated such as cofactor independence, availability and cheap enzymes, non-reaction of 
water as well as solubility of substrates in the used OS (Zaks and Klibanov, 1985). BSLA 
meets all this requirements. The aim therefore, in this part was to select non-conventional 
media for the investigation of BSLA WT solvent resistance. An important factor for the 
selection of the non-conventional media for BSLA screening was the water-miscibility of the 
solvent since the reaction system of the assay is a hydrolysis. Three OS with different 
polarities and four different ionic liquids (ILs) should be selected. The experiments were 
carried out in 96-well MTPs. In the first steps of the experiment, two OS and eight ILs (Table 
2-2) were analyzed. Each 10 µL supernatant (BSLA WT or EV) was incubated (2 h, 
1000 rpm, RT) on a shaker (Edmund Bühler Microtiter shaker, Hechingen, Germany) with 
50% (v/v) co-solvent (or buffer as control). The freshly prepared substrate solution 
(100 µL/well) was added to the incubation mixture and the absorbance was measured 
(410 nm, 8 min, RT) in a MTP reader (Tecan infinite
®
 M200Pro Austria GmbH, Männedorf, 
Switzerland).  
Table 2-2: List of first selected three OS and eight ILs. 
OS Ionic liquids 
DMSO: dimethyl sulfoxide  [BMIM][Cl] : 1-butyl-3-methylimidazolium chloride 
1,4-dioxane [BMIM][TfO]: 1-butyl-3-methylimidazolium trifluoromethanesulfonate 
TFE: 2,2,2-trifluoroethanol [BMPy][TFA]: 1-methylpyrrolidinium trifluoroacetat 
 [EMIM][MMPO4]: 1-ethyl-3-methylimidazolium dimethyl phosphate 
 [EMIM][TFA]: 1-ethyl-3-methylimidazolium trifluoroacetat 
 [EMIM][MeSO3]: 1-ethyl-3-methylimidazolium methanesulphate 
 [EMIM][MeSO4]: 1-bthyl-3-methylimidazolium methylsulphate 
 [MMIM][MMPO4]: 1,3 dimethylimidazolium dimethyl dimethyl phosphate 
[BMIM][Cl] obtained as solid were dissolved by adding water while stirring (2-3 days) 
until homogenous IL solutions were obtained. In order to determine the concentration for 
screening, each non-conventional media was supplemented with the assay buffer to obtain OS 
or IL solutions with different concentrations. Concentrations leading to a residual activity of 
the BSLA WT between 30% and 40% were chosen for screening. The screening assay with 
ILs was performed in polystyrene MTPs (flat-bottomed, polystyrene plates, Greiner Bio-One 
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GmbH, Frickenhausen, Germany) while screening with OS was performed in polypropylene 
MTPs (flat-bottomed, polystyrene plates, Greiner Bio-One GmbH, Frickenhausen, Germany), 
which are resistant to the aggressivity of some OS as 1,4-dioxane. 
2.2 Results and Discussion 
2.2.1 PCR Amplification by SSM and SDM 
Site saturation mutagenesis (SSM) was performed at every amino acid position of 
BSLA to elucidate the contribution of each amino acid substitution at each position of BSLA 
IL resistance and OS resistance. Obtaining the expected full diversity coverage remains an 
ideal goal of each SSM experiment. To achieve this goal, the choice of the appropriate 
degenerate codon plays an important role. NNS codons were selected to reduce the amount of 
possible inactive variants resulting from introduction of stop codons. NNS and NNK 
degenerated primers encode all 20 canonical amino acids with the advantage of creating 32 
codons and only one stop codon instead of 64 codons and three stop codons as observed with 
NNN codons. In total, 181 SSMs and 341 SDMs were performed (after sequencing of SSM 
libraries, missing substitutions were generated by SDMs to complete the libraries). The 
success of the SSM and SDM amplifications was verified on 1% agarose gel (Figure 2-4). 
The amplified products with expected size of 6019 bp were digested with DpnI as described 
before (section 2.1.5.3) and used for electro transformation in E. coli BL21-Gold (DE3) 
(section 2.1.5.4) or chemical transformation in E. coli DH5α (section 2.1.6.1). 
 
 
Figure 2-4: Exemplary agarose gel for SSM and SDM (QuikChange) at selected BSLA amino acid positions. 3 µL of 
each sample were mixed with 0.5 µL 6X loading dye and loaded. M (DNA marker, GeneRuler 1 kb DNA Ladder, Fermentas, 
St. Leon-Rot, Germany) is used for estimation of obtained DNA fragment sizes; NC= negative control. The expected size for 
each product was 6019 bp. 
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2.2.2 Sequencing of Generated Libraries 
In total, 91 SSM-BLSA libraries were generated in RWTH Aachen (this work) and 90 
SSM-BLSA libraries (Fulton, 2015) were generated in Research Center Juelich (Alexander 
Fulton in a BioNoCo project cooperation, FZJ). The quality control of the library generation 
was performed by sending 10 clones per library for sequencing. Our strategy to ensure full 
diversity coverage in the created libraries was to regenerate libraries displaying more than 
20% wild type. In total, 16652 clones were picked in microtiter plates (MTPs) from the 181 
SSM libraries (92 clones per amino acid-position x 181 amino acid-positions). The 16652 
clones were fully sequenced and 3279 different BSLA variants were obtained (represent 
90.6% completeness). In order to achieve 100% coverage, the missing 341 variants were 
generated by individual site directed mutagenesis (SDM), and each variant was confirmed by 
sequencing. Overall, 18547 clones corresponding to 3620 (181 BSLA amino acid positions x 
20 naturally occurring amino acids) variants were generated and used for the screening in 
presence of ionic liquids and OS. Once all 181 Libraries were generated and confirmed by 
sequencing, they were replicated and exchanged between the cooperation partners to enable 
each PhD fellow to work on the complete BSLA libraries. 
2.2.3 Selection of Optimal Medium for BSLA Expression Medium in pET22b(+) 
This part focuses on the selection of the appropriate medium for BSLA expression. 
Protein expression (37 °C, 12 h, 250 rpm) in pET22b(+)-BSLA WT was successfully 
performed in all three auto-induction media (ZYP-5052, LS-5052 and MAIM) in flasks 
(2.1.6.2) followed by lipase activity detection by formation of p-nitrophenolate using pNPP as 
substrate. The highest lypolytic activity was measured in the MAIM media (Figure 2-5A), 
which was selected as expression media for the BSLA screening assay. Consequently, the 
BSLA expression level in MAIM as auto-induction medium was verified by SDS-PAGE 
(2.1.6.3) loading crude cell extracts on 12% SDS-gel (Figure 2-5B). 
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A 
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Figure 2-5: Comparison of BSLA WT activity in different auto-induction media (A) and BSLA protein expression in 
MAIM (B). A: ZYP-5052; MAIM and LS-5052 were used for expression followed by activity assay with pNPP as substrate. 
All measurements were performed in triplicate and errors were calculated and are represented as bar. B: Protein visualization 
of BSLA cultures on a 12% SDS-PAGE gel: 1) Molecular weight standard (PageRuler, Fermentas), 2) EV (empty vector), 3) 
BSLA WT. The red box marks the expected molecular weight of BSLA WT  19.3 kDa. 
2.2.4 Optimization of Screening Conditions 
2.2.4.1 Standard Curve of p-Nitrophenol 
To monitor the release of p-nitrophenolate during the assay, a calibration curve (Figure 
2-6B) was generated using p-nitrophenolate dissolved in Sørensen buffer (50 mM, pH  8.0). 
p-Nitrophenolate is released during the hydrolysis reaction, which is visible by a yellow 
coloration (Figure 2-6A) whose absorption was monitored to quantify the activity of BSLA. A 
linear detection range at least up to 0.5 mM para-nitrophenol could be detected. 
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A                              
B 
 
Figure 2-6: (A) Color development of p-nitrophenol relating to the concentration and (B) standard curve of p-
nitrophenol. p-Nitrophenol was dissolved in Sörensen buffer (50 mM, pH 8.0) and different concentrations (0 to 4.0 mM) 
were obtained by dilution. Absorbance at A410 nm was measured in triplicate for each sample. Errors were calculated and 
are represented as bar. 
2.2.4.2 Selection of Suitable BSLA Model Substrate  
BSLA WT activity was measured with p-nitrophenyl palmitate (pNPP), p-nitrophenyl 
caprylate (pNPC) and p-nitrophenyl butyrate (pNPB) as substrates (2.1.7.1). Experiments 
showed that higher activity was obtained for BSLA WT as well as a higher substrate 
background for the empty vector using pNPP (Figure 2-7). Despite our attempts to increase 
pNPP solubility by addition of emulsifiers (NADOC, gum arabic) in the substrate solution, a 
considerably high background remained. This may also be the reason for the higher activity 
obtained in BSLA WT. The higher background observed in pNPP could negatively impact on 
activity determination (for example values outside the linear assay range) and should 
therefore be avoided. Since the intention was to establish an assay with very low background 
absorbance and avoid usage of emulsifiers, pNPB was selected for the screening of BSLA 
libraries. Minimal spontaneous hydrolysis and high solubility in water compared to other long 
chain substrates are properties which favor pNPB use as substrate for lipases (Yedavalli and 
Rao, 2013). Eggert and co-workers tested BSLA towards p-nitrophenylesters with different 
chain lengths (C4 to C18) and reported higher specific activities for substrates with C4 to C8 
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Chapter 2: Optimization of Screening System in MTP Format 
 
53 
 
chain lengths while very low catalytic activities were observed for C18 substrates (Eggert et 
al., 2000). 
 
Figure 2-7: Comparison of BSLA WT activity using pNPB, pNPC, and pNPP. Endpoint measurement was performed at 
410 nm (after 10 min incubation at RT) to determine BSLA WT activity with pNPB, pNPC and pNPP as substrates. All 
measurements were performed in sextuple and errors were calculated and are represented as bar. 
2.2.4.3 Selection of Suitable Reaction Buffer  
Six buffers (50 mM KPi with pH 7.2, 50 mM MOPS with pH 7.2, 50 mM Tris-HCl 
with pH 7.5, 50 mM Tris-HCl with pH 8.0, 50 mM HEPES with pH 7.1, and 50 mM TEA 
with pH 7.4) were evaluated in preliminary experiments to identify the best one for screening 
of BSLA resistance in presence of 50% v/v non-conventional media (in the incubation 
mixture with the supernatant before adding the substrate solution) such as DMSO, TFE and 
[BMIM][Cl]. BSLA culture supernatant was incubated with each buffer (2.1.7.2) and pH 
values were measured. The pH shifts were calculated by subtracting the measured pH values 
from the expected ones. High pH shifts were particularly observed in DMSO for the following 
buffers: Kpi, HEPES, Tris-HCl (pH 8.0), and MOPS. [BMIM][Cl] in contrast, seemed to be 
more tolerant to most of the buffers except Tris-HCl (pH 7.5) and KPi in which higher pH 
shifts were measured. Best buffer capacity meaning less pH shift was obtained with 50 mM 
TEA buffer (pH 7.4) (Figure 2-8). Therefore, TEA buffer was selected for the screening 
assay. 
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Figure 2-8: Comparison of buffer capacity for BSLA screening. The co-solvents (50% v/v) were incubated with BSLA 
culture supernatants (2h, RT, 1000 rpm) and substrate solution was added. Afterwards, pH values were measured and pH 
shifts were calculated (expected pH - measured pH). The measurements were performed in triplicate and errors were 
calculated and are represented as bar. DMSO: dimethyl sulfoxide; TFE: 2,2,2-trifluoroethanol; [BMIM][Cl]: 1-Butyl-3-
methylimidazolium chloride. 
2.2.4.4 Determination of the Standard Deviation of pNPB Assay in Buffer 
To determine the standard deviation of the screening assay, the activity was measured 
in a 96-well MTP containing only BSLA WT and another 96-well MTP containing only EV. 
The apparent standard deviation was calculated without subtracting the background, while the 
true standard deviation was obtained after background subtraction. The true and apparent 
standard deviations of the assay in buffer were 11% and 9% (Figure 2-9), respectively. 
Screening systems with standard deviations up to 25 % have successfully been used in 
directed evolution experiments (Kardashliev et al., 2014; Tee and Schwaneberg, 2007). 
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Figure 2-9: Standard deviation of BSLA activity in buffer. Activity values in decreasing order of the BSLA WT in a 96-
well MTP using the optimized assay conditions. The apparent standard deviations were calculated without subtracting the 
background and the true standard deviations after background subtraction. 
2.2.4.5 Selection of Non-conventional Media for the Screening of BSLA Mutant 
Libraries 
In the first experiment, three OS and eight ILs were pre-selected. Each non-
conventional media was incubated with BSLA/EV in 50% v/v concentration following by 
activity measurements at 410 nm (2.1.7.5). Residual activity was calculated using the formula 
below.  
 
Residual activity (R) [%] 
 
= 
Slope (BSLA variant/WT - EV) in non-conventional media 
Slope (BSLA variant/WT - EV) in buffer 
Results showed that DMSO, 1,4-dioxane, and TFE (Figure 2-10) were appropriate for 
BSLA screening assay. Since a residual activity of 30-40% for BSLA WT was required in 
order to enable an adequate range for improvements, the concentration of both OS needed to 
be adjusted. In a first experiment with 50% v/v co-solvent for each non-conventional media, 
few patterns were observed in presence of ILs. [BMIM][Cl] (1-Butyl-3-methylimidazolium 
Chloride, 100%) showed 4-fold higher residual activity than [BMIM][TfO] (1-butyl-3-
methylimidazolium trifluoromethanesulfonate, 25%) although both ILs share the same cation. 
Likewise, [EMIM][MMPO4] (1-ethyl-3-methylimidazolium dimethyl phosphate, 53%) and 
[EMIM][TFA] (1-ethyl-3-methylimidazolium trifluoroacetat, 42%) displayed 42-fold and  53-
fold higher residual activity than [EMIM][MeSO3] (1-ethyl-3-methylimidazolium 
methanesulphate, 0%) and [EMIM][MeSO4] (1-ethyl-3-methylimidazolium methylsulphate, 
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0%), respectively despite sharing the same cation. [EMIM][MeSO3] and [EMIM][MeSO4] 
were experimentally found to be acidic and should reduce the pH of the assay solution 
inhibiting therefore, product detection. Indeed, the low pH values of both ILs did not allow 
the yellow color formation of the product (p-nitrophenolate, pKa 7.16), which is detectable in 
neutral to basic range at 410 nm. p-Nitrophenol was reported to have two states, with unique 
spectral characteristics in the 240 nm to 600 nm range: absorbance of phenol happens in 
acidic conditions in the lower range, while absorbance of phenolate occurs in basic conditions 
in the higher range (Max et al., 2012). The results obtained suggested the foremost 
importance of the anion part of ILs over the cation part as reported in literatures (Anderson et 
al., 2002; Huddleston et al., 2001). Furthermore, residual activity of [EMIM][TFA] (53%) 
was only 1.3-fold increased than residual activity of [BMPy][TFA] (1-methylpyrrolidinium 
trifluoroacetat, 40%) although both ILs comprise the same anion. This confirmed our 
suggestions as well as the reports about the crucial role of IL-anion in the interactions with 
enzymes. Therefore, [BMIM][TfO] and [BMIM][Cl] were selected for further use. [BMIM]-
based ILs are well characterized and numerous reports certified their broad application. 
 
 
Figure 2-10: Selection of non-conventional media. EV and each BSLA sample were incubated with 50% v/v non-
conventional media (2 h, RT, 1000 rpm) and the absorbance was recorded (410 nm, 8 min). The given co-solvent 
concentrations are related to the concentration in the 100 µL incubation mixture (10 µLsupernatant + 90 µL co-solvent 
solution). A buffer MTP was also measured as control to enable residual activity calculation. Each sample was measured in 
triplicate and errors were calculated and are represented as bar. OS: DMSO (dimethyl sulfoxide), 1,4-dioxane, and TFE 
(2,2,2-Trifluoroethanol). ILs: [BMIM]: 1-butyl-3-methylimidazolium; [Cl]: chloride; [TfO]: trifluoromethanesulfonate, 
[BMPy]: 1-methylpyrrolidinium, [TFA]: trifluoroacetat, [EMIM]: 1-ethyl-3-methylimidazolium, [MeSO3]: methanesulphate, 
[MeSO4]: methylsulphate; [MMIM]: 1,3-Dimethylimidazolium Dimethyl, [MMPO4]: dimethyl phosphate, [AC]: acetate. 
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In conclusion, the three OS tested (DMSO, 1,4-dioxane, and TFE) as well as two ILs 
([BMIM][TfO] and [BMIM][Cl]) were selected. BSLA had to be tested for resistance in 
presence of three OS and four ionic liquids therefore, one OS and two [BMIM]-based ILs 
with different anions had to be further tested. New batches of OS were tested to select the 
concentration leading to 30 to 40% BSLA WT residual activity in presence of each non-
conventional media. Co-solvent concentrations applied in the incubation mixtures were 
between 0 to 70% v/v for ILs (Figure 2-11A) and between 0 to 80% v/v for OS (Figure 
2-11B). From these results, [BMIM]]Cl] and [BMIM]]Br] should be used at concentration 
≤30% v/v. [BMIM]]I] should be used at concentration ≥30% v/v and [BMIM]]TfO] should be 
used at concentration ≥15% v/v. Both ILs deactivated BSLA WT at relatively low 
concentrations. [BMIM][Br] appeared to have high deactivation effects on BSLA since only 
10% residual activity was observed for a concentration range from 40 to 70% v/v. Among the 
OS, DMSO caused less deactivation effects and BSLA WT retained one quarter of its residual 
activity in DMSO. TFE and 1,4-dioxane in contrast, deactivated BSLA WT in low 
concentrations range. After preliminary tests (results not shown), [BMIM][I], [BMIM][Br] 
were selected to complete the number of solvents required for the screening (three OS and 
four ILs). 
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Figure 2-11: Adjustment of the concentrations on non-conventional media for BSLA screening. The aim was to adjust 
the concentration of each IL and OS to obtain 30 to 40% BSLA WT residual activity. EV and each BSLA sample were 
incubated with concentrations between 0 and 70% v/v OS or 0 to 80% v/v IL (2 h, RT, 1000 rpm) and the absorbance was 
recorded (410 nm, 8 min). The given co-solvent concentrations are related to the concentration in the 100 µL incubation 
mixture (10 µL supernatant + 90 µL co-solvent solution). A buffer MTP was also measured as control to enable residual 
activity calculation. Each sample was measured in triplicate and errors were calculated A: selected ILs (blue): [BMIM]: 1-
butyl-3-methylimidazolium, [Cl]: chloride, [Br]: bromide, [I]: Iodide, [TfO]: trifluoromethanesulfonate, B: selected OS 
(pink): DMSO (dimethyl sulfoxide), TFE (2,2,2-Trifluoroethanol) and 1,4-dioxane. Each sample was measured in triplicate 
and errors were calculated and are represented as bar. 
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2.3 Conclusions 
This chapter outlined experiments performed to establish and optimize all factors 
(expression medium, screening buffer, substrate for screening, and selection of four ILs and 
three OS) and conditions required for BSLA libraries generation as well as the screening of 
the generated libraries in presence of non-conventional media. Therefore, SSM on the whole 
BSLA sequence was performed (BSLA-SSM 1-91 in this work and SSM-BSLA 92-181 in 
Research Center Juelich by Alexander Fulton). After sequencing of the SSM libraries, the 
missing 341 variants were generated by SDM to complete the full diversity. In total, 18547 
clones corresponding to 3620 BSLA variants (181*20) were generated. In parallel to libraries 
generation, the expression system and the screening system for BSLA were optimized. Hence, 
pNPB was selected as substrate, TEA buffer (pKA 7.76, pH7.4, 50 mM) was chosen as assay 
buffer and the standard deviation of the assay in buffer was determined (apparent standard 
deviation: 9% and true standard deviation: 11%). After testing three OS and ten ILs (results 
not all shown in this chapter), all three OS (DMSO, TFE, and 1,4-dioxane) and four ILs 
([BMIM][Cl], [BMIM][Br], [BMIM][I], and [BMIM][TfO]) were selected to screen BSLA 
resistance. The concentration of OS and ILs leading to 30-40% residual activity of BSLA WT 
was adjusted and used to screen the SSM-BSLA libraries for the selected ILs (chapter 3) and 
OS (chapter 4) on BSLA resistance. 
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3 Towards Understanding of Directed Evolution: More Than 
Half of All Amino Acid Positions Contributed to Ionic Liquid 
Resistance of Bacillus subtilis Lipase A  
3.1 Abstract 
Ionic liquids (ILs) have been used as (co)solvents in biocatalytic reactions and are 
attractive for biocatalysis due to unique solvent properties. However, in solutions with high 
concentration of IL (>10%), enzymes usually show significantly decreased activity. No 
general principles have so far been identified to improve IL resistance of enzymes by protein 
engineering despite of a few successful directed evolution campaigns. In a systematic study to 
elucidate first general engineering principles, site saturation mutagenesis (SSM) on the 
complete sequence of bsla was performed and sequencing confirmed that each naturally 
possible single amino acid exchange was generated at each amino acid position of BLSA. 
Improvements in IL resistances that are obtainable by a single amino acid substitution were 
determined by screening in presence of four [BMIM]-based ILs. Surprisingly, two unexpected 
lessons on directed evolution were discovered: 1) resistance improvements were obtained at 
50-69% of all amino acid positions of BLSA, which explained why improved enzyme 
variants can often be identified from small sized random mutant libraries (1000-2000 clones) 
and 2) often only few substitutions per amino acid position led to improved resistance (6-13% 
of all substitutions). Substitutions with chemically different amino acids (e.g. aromatic amino 
acids substituted by polar/aliphatic/charged amino acids) were predominantly preferred (66-
95%) among the beneficial substitutions. The latter indicates that mutagenesis methods that 
introduce transversions should at least for lipases like BSLA be favored to generate variants 
with improved IL resistance. 
 
Keyswords: BSLA, protein engineering, directed evolution, site saturation mutagenesis, ionic 
liquid (IL). 
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3.2 Highlights 
Project objective:  
 A systematic study to understand the contribution of single amino acid substitution, 
position and location to BSLA resistance towards [BMIM][Cl], [BMIM][Br], 
[BMIM][I], and [BMIM][TfO]. 
 
Main Findings:  
 6-13% of all amino acid substitutions at 50-69% of all amino acid positions led to 
improvement in IL resistance of BSLA. 
 Polar or charged amino acid substitutions primarily lead to improvement of BSLA´s 
IL resistance. 
 At solvent exposed positions: charged substitutions are more preferential for 
improving BSLA´s IL resistance towards [BMIM][Cl], [BMIM][Br], and [BMIM][I]. 
But opposite trend was observed for [BMIM][TfO]. 
 At buried positions: polar substitutions are more preferential for improving BSLA´s IL 
resistance.  
 Substitutions with chemically different amino acids significantly improved BSLA 
resistance indicating that mutagenesis methods introducing transversions will be 
favorable for improving IL resistance of lipases at least for BSLA. 
 
Novelty: 
 The first systematic investigation of whole sequence SSM-BSLA library for 
improving the IL resistance.  
 For the first time from an experimental point of view, it was explained why often the 
screening of small sized libraries (1000-2000 variants) is sufficient to find improved 
variants. 
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3.3 Introduction 
The ionic nature of ionic liquids (ILs) is critical in affecting enzyme performance 
resulting in enzyme inactivation through unfolding and/or aggregation (Yang, 2009) as 
enzymes have been designed by nature to efficiently function in aqueous solutions. Enzyme 
activity in IL solutions is influenced by the physicochemical properties of ILs, which are 
governed by the proper combination of cation and anion. Numerous studies on the impact of 
ILs on enzymes performance revealed the dominant role of the IL-anion (Anderson et al., 
2002; Huddleston et al., 2001) while cations held a rather secondary role (Micaêlo and 
Soares, 2008). This is mainly due to the usually small size of anions as they possess a smaller 
surface than cations, leading therefore to stronger Coulomb interactions with enzymes (Klähn 
et al., 2011). H-bond basicity and nucleophilicity of IL-anions as well as the experimental 
Hofmeister series of salts (kosmotropic/chaotropic) are mostly applied to explain the impact 
of IL-anions on enzyme performance. Nucleophilic anions (as Cl
-
, Br
-
, OAc
-
) were reported to 
coordinate more strongly to the positively charged amino acids in an enzyme, causing 
conformational changes (De Diego et al., 2005; Kaar et al., 2003; Lau et al., 2004; Sheldon et 
al., 2002). Hydrogen bonding of the IL-anions is an important factor influencing interactions 
between enzymes and ILs and therefore, affecting the enzyme activity (Anderson et al., 2002; 
Huddleston et al., 2001; Kaar et al., 2003; Lou et al., 2006; Yang and Pan, 2005). The IL-
protein interactions may (Constantinescu et al., 2007; Constatinescu et al., 2010) or may not 
follow (Yang et al., 2009; Zhao et al., 2006) the Hofmeister series. A strong propensity for 
protein denaturation as well as dissociation of the hydrogen bonds maintaining the enzyme 
structure can be obtained in presence of IL anions with high H-bond basicity as halides, 
acetate, dicyanamide (Domínguez de María, 2012; Lau et al., 2004). However, the influence 
of ILs on enzymes on a molecular level currently remains not fully understood since 
additional factors such as viscosity, hydrophobicity/hydrophilicity or ILs impurities can also 
influence.  
Improved activity, stability and/or resistance of enzymes in ILs can be achieved by 
chemical modification of enzymes through PEGylation (Maruyama et al., 2002; Nakashima et 
al., 2006) and succinylation (Jia et al., 2013; Nordwald and Kaar, 2013; Nordwald et al., 
2014b) as well as by immobilization (Madeira Lau et al., 2000; Toral et al., 2007). 
Additionally, protein engineering by directed evolution can be applied as an attractive 
alternative to improve enzymes properties through iterative cycles of diversity generation and 
screening (Lehmann et al., 2014; Liu et al., 2013). Enzyme classes such as oxidoreductases 
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(e.g. laccase (Liu et al., 2013), formate dehydrogenase (Carter et al., 2014)) and hydrolases 
(e.g. celullase (Chen et al., 2013; Lehmann et al., 2014; Pottkämper et al., 2009) have been 
successfully reengineered by protein engineering for improved IL resistance/tolerance. 
However, up to now, only six reports on improving IL resistance of enzymes are described 
(Carter et al., 2014; Chen et al., 2013; Lehmann et al., 2014; Liu et al., 2013; Nordwald et al., 
2014a; Pottkämper et al., 2009). These reports mostly focused on identifying beneficial 
substitutions that govern IL resistance. Despite first success stories on improving IL 
resistance, there is still lack of basic knowledge indispensable to the understanding and 
improvement of enzyme towards ILs. General design principles to guide protein engineering 
campaigns have still not been discovered and are therefore needed. 
Hydrolases and particularly lipases are an industrially important enzyme class (e.g. 
Candida antarctica lipase B (CALB), Candida rugosa lipase (CRL); and Pseudomonas 
cepacia lipase (PCL)). Bacillus subtilis lipase A (BSLA) has been investigated for its organic 
solvent resistance (Reetz et al., 2010; Yedavalli and Rao, 2013), thermostability (Acharya et 
al., 2004; Ahmad and Rao, 2009; Ahmad et al., 2008; Kumar et al., 2014) and 
enantioselectivity (Funke et al., 2003). BLSA possesses a minimal α/β-hydrolase fold, a small 
size (181 amino acids and 19.3 kDa) and does not show interfacial activation (van 
Pouderoyen et al., 2001). 
In this chapter, a systematic study was carried out to understand to what extend a single 
amino acid substitution at each position of BSLA can contribute to improve the resistance of 
BSLA towards four ILs ([BMIM][Cl], [BMIM][Br], [BMIM][I], and [BMIM][TfO]). All the 
natural diversity was generated at each amino acid position of BSLA (181 positions; SSM + 
SDM) and screened after sequencing of all 18547 clones to confirm the ‘completeness’ of the 
libraries. In summary for the first time, a data set was generated enabling 1) identification of 
the amino acid positions in BSLA, which improve ILs resistance, 2) study of the influence of 
each amino acid substitution on the molecular level, and 3) performance of a comprehensive 
statistical data analysis (number of amino acid positions contributing to ILs resistance; trends 
in chemical composition of amino acid substitutions, and the influence of residues location 
(surface exposed and buried amino acids). 
3.4 Experimental Section 
All chemicals, reagents and methods used in this part were described in chapter 2. 
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3.4.1 Optimization of Screening Conditions in Presence of ILs 
Four [BMIM] containing ILs with different anions were used in this chapter to screen 
the generated BSLA libraries: [BMIM][Cl], [BMIM][Br], [BMIM][I], and [BMIM][TfO] 
(Figure 3-1). BMIM][Cl] and [BMIM][Br] were obtained as solids and were dissolved by 
adding 8.6% (v/w) and 10% (v/w) water, respectively. IL solutions with different 
concentrations were prepared by supplementing ILs with TEA buffer (pKa 7.76, pH 7.4, 
50 mM). These solutions were used to determine the concentration of the four ILs for the 
screening. All four ILs were miscible with water as described in the data sheets provided by 
SOLVIONIC company (en.solvionic.com, Toulouse, France). Besides, pH shifts less than 0.2 
unit of pH were obtained in the presence of ILs. Concentrations leading to a residual activity 
between 30% and 40% of the BSLA WT (2.2.4.5) were chosen for the screening. Polystyrene 
MTPs (flat-bottomed, polystyrene plates, Greiner Bio-One GmbH, Frickenhausen, Germany) 
were used for the screening assay with ILs. In each well of a 96-well MTP, 10 µL supernatant 
were incubated with 90 µL of the IL solution (2 h, 1000 rpm, RT) on a MTP shaker (Edmund 
Bühler Microtiter shaker, Hechingen, Germany) at the adjusted IL concentration (Table 3-1). 
For each position, the plate for the reaction only in buffer was used as reference to enable the 
calculation of the residual activity given as percentage (2.2.4.5). The freshly prepared 
substrate solution (100 µL/well) was then added to the incubation mixture and the absorbance 
was measured (410 nm, 8 min, RT). For each well, the same amount of supernatant was 
incubated with or without ILs and the ratio of “activity in presence of IL divided by the 
activity in absence of IL” was used to evaluate the IL resistance of BSLA variants. No 
influence was observed even using two to three times more BSLA supernatant. 
 
Figure 3-1: Chemical structures of the four selected ILs. [BMIM][Cl], [BMIM][Br], [BMIM][I], and [BMIM][TfO]. 
[BMIM] = 1-butyl-3-methylimidazolium [Cl] = chloride; [Br] = bromide, [I] =iodide, [TfO] = trifluoromethanesulfonate. 
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3.5 Results and Discussion 
Can ILs resistance of hydrolases such as BSLA be efficiently improved by protein 
engineering? This question was elucidated in a systematic study by the screening of 181 
BSLA libraries in presence of [BMIM][Cl], [BMIM][Br], [BMIM][I], and [BMIM][TfO]. 
The generated 181 BSLA libraries contained each of the 3620 naturally possible variants as 
confirmed by extensive sequencing. The results in this chapter were divided in eight sections. 
The first section summarizes the generation of the SSM libraries for the complete lipA gene 
from B. subtilis, the second section deals with the conditions used for the screening of SSM-
BSLA libraries in presence of the four used ILs. The third section focuses on the analysis of 
the number of amino acids positions that influence IL resistance of BSLA 
(improved/decreased/unchanged IL resistance and inactivation). In the fourth section, all 
substitutions were analyzed to determine the number of single amino acid substitutions on 
BSLA resistance towards the four selected ILs. The amino acid substitutions were grouped 
into four types (aromatic, aliphatic, polar, and charged) and the influence of each type of 
amino acid on BSLA resistance was depicted in the fifth section. In the sixth section, the 
effect of substituting each type of amino acid with all the four types (aromatic, aliphatic, 
polar, and charged) was investigated. The seventh section discusses the effect of amino acid 
locations on IL resistance of BSLA. In the last section, the best variants contributing to the 
highest BSLA resistance in each IL were summarized. 
The libraries containing all the variants generated with SSM and SDM were defined as 
“SSM-BSLA libraries” in this work. In all analysis, the SSM-BSLA variants were grouped as 
following: “+” representing variants with improved resistance (RV ≥ RWT + 3); “=” 
representing variants with unchanged resistance (RV < RWT + 3 and RV > RWT - 3); “-” 
representing variants with decreased resistance (RV ≤ RWT - 3) and “x” representing inactive 
variants in buffer (AV < AEV + 3). R: Residual activity (2.2.4.5); A: activity; V: variant; WT: 
wild type; EV: empty vector; : standard deviation. Due to the different values obtained for 
BSLA WT in each solvent, comparison of the results using the residual activity values was 
almost impossible. Therefore, a ratio (RV/RWT) was applied to easily compare all results based 
on the same factor. This ratio (RV/RWT) was obtained by dividing the residual activity of each 
BSLA variant (RV) by the residual activity of BSLA WT (RWT) at each position and in each 
IL. 
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3.5.1 Screening Conditions for BSLA Libraries in Presence of Four ILs  
All 3620 BSLA variants were screened in the presence of four ILs containing the same 
cation [BMIM]
+
 which allowed an analysis of the influence of IL-anion on BSLA resistance. 
IL concentrations were selected to obtain a residual BSLA WT activity of 30 to 40% (Table 
3-1). True standard deviations of 11.3% to 14.5% were calculated for the screening system 
with the four ILs as co-solvents. Screening systems with standard deviations around 12% 
were generally applied in directed evolution experiments (Lehmann et al., 2012; Tee and 
Schwaneberg, 2007). 
 
Table 3-1: ILs and conditions used for the screening of BSLA libraries. Calculated standard deviations of the screening 
system are also showed. C: concentration, RWT: residual activity of BSLA WT, stdev: standard deviation, App: apparent. 
[BMIM] = 1-butyl-3-methylimidazolium, [Cl] = chloride, [Br] = bromide, [I] =iodide, [TfO] = trifluoromethanesulfonate. 
Selected ILs C [M ] (%v/v)* RWT [%] App stdev [%] True stdev [%] 
[BMIM][Cl] 1.2 (  18.3 ) 35.0 3.0 11.3 
[BMIM][Br] 0.9 (  13.2) 39.0 7.6 14.5 
[BMIM][I] 0.6 (  10.0) 37.0 7.6 12.3 
[BMIM][TfO] 0.7 (  15.0) 30.0 6.0 13.0  
* Concentration used in the incubation steps. 
The order of H-bond basicity of anions in aqueous solution is: Cl
- 
>
 
Br
- 
>
 
I
- 
>TfO
-
 and 
the order in the Hofmeister series is: Cl
-
 > Br
-
 > TfO
-
 > I
- 
(Naushad et al., 2012).
 
Deactivation 
effect of ILs on enzymes has been often reported to increase with higher H-bond basicity 
(Heller et al., 2010; Lou et al., 2006; Turner et al., 2003). However, the results of the BSLA 
resistance screening do not correlate with the nucleophilicity/basicity of the anions. Among 
the four BMIM-based ILs, [BMIM][TfO] displayed the highest inactivation effect (Table 
3-1). 0.7 M (15.0% v/v) of [BMIM][TfO] resulted in 70% activity loss which might be 
attributed to: 1) delocalized charge distribution of TfO
-
 which has a weaker solvation shell 
can therefore, easily form H-bonds with enzyme backbone amides, than the halides Cl
-
, Br
-
 
and I
-
, 2) a single TfO
-
 might form multiple H-bonds with amino acids of BSLA and perturb 
the enzyme structure more dramatically than halides anions Cl
-
, Br
-
 and I
-
 that can only form 
single H-bonds. In a MD simulations study, NO3
-
(with a similar structure to TfO
-
) was 
described to form double the amount of H-bonds between the enzyme backbone amides and 
itself (Micaêlo and Soares, 2008). NMR was used in another study to determine the role of IL 
anion on protein destabilization: the binding of weakly hydrated anions to positively charged 
or polar residues destabilize protein structure as consequence of the partial dehydration of the 
protein backbone groups (Figueiredo et al., 2013). This might justify why [BMIM][Cl] 
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displayed the least inactivation effect since among the four selected anions in this study, Cl
-
 is 
most hydrated and should therefore, be less available for interactions with BSLA.  
Residual activity of a given variant (RV) and the residual activity of the WT (RWT) 
were calculated after the screening of all 181 BSLA libraries. The variants were classified into 
four categories as described above based on the Gaussian distribution curve ( is the true 
coefficient of variation of the screening system, Table 3-1). 
3.5.2 Influence of the Number of Amino Acid Positions on BSLA’s Resistance 
Towards ILs 
Figure 3-2 displays the number of amino acid positions of BSLA leading to 
improved/unchanged/decreased IL resistance as well as inactive BSLA variants after 
screening of all 181 BSLA libraries. [BMIM][Cl] (124 positions, 69% of all positions) yields 
20 more positions than [BMIM][TfO] (104, 57%), 29 more than [BMIM][I] (95, 52%), and 
33 more than [BMIM][Br] (91, 50%) for the IL resistance type “+”. In case of the IL 
resistance type “=”, at least one amino acid substitution was found that did not influence IL 
resistance of BSLA at each of the 181 amino acid positions. For the IL resistance type “-”, it 
was found that [BMIM][Cl] (117, 65% of all positions) yields almost the same number of 
positions than [BMIM][I] (115; 64%) ~ [BMIM][TfO] (102; 56%) > [BMIM][Br] (89; 49%). 
For the resistance type “x”, at least one amino acid substitution corresponding to the wild type 
was found at 99 (55%) amino acid positions which inactivated BSLA already in the buffer 
solution. Analysis of the number of substitution influencing BSLA´s IL resistance 
(improved/decreased/unchanged) as well as BSLA´s inactivation at each position of BSLA is 
detailed in Table 7-3 to Table 7-6.  
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Figure 3-2: Number of amino acid positions, which lead to improved/unchanged/decreased IL resistance and/or 
inactivation of BSLA in buffer. All SSM-BSLA variants were grouped as described in the text: “+” representing variants 
with improved resistance, “=” representing variants with unchanged resistance, “-” representing variants with decreased 
resistance and “x” representing inactive variants in buffer. 
3.5.3 Influence of the Number of Single Amino Acid Substitutions on BSLA´s 
Resistance Towards ILs 
Figure 3-3 depicts the number of variants with improved “+”, unchanged “=”, 
decreased “-” resistance and ‘‘inactive’’ variants “x” in presence of [BMIM][Cl], 
[BMIM][Br], [BMIM][I], and [BMIM][TfO]. [BMIM][Cl] (462 out of 3620; 13% of all 
substitutions) yields 170 substitutions more than [BMIM][TfO] (292, 8%), 199 more than 
[BMIM][I] (263, 7%) and 256 more than [BMIM][Br] (206, 6%) for the IL resistance type 
“+”. Among the variants with increased resistance towards [BMIM][Cl], 1% displayed a 
resistance improvement higher than 2.5-fold. In the remaining three ILs, less than 0.3% of the 
BSLA variants were obtained with resistances higher than 2.5-fold. In general, a large 
majority 62-72% (2254-2591 out of 3620) of all substitutions does not affect BSLA resistance 
type “=” towards the four selected ILs. [BMIM][I] (544 out of 3620; 15% of all substitutions) 
yields 138 more substitutions than [BMIM][Cl] (406; 11%), 139 more substitutions than 
[BMIM][TfO] (405, 11%), and 219 more than [BMIM][Br] (325, 9%) for the IL resistance 
type “-”. In case of IL resistance type “x”, 498 (14%) substitutions resulted in inactivation of 
BSLA. 
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Figure 3-3: Number of SSM-BSLA variants, which lead to improved/unchanged/decreased IL resistance towards four 
ILs and/or inactivation of BSLA in buffer. All SSM-BSLA variants were grouped as described in the text: “+” 
representing variants with improved resistance, “=” representing variants with unchanged resistance, “-” representing variants 
with decreased resistance and “x” representing inactive variants in buffer. 
Overall, 50% to 69% amino acid positions (Figure 3-2) contributed to the improved 
BSLA´s IL resistance towards [BMIM][Br] (50%), [BMIM][I] (52%), [BMIM][TfO] (57%), 
and [BMIM][Cl] (69%). A large fraction of the amino acid positions in BSLA can therefore 
contribute to its stabilization in presence of ILs. Among the 3620 BSLA variants that cover 
the naturally occurring diversity at each amino acid position, only 6-13% of all the amino acid 
exchanges improved IL resistance. In case of [BMIM][Cl] 1% and in case of  [BMIM][Br], 
[BMIM][I] and [BMIM][TfO], 0.3% of the variants exhibit a significantly increased IL-
resistance (>2.5-fold). Analysis of these screening results reveals an important new lesson in 
directed evolution and provides a first experimental explanation of why the screening of small 
libraries with a few thousand variants yields often improved variants in directed evolution 
experiments, especially for properties that have not been under selection pressure. In addition, 
the on average low number of amino acid substitutions per amino acid positions discloses 
why saturation mutagenesis experiments on amino acid positions that have been discovered 
by random mutagenesis yield only <50 % variants with better improvements. 
Chapter 3: Towards Understanding of Directed Evolution: More Than Half of All Amino 
Acid Positions Contributed to Ionic Liquid Resistance of Bacillus subtilis Lipase A  
71 
 
3.5.4 Effect of Different Type of Amino Acid Substitutions (Aromatic, Aliphatic, 
Charged, Polar) on BSLA´s Resistance Towards ILs  
The 20 amino acid substitutions were classified into four “types” in order to be 
consistent with previous reports (Verma et al., 2014; Wong et al., 2006b, 2007a): 15% 
aromatic (F, Y, and W), 25% aliphatic (A, V, L, I, and G), 25% charged (D, E, H, K, and R) 
and 35% polar (termed neutral in the cited papers; C, M, P, S, T, N, and Q) amino acids. 
Glycine (G), cysteine (C) and proline (P) could also be classified as special amino acids. 
Figure 3-4 depicts the effect of each type of amino acid substitution on BSLA resistance 
towards the four [BMIM]-based ILs. Inactive variants were defined as the variants which 
showed no activity in buffer. Supplementing of IL was not in single case able to recover 
BSLA activity. Overall, 183 out of 498 inactive BSLA variants (“x” type in buffer) harbored 
charged substitutions (37%), 152 polar (31%), 87 aromatic (17%), and 76 aliphatic (15%). 
Figure 3-4A-D illustrates improvements for the IL resistance type “+” towards 
[BMIM][Cl] resistance in case of 148 out of 462 to polar amino acids (32%), 144 to charged 
(31%), 98 to aliphatic (21%), and 72 to aromatic (16%). For [BMIM][Br] resistance, 64 out of 
206 to charged (31%), 62 to polar (30%), 48 to aliphatic (23%), and 32 to aromatic (16%). 
[BMIM][I] resulted in 87 out of 263 variants to charged (33%), 74 to polar (28%), 53 to 
aliphatic (20%), and 49 to aromatic (19%). [BMIM][TfO] led in 100 out of 292 to polar 
(34%), 87 to charged (30%), 54 to aliphatic (18%), and 51 to aromatic (17%). Taken together, 
the highest number of improved BSLA variants were achieved for [BMIM][Cl] (462) 
followed by [BMIM][TfO] (292), [BMIM][I] (263), and [BMIM][Br] (206) (Figure 3-4A-D). 
Overall, most substitutions improving BSLA resistance for all four ILs variants were achieved 
with polar or charged amino acids.  
Table 3-2: Number of each type of amino acid substitution for each resistance type for all four [BMIM]-
based ILs. All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved 
resistance, “=” representing variants with unchanged resistance, “-” representing variants with decreased resistance 
and “x” representing inactive variants in buffer. 
Resistance type Aromatic [%] Aliphatic [%] Polar [%] Charged [%] 
+ 17-19 18-21 28-34 30-33 
= 14 28-29 35-36 22 
- 14-19 19-24 36-41 21-27 
x 17 15 31 37 
A comparable amino acid substitution profile was obtained for all four ILs: 35-36% 
polar, 28-29% aliphatic, 22% charged, and 14% aromatic in the case of IL resistance type “=“ 
(Table 3-2). 
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Figure 3-4: Distribution of amino 
acid substitutions of SSM-BSLA 
libraries with improved/unchanged 
/decreased IL resistance. 
A: Resistance towards [BMIM][Cl], 
B: Resistance towards [BMIM][Br],  
C: Resistance towards [BMIM][I], 
D: Resistance towards [BMIM][TfO], 
E: Distribution of the 20 amino acids 
and amino acid composition of BSLA 
WT. Amino acids are grouped into: 
aromatic (F, Y, and W), aliphatic (A, V, 
L, I, and G), charged (D, E, H, K, and 
R), and polar (C, M, P, S, T, N, and Q). 
The X-axis represents the extent of 
resistance improvement of BSLA 
variants toward different ILs in four 
categories (“+”; “=”; “-“, and “x”). The 
primary Y-axis (on the left) displays the 
total number of variants and positions, 
at which an effect on BSLA resistance 
is observed. The secondary Y-axis (on 
the right) represents the chemical 
distribution of the amino acids in 
categories. All SSM-BSLA variants 
were grouped as described in the text: 
“+” representing variants with 
improved resistance, “=” representing 
variants with unchanged resistance, “-” 
representing variants with decreased 
resistance and “x” representing inactive 
variants in buffer. AA: amino acid. 
 
. 
Chapter 3: Towards Understanding of Directed Evolution: More Than Half of All Amino 
Acid Positions Contributed to Ionic Liquid Resistance of Bacillus subtilis Lipase A  
73 
 
The IL resistance type “-” displayed for [BMIM][Cl], 147 out of 406 substitutions to 
polar amino acids (36%), 97 to aliphatic (24%), 86 to charged (21%), and 76 to aromatic 
(19%). For [BMIM][Br], 125 out of 325 to polar (38%), 85 to charged (26%), 63 to aliphatic 
(19%), 52 to aromatic (16%) were obtained. For [BMIM][I], 222 out of 544 to polar (41%), 
131 to charged (24%), 115 to aliphatic (21%), 76 to aromatic (14%) were achieved. For 
[BMIM][TfO], 144 out of 405 to polar (36%), 108 to charged (27%), 87 to aliphatic (21%), 
and 66 to aromatic (16%) were found. Remarkably, BSLA variants with polar amino acid 
substitutions often led to a decreased resistance for all four ILs and significant discrepancy in 
the total number was observed (325 substitutions in [BMIM][Br] vs 544 in [BMIM][I]). The 
amino acid composition of BSLA (8.3% aromatic, 43.6% aliphatic, 29.8% polar, and 18.2% 
charged amino acids) is optimized for higher efficiency in aqueous solution with a common 
preference for aliphatic amino acids. Statistical analysis of chemical substitutions for all four 
ILs revealed improved variants by substitution to aromatic (17-19%), aliphatic (18-21%), 
polar (28-34%), and charged (30-33%) amino acids. As general trend, one can conclude that 
beneficial substitutions to polar and/or charged amino acid residues will lower the fraction of 
aliphatic amino acids in improved BSLA variants. Interestingly, the latter trend correlates 
roughly with natural distribution of amino acids: aromatic (15%), aliphatic (25%), polar 
(35%), and charged (25%). 
For [BMIM][Cl] (Figure 3-4A ) and [BMIM][Br] (Figure 3-4B), the number of 
beneficial substitutions followed this order: polar = charged > aliphatic > aromatic. The order 
for [BMIM][I] (Figure 3-4C) was however: charged > polar > aliphatic = aromatic and in 
[BMIM][TfO] (Figure 3-4D): polar > charged > aliphatic = aromatic. The following order: 
polar > aliphatic > charged > aromatic was observed for all four ILs for the variants with IL 
resistance type “=“. The number of variants for IL resistance type “-” were ranked as follows: 
polar > charged > aliphatic > aromatic in presence of all ILs except [BMIM][Cl] (polar > 
aliphatic > charged >aromatic). To conclude, the main category of substitutions leading to 
improvements was either charged or polar for all four ILs. These findings were in agreement 
with reports of other groups on IL resistance of cellulases. Accordingly, three cellulase 
mutants with improved IL resistance (from SeSaM mutant libraries) were obtained with 
charged and polar substitutions (Pottkämper et al., 2009). Introduction of charged amino acids 
at positions selected by using NMR were also reported to significantly improve IL tolerance 
of BSLA towards [BMIM][Cl] (Nordwald et al., 2014a). Further, the stabilization of cellulase 
Cel5A Tma in [C2mim] solution by introducing two charged substitutions (distal from active 
sites) were described (Chen et al., 2013).  
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3.5.5 Effect of Amino Acid Substitution Types on IL Resistance of BSLA: 
Comparison Between WT and Variants 
Table 3-3 summarizes the effect of each type of amino acid substitution (to polar, 
aliphatic, charged and aromatic) on IL resistance of BSLA in a matrix of 16 substitution 
types. In all cases, improved IL resistance with significant differences in orders and trends 
was obtained with substitutions to chemically different amino acids as demonstrated in detail 
in the next four paragraphs. Table 3-3 provides general trends on amino acid substitution 
patterns and answers in contrast to Figure 3-4 the question what preferred types (aromatic, 
aliphatic, polar, charged) of amino acid exchanges exist. Table 7-7 displays the effect of 
charged acidic and charged basic amino acids. However, no trend equivalent to the one 
reported by Nordwald and co-workers was observed in this work (Nordwald and Kaar, 2013). 
They suggested stabilization and destabilization of chymotrypsin in [BMIM][Cl] by 
interactions between anions and cations, respectively. Indeed, chymotrypsin modified by 
anions was described to interact more with [BMIM] while chymotrypsin modified by cations 
was found to interact more with [Cl
-
] and is destabilized (Nordwald and Kaar, 2013). 
3.5.5.1 Substitution of Aromatic Amino Acids 
The substitution of aromatic amino acids with chemically different amino acids 
(aliphatic, charged, and polar) led to significantly improved resistance “+” towards all four 
ILs. The number of improved variants were observed with the following order of substitution 
types: polar > aliphatic > charged > aromatic for [BMIM][Cl] and [BMIM][TfO]. In 
[BMIM][Br], the obtained order was: polar > aliphatic > aromatic > charged and in case of 
[BMIM][I] the order was: polar > charged > aromatic > aliphatic. 
3.5.5.2 Substitution of Aliphatic Amino Acids 
The substitution of aliphatic amino acids with chemically different amino acids 
(aromatic, charged, and polar) led to improved resistance “+” towards all four ILs. The 
number of improved variants was ranked in the following order of substitution types: polar ≥ 
charged > aliphatic ≥ aromatic for [BMIM][Cl], [BMIM][I], and [BMIM][TfO]. For 
[BMIM][Br], the order was: charged > polar > aliphatic > aromatic. 
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Table 3-3: Effect of each amino acid type substitution (polar, aliphatic, charged and aromatic) on IL resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 patterns 
per IL are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and 
R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants with unchanged 
resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer.  
 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
  
  Amino acid types in BSLA-WT   
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
   
+ 
(42) 
= 
(199) 
- 
(32) 
X 
(27) 
+ 
(215) 
= 
(852) 
- 
(200) 
x 
(313) 
+ 
(121) 
= 
(771) 
- 
(111) 
x 
(77) 
+ 
(84) 
= 
(432) 
- 
(63) 
x 
(81) 
[B
M
IM
][
C
l]
 
Aromatic  14% 19% 6% 0% 13% 13% 20% 19% 14% 14% 22% 19% 25% 13% 17% 15% 
Aliphatic  26% 25% 28% 19% 20% 33% 18% 12% 21% 26% 32% 16% 24% 25% 25% 25% 
Polar 40% 32% 41% 44% 35% 37% 39% 27% 28% 38% 28% 29% 26% 34% 41% 43% 
Charged 19% 25% 25% 37% 33% 17% 24% 42% 37% 23% 18% 36% 25% 28% 16% 17% 
                  
  
+ 
(25) 
= 
(208) 
- 
(40) 
x 
(27) 
+ 
(79) 
= 
(1014) 
- 
(174) 
x 
(313) 
+ 
(53) 
= 
(869) 
- 
(81) 
x 
(77) 
+ 
(49) 
= 
(500) 
- 
(30) 
x 
(81) 
[B
M
IM
][
B
r]
 
Aromatic  20% 18% 8% 0% 14% 14% 17% 19% 13% 14% 17% 19% 18% 14% 20% 15% 
Aliphatic  28% 25% 25% 19% 20% 31% 17% 12% 26% 26% 21% 16% 22% 25% 23% 25% 
Polar 36% 34% 35% 44% 29% 37% 40% 27% 32% 36% 36% 29% 27% 34% 43% 43% 
Charged 16% 23% 33% 37% 37% 19% 27% 42% 28% 24% 26% 36% 33% 26% 13% 17% 
                  
  
+ 
(18) 
= 
(191) 
- 
(64) 
x 
(27) 
+ 
(95) 
= 
(854) 
- 
(318) 
x 
(313) 
+ 
(88) 
= 
(802) 
- 
(113) 
x 
(77) 
+ 
(62) 
= 
(468) 
- 
(49) 
x 
(81) 
[B
M
IM
][
I]
 Aromatic  22% 20% 5% 0% 16% 14% 14% 19% 15% 14% 16% 19% 27% 13% 22% 15% 
Aliphatic  17% 27% 23% 19% 19% 32% 20% 12% 22% 27% 22% 16% 21% 26% 24% 25% 
Polar 33% 32% 41% 44% 33% 35% 43% 27% 28% 36% 35% 29% 19% 35% 39% 43% 
Charged 28% 21% 31% 37% 33% 19% 23% 42% 35% 23% 27% 36% 32% 26% 14% 17% 
                  
  
+ 
(21) 
= 
(208) 
- 
(44) 
x 
(27) 
+ 
(118) 
= 
(925) 
- 
(224) 
x 
(313) 
+ 
(82) 
= 
(821) 
- 
(100) 
x 
(77) 
+ 
(71) 
= 
(471) 
- 
(37) 
x 
(81) 
B
M
IM
][
T
fO
] 
Aromatic  5% 20% 5% 0% 14% 13% 17% 19% 16% 14% 19% 19% 28% 13% 19% 15% 
Aliphatic  33% 24% 30% 19% 15% 32% 19% 12% 18% 27% 21% 16% 20% 26% 27% 25% 
Polar 38% 33% 39% 44% 37% 37% 38% 27% 34% 36% 29% 29% 28% 35% 32% 43% 
Charged 24% 23% 27% 37% 33% 18% 25% 42% 32% 23% 31% 36% 24% 27% 22% 17% 
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3.5.5.3 Substitution of Polar Amino Acids 
The substitution of polar amino acids with chemically different amino acids (aromatic, 
aliphatic, and charged) led to improved resistance “+” towards all four ILs. For [BMIM][Cl] 
and [BMIM][I] the order was: charged > polar > aliphatic > aromatic. Interestingly, for 
[BMIM][Br] and [BMIM][TfO], polar amino acids were more frequently substituted by a 
chemically similar amino acid and the order was therefore: polar > charged > aliphatic > 
aromatic. 
3.5.5.4 Substitution of Charged Amino Acids 
The substitution of charged amino acids with chemically different amino acids 
(aromatic, aliphatic, and polar) led to improved resistance “+” towards all four ILs. The most 
common amino acid substitution type to substitute charged amino acids was different for the 
four ILs. For [BMIM][Cl], a comparable number of improved variants was observed for 
substitutions to aromatic, aliphatic, polar, and also charged residues. In case of [BMIM][Br], 
the observed order was: charged > polar > aliphatic > aromatic. In case of [BMIM][I], 
charged > aromatic > aliphatic > polar, and in case of [BMIM][TfO] polar = aromatic > 
charged > aliphatic. Overall, chemically different amino acids (e.g. aromatic to 
polar/aliphatic/charged amino acids) were preferred in 66-95% of all substitutions (Table 
7-8).  
This finding lectures one more lesson for directed enzyme evolution: the probability to 
find BSLA variants with improved IL resistance reducing thereby the screening effort 
increases by random mutagenesis methods generating chemically diverse amino acid 
substitution patterns (e.g. from aliphatic to charged or to polar ones). Chemically diverse 
mutant libraries are generated with a transversion bias or by subsequent mutations in a codon 
(Seng Wong et al., 2004; Wong et al., 2007a; Zhao et al., 2014) and consequently, 
transversion enriched methods should be preferred (Mundhada et al., 2011). Remarkably, 
frequently used epPCR random mutagenesis methods possess a strong transition bias 
preserving the chemical properties (Wong et al., 2007c). 
3.5.6 Effect of the Location of Amino Acid Substitution on BSLA´s IL 
Resistance 
Around 29% amino acid residues of BSLA are buried and 71% are surface exposed. 
The solvent accessible surface for each residue was determined using the Accelrys Discover 
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Studio software package employing a water probe with a radius of 1.5 Å and a cutoff of <5% 
solvent accessibility for buried residues (Chothia, 1976) based on the chain A of the BSLA X-
ray crystal structure (PDB ID: 1I6W) (van Pouderoyen et al., 2001). The effect of amino acid 
location on IL resistance of BSLA is illustrated in Table 3-4A. Exposed and buried amino 
acid positions led to improved IL resistance (“+”) for all four types of substitutions. As 
reported for other enzymes (Chen et al., 2013; Liu et al., 2013; Nordwald and Kaar, 2013; 
Nordwald et al., 2014a), beneficial substitutions were located on the surface and in buried 
regions of BSLA. Analysis of the amino acid substitution patterns of surface exposed and 
buried amino acid revealed discrepancies. At exposed positions, charged substitutions resulted 
in more improved variants than polar substitutions when exposed to [BMIM][Cl], 
[BMIM][Br], and [BMIM][I], which all contained a halide anion (Cl
-
, Br
-
 or I
-
). These results 
differ from the natural distribution in BSLA WT (Table 3-4B) showing more aliphatic amino 
acids exposed as well as buried. An opposite trend was however, observed for [BMIM][TfO], 
in which more polar and charged amino acids were found to be beneficial for the resistance at 
exposed surfaces. Furthermore, at buried positions, polar substitutions were always preferred 
for improved IL resistance (type “+”) and yielded more improved variants than charged 
substitutions for all four ILs. Remarkably, the fraction of polar substitutions resulting in 
inactive BSLA variants (type “x”) was significantly higher (26% buried positions and 38% 
exposed positions). It is noteworthy that charged substitutions at the buried positions resulted 
in a high fraction of inactive variants (type “x”; 41%) and substitutions to polar amino acids 
predominantly lowered activity (type “-”; 39-44% for all four ILs). Moreover, 11 polar and 
only 4 charged amino acid residues were represented among all 53 buried positions (Table 3-
4B). Introduction of charged substitutions with stabilizing effects is difficult to achieve in 
buried positions and it is harder to find the counterpart amino acid to form a salt bridge than 
introduction of a polar substitution which is stabilized through H-bonds. Moreover, the α/β-
hydrolase fold is an evolutionary very successful protein fold which can be found in many 
hydrolases. Therefore, the results achieved for BSLA can likely be generalized to other 
hydrolases and enzyme classes with an α/β-hydrolase fold. 
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Table 3-4: Effect of the amino acid locations on IL resistance of BSLA when replacing each type of amino acid in 
BSLA WT. 16 patterns per IL are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids 
are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and R), and polar (C, M, P, S, T, 
N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved 
resistance, “=” representing variants with unchanged resistance, “-” representing variants with decreased resistance and “x” 
representing inactive variants in buffer. 
A 
 
 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is 
not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 18.2 % charged, and 8.3% aromatic). Highest values 
among the resistance type “+” are highlighted in blue. Column “x” shows that the number of inactive variants resulted from 
amino acid substitutions. The activity was measured in a buffer plate which was used as reference (absence of IL) for 
comparison. Therefore, the number of inactive variants was the same for the four ILs. 
B 
 
 
AA: amino acid 
Figure 3-5 to Figure 3-8 represent 3D models of BSLA for visualization of the 
beneficial positions found during screening with all four ILs. [BMIM[[Cl] showed few 
positions holding more than eight variants (colored in red) with improved IL resistance in the 
core of BSLA (Figure 3-5). In contrast, for [BMIM][Br], [BMIM][I], and [BMIM][TfO] in 
most cases only one variant per position (colored in blue) at buried positions (Figure 3-6 to 
Figure 3-8) was able to improve BSLA resistance. Besides, considering secondary structure 
  
  Location of amino acid positions in BSLA   
  Exposed positions (128; 71%) Buried positions (53; 29%) 
   
+ 
(343) 
= 
(1781) 
- 
(247) 
x 
(189) 
+ 
(119) 
= 
(473) 
- 
(159) 
x 
(309) 
[B
M
IM
][
C
l]
 
Aromatic  15% 14% 22% 15% 16% 12% 14% 19% 
Aliphatic  22% 27% 23% 17% 18% 34% 25% 14% 
Polar 30% 36% 34% 38% 38% 39% 40% 26% 
Charged 32% 24% 21% 30% 28% 15% 22% 41% 
          
  
+ 
(172) 
= 
(2077) 
- 
(122) 
x 
(189) 
+ 
(34) 
= 
(514) 
- 
(203) 
x 
(309) 
[B
M
IM
][
B
r]
 
Aromatic  16% 15% 20% 15% 12% 13% 14% 19% 
Aliphatic  23% 26% 17% 17% 26% 33% 21% 14% 
Polar 30% 35% 38% 38% 32% 39% 39% 26% 
Charged 31% 24% 25% 30% 29% 14% 27% 41% 
          
  
+ 
(236) 
= 
(1897) 
- 
(238) 
x 
(189) 
+ 
(27) 
= 
(418) 
- 
(306) 
x 
(309) 
[B
M
IM
][
I]
 Aromatic  19% 15% 15% 15% 15% 13% 13% 19% 
Aliphatic  19% 27% 22% 17% 26% 37% 20% 14% 
Polar 27% 35% 37% 38% 37% 35% 44% 26% 
Charged 34% 23% 26% 30% 22% 15% 22% 41% 
          
  
+ 
(248) 
= 
(1962) 
- 
(161) 
x 
(189) 
+ 
(44) 
= 
(463) 
- 
(244) 
x 
(309) 
B
M
IM
][
T
fO
] 
Aromatic  19% 14% 17% 15% 11% 12% 16% 19% 
Aliphatic  19% 27% 22% 17% 14% 36% 21% 14% 
Polar 33% 35% 31% 38% 43% 38% 39% 26% 
Charged 29% 24% 29% 30% 32% 14% 25% 41% 
Number of each type of amino acids exposed and buried in BSLA. 
Exposed AA residues   
  Aliphatic Aromatic Polar Charged Total 
Number of AA 44 (34%) 12 (9%) 43 (34%) 29 (23%) 128 (100%) 
Buried AA residues   
Number of AA 35 (66%) 3 (6%) 11 (21%) 4 (8%) 53 (100%) 
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elements of BSLA, more than 85% of the beneficial amino acid positions for IL resistance of 
BSLA were localized on the helices and loops of BSLA (Table 7-10). 
 
Figure 3-5: 3D model of BSLA (Protein Database code: 1I6W) displaying regions which contribute to the resistance of 
BSLA towards [BMIM][Cl] with a color scale. Positions at which no substitution led to improvements are colored grey. 
Positions with one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to 
improvements are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more 
substitutions leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, 
B) Van der Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. 
The two N-terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
 
 
Figure 3-6: 3D model of BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of [BMIM][Br] in a color scale. Positions at which no substitution led to improvements are colored grey. Positions 
with one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to 
improvements are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more 
substitutions leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, 
B) Van der Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. 
The two N-terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
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Figure 3-7: 3D model of BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of [BMIM][I] in a color scale. Positions at which no substitution led to improvements are colored grey. Positions 
with one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to 
improvements are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more 
substitutions leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, 
B) Van der Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. 
The two N-terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
 
 
 
Figure 3-8: 3D model of BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of [BMIM][TfO] in a color scale. Positions at which no substitution led to improvements are colored grey. 
Positions with one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to 
improvements are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more 
substitutions leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, 
B) Van der Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. 
The two N-terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
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3.5.7 The SSM-BSLAVariants Showing Improved IL Resistance ˃2.5-fold 
The results presented above (Figure 3-2 to Figure 3-8 and Table 3-2 to Table 3-4) are 
summarizing the overall general trends. At present section, the focus is on the best variants 
leading to an improvement of BSLA´s IL resistance >2.5-fold. As already mentioned, highest 
number of positions and substitutions for improved IL resistance were achieved for 
[BMIM][Cl]. Considering the single amino acid substitutions, 38 (1%) variants with 
resistance improvement >2.5-fold were found for [BMIM][Cl] which represented 28 (0.3%), 
31 (0.2%) and 32 (0.2%) variants for [BMIM][TfO], [BMIM][I], and [BMIM][Br] (Table 3-
5), respectively. Highest RV/RWT values (section 3.5) achieved for the ILs were 15.1, 12.5, 
7.1, and 5.0 for [BMIM][Cl], [BMIM][Br], [BMIM][TfO], and [BMIM][I], respectively. 
RV/RWT was obtained dividing the residual activity of each BSLA variant (RV) by the residual 
activity of BSLA WT (RWT) at each position and in each IL. Positions Met78 (helix, exposed) 
and Asp91 (loop, exposed) are the only two positions at which highest improvements were 
obtained for all four ILs. 
Comparing all types of amino acid exchanges (e.g aromatic exchanged by aromatic, 
aliphatic, polar, charged acidic, or charged basic), replacement of aliphatic residues in BSLA 
WT with charged acidic amino acids resulted in highest number of variants with improvement 
 >2.5-fold for all four ILs followed by replacement of polar residues in BSLA WT (Figure 3-
9). Interestingly, replacement of charged acidic residues with aromatic amino acids also 
resulted in many significantly more resistant variants. These results are in accordance with 
our previous findings on the general trend when considering all improved variants: 
substitutions of BSLA WT residues with polar and charged amino acids predominantly led to 
more improved variants. Furthermore, similar findings were obtained with variants displaying 
higher improvements (>2.5 fold) (Table 3-5). Met78 (helix, exposed) and Asp91 (loop, 
exposed) are both the only residues showing higher improvements for all four ILs. Chen et al. 
also found surface located residues contributing to increased specific activity for 
C2mim][OAc] pretreated substrate. They suggested that the presence of mutations on the 
surface of protein probably induced changes in the interaction mechanisms between protein 
and solvent system (Chen et al., 2013).  
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Table 3-5: Variants showing >2.5-fold improved IL resistance for all four ILs. The numbers represents improvement of each variant. All variants listed have a ratio >2.5-fold. Amino acids are 
grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged acidic (D, E), charged basic (H, K, and R), and polar (C, M, P, S, T, N, and Q). 
 
RV/RWT values are represented in blue bars for [BMIM][Cl], in grey bars for [BMIM][Br], in green bars for [BMIM][TfO], and in pink bars for [BMIM][I]. 
 
Chapter 3: Towards Understanding of Directed Evolution: More Than Half of All Amino 
Acid Positions Contributed to Ionic Liquid Resistance of Bacillus subtilis Lipase A  
83 
 
Although polar and charged substitutions led to higher number of improved variants 
for all four ILs when looking at all variants, highest improvements were however found by 
substitutions from charged acidic to aromatic amino acid (Asp91Trp) for [BMIM][Cl] 
(Rv/RWT = 15.1) and [BMIM][Tfo] (Rv/RWT = 7.1). This finding is supported by reports 
speculating that replacement of noncritical charged surface residues by uncharged amino 
acids can stabilize a protein for use in non-aqueous solvents (Arnold, 1988, 1990). This might 
be a result of the decreased hydrophobilicity of the protein surface, which is less dependent on 
solvation by water for proper folding (Arnold, 1988, 1990). In addition, Ala, Asn, and Leu 
were found to improve the stability of subtilisin E in presence of 80% v/v DMF (Martinez et 
al., 1992). 
 
Figure 3-9: Number of improved variants with >2.5-fold improved IL resistance according to the amino acid 
substitution of BSLA WT for all four ILs. Variants with a value >2.5-fold are represented here. The nature of the 
substitution for each variant is also illustrated. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, 
and G), charged acidic (D, E), charged basic (H, K, and R), and polar (C, M, P, S, T, N, and Q). 
Substitutions from polar to polar led to the variants with highest improvements (3.6-
fold) for [BMIM][I], and substitutions from charged basic to polar led to variants with highest 
improvements (8.7-fold) for [BMIM][Br]. Substitution of aliphatic residues in BSLA WT 
with charged acidic residues were found to lead to the highest number of improved variants 
(42%, 13 variants out of 31) with improvements >2.5-fold (figure 3-9). This correlates with a 
report speculating that addition of negative surface residues may repulse the binding of anions 
to the enzymes via electrostatic effects since the clustering of acidic amino acids on the 
surface of halophilic proteins were found to attract water molecules and therefore, increase 
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salt bridges, protein interaction and reduce aggregation. This might prevent salting out and 
stabilize the protein (Nordwald and Kaar, 2013).  
3.6 Conclusions 
This chapter attempted to elucidate the influence of each amino acid position, 
substitution, as well as the effect of their location on the resistance of Bacillus subtilis Lipase 
A (BSLA) in presence of four ILs. To achieve this goal, single site saturation mutagenesis at 
all the 181 amino acids of BSLA was performed and the obtained libraries were screened in 
the presence of four commonly used [BMIM]-based ILs ([BMIM][Cl], [BMIM][Br], 
[BMIM][I], and [BMIM][TfO]). Screening of the 181 generated BSLA libraries, revealed that 
>50% of amino acid positions contributed to improvements in four ILs resistance of BSLA. 
The latter demonstrates that directed evolution can very effectively improve IL resistance of 
BSLA and most likely other hydrolases. The high number of positions (50-69%) that improve 
IL resistance explains for the first time from an experimental point of view why often the 
screening of small sized libraries (1000-2000 variants) is sufficient to find improved variants. 
Additionally, screening efforts can be minimized by mutagenesis methods that introduce 
chemically different amino acids substitutions through transversions and consecutive 
mutations.  
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4 Nature of Amino Acid Residues Contributing to Organic 
Solvent Resistance of Bacillus subtilis Lipase A 
4.1 Abstract  
Native enzymes have not been designed to work in non-aqueous medium such as 
organic solvents (OS) which usually cause destabilization. Therefore, numerous attempts have 
been invested to enhance OS resistance of enzymes by strategies as protein engineering. In 
this chapter, the nature and location of amino acids substitutions as well as the number of 
positions influencing enzyme resistance towards three polar OS was investigated. The 
complete lipA gene from B. subtilis was subjected to site saturation mutagenesis (SSM), 
followed by screening in presence of dimethyl sulfoxide (DMSO), 1,4-dioxane, and 2,2,2-
trifluoroethanol (TFE). Increased OS resistance was obtained at 41-59% of BSLA positions 
but only with 4-10% of all possible BSLA single amino acid substitution variants. 
Additionally, improved OS resistance was mostly achieved with charged amino acids for 
1,4-dioxane and TFE and rather with polar amino acids for DMSO. Furthermore, two patterns 
of amino acid substitutions were obtained: polar substitutions primarily led to improved 
BSLA resistance towards DMSO while charged amino acids resulted in highest number of 
improved BSLA variants for 1,4-dioxane and for TFE. Furthmore, on the surface of BSLA 
charged substitutions primarily led to improved resistance while in the buried region of BSLA 
polar ones were more preferred. This emphasizes the importance of engineering surface 
residues for improving OS resistance of enzymes. Among the beneficial substitutions, 58-93% 
of improved substitutions were achieved with chemically different amino acids (e.g. aromatic 
amino acids substituted by polar/aliphatic/charged amino acids). Therefore, mutagenesis 
methods introducing transversions which will encode chemically different amino acids will be 
beneficial for generating variants with improved OS resistance at least for lipases like BSLA.  
 
Keyswords: BSLA, directed evolution, protein engineering, site saturation mutagenesis, 
Organic Solvents (OS).  
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4.2 Highlights 
Project objective:  
 A systematic study to understand the contribution of single amino acid substitution, 
position and location to BSLA resistance towards DMSO, 1,4-dioxane, and TFE. 
Main Findings:  
 4-10% of all amino acid substitutions at 41-59% of all amino acid positions 
contributed to improved OS resistance of BSLA. 
 Polar or charged amino acid substitutions primarily lead to improvement of BSLA´s 
OS resistance for DMSO and for 1,4-dioxane/TFE, respectively. 
 At exposed positions, charged substitutions mainly improved BSLA´s OS resistance 
towards all three OS. 
 At buried positions, polar substitutions were mainly favored improved BSLA´s OS 
resistance. 
 Substitutions with chemically different amino acids predominantly improved OS 
resistance of BSLA indicating that mutagenesis methods introducing transversions 
will be favorable for improving organic solvent resistance of lipases at least for BSLA. 
 
Novelty: 
 The first systematic investigation of whole sequence SSM-BSLA library for 
improving the OS resistance.  
 For the first time, from an experimental point of view explained why often the 
screening of small sized libraries (1000-2000 variants) is sufficient to find improved 
variants. 
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4.3 Introduction 
Organic Solvent (OS) are commonly used in industrial enzymatic reactions because of 
the numerous advantages they offer: increased solubility of substrates and products, easy 
product recovery, suppression of unwanted side reactions (Zaks and Klibanov 1985), and 
suppression of microbial contamination (Arnold, 1990; Castro and Knubovets, 2003). 
However, enzymes usually display optimal function in aqueous solutions where they fold with 
a define pattern according to the properties of the amino acids. Therefore, most of the 
enzymes dramatically lose their activity in presence of OS only with a few exceptions, e.g. 
three lipases (porcine pancreatic, Candida cylindracea; and Mucor sp.) maintained a robust 
catalytic activity in 99.98% 2-pentanone by a lipase-catalyzed transesterification reaction 
between tributyrin and heptanol (Zaks and Klibanov, 1985). The low activity of most 
enzymes in the presence of OS considerably limits their industrial applicability. 
Enzymes are usually designed by nature to mostly have ionizable amino acid residues 
forming a hydrophilic area on the surface which is in contact with the aqueous environment, 
while hydrophobic ones are sequestered inside the enzyme to form the hydrophobic core and 
neutral ones occupy intermediate positions (Oobatake and Ooi, 1993). The structural 
conformation of enzymes is maintained through intramolecular interactions among the amino 
acid residues (Ogino and Ishikawa, 2001). Besides, the aqueous phase surrounding enzymes 
also interacts with enzymes through electrostatic and hydrophobic interactions (Arnold, 1990; 
Doukyu and Ogino, 2010).  
Effects of OS on enzymatic properties differ according to their polarity. Hydrophilic OS 
with similar polarity to water can form a homogeneous co-solvent system (Park et al., 2012), 
in which organic molecules can strip or replace water molecules inside and around an enzyme 
causing deformation or denaturation (Ogino and Ishikawa, 2001; Yang et al., 2004). 
Hydrophobic OS are in contrast unable to remove substantial amounts of water from enzyme 
(Gorman and Dordick, 1992) and are therefore more friendly to enzymes. Besides, it was 
found that OS molecules can compete with the substrate molecules to enter the substrate 
tunnel and coordinate the haem iron leading to inhibition of P450 BM3 (Kuper et al., 2012; 
Seng Wong et al., 2004). Almost total inactivation effect of organic cosolvent on enzyme can 
be expected at concentrations above at 60-70% (v/v) (Stepankova et al., 2013). 
In the last years, numerous studies have focused on investigating the effects of OS on 
enzymes properties such as stability (Kawata and Ogino, 2009, 2010; Koudelakova et al., 
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2013; Liu et al., 2009; Martinez and Arnold, 1991; Stepankova et al., 2013; Timasheff, 1993), 
which plays a crucial role in the industrial applicability of enzymes. Isolation of novel 
enzymes, protein engineering, and medium engineering are strategies developed to achieve 
increased enzymes stability/resistance in presence of OS (Carrea and Riva, 2000; Illanes et 
al., 2012; Stepankova et al., 2013).  
Protein engineering has been successfully used to improve catalytic properties of 
numerous enzymes under reaction conditions including also OS tolerance (Carrea and Riva, 
2000; Klibanov, 2001; Stepankova et al., 2013). Due to the lack of understanding of the 
complex interactions between enzyme and solvent molecules, improvement of OS stability of 
enzymes has been mostly obtained by means of directed evolution (Chen and Arnold, 1991, 
1993; Dror et al., 2014; Kawata and Ogino, 2009; Kumar et al., 2006; Seng Wong et al., 
2004; Song and Rhee, 2001; Takahashi et al., 2005; Zumárraga et al., 2007a, 2007b). Only 
few cases for enhanced OS stability by rational design have been reported (Dror et al., 2014; 
Kawata and Ogino, 2010; Martinez et al., 1992; Park et al., 2012, 2013; Takagi et al., 2000) 
and semi-rational design yielded in few cases OS tolerant variants (Reetz et al., 2006, 2010; 
Yedavalli and Rao, 2013).  
The goal of this study was to investigate the contribution of single amino acid 
substitutions at each amino acid position of BSLA to improve BSLA resistance towards the 
polar OS dimethyl sulfoxide (DMSO), 1,4-dioxane, and 2,2,2-trifluoroethanol (TFE). BSLA 
belongs to the lipase subfamily I-4, contains 181 amino acid residues in its mature form and 
shares 74-80% sequence identity with other members of this subfamily (Arpigny and Jaeger, 
1999; Bustos-Jaimes et al., 2010). Here for the first time, a comprehensive statistical data 
analysis was performed to determine the number of amino acid positions and substitutions 
contributing to BSLA´s OS resistance. Thus, all amino acid positions and substitutions 
displaying improved OS resistance of BSLA were identified. Further, trends in chemical 
composition of beneficial amino acid substitutions as well as the importance of residues 
location (surface exposed and buried amino acids) were elucidated.  
4.4 Experimental Section 
All chemicals, reagents and methods used in this part were described in chapter 2. 
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4.4.1 Optimization of Screening Conditions in OS 
In this chapter, the generated 181 SSM-BSLA libraries were screened in the presence of 
DMSO, 1,4-dioxane and TFE (Figure 4-1). In order to determine the concentration of the 
three OS for SSM libraries screening, the solvents were supplemented with TEA buffer (pKa 
7.76, pH 7.4, 50 mM) to obtain OS with different concentrations. All three OS were water-
miscible as described in the safety sheets provided by the suppliers Sigma Aldrich (Steinheim, 
Germany) and Carl Roth (Karlsruhe, Germany). Besides, the shifts in pH of the buffer 
solutions were less than 0.22 units of pH in the presence of OS. Concentrations leading to a 
residual activity between 30% and 40% of the BSLA WT were chosen to screen all libraries. 
The screening assay with OS was performed in polypropylen MTP (flat-bottomed, 
polypropylen MTP plate, Greiner Bio-One GmbH, Frickenhausen, Germany), which are 
resistant to OS as 1,4-dioxane. In each well of a 96-well MTP, 10 µL supernatant were 
incubated with 90 µL of the OS solution (2 h, 1000 rpm, RT) on a shaker (Edmund Bühler 
Microtiter shaker, Hechingen, Germany) at the adjusted OS concentration (Table 4-1). An 
additional plate only with buffer as reference was measured for each position to enable the 
calculation of the residual activity given as percentage (2.2.4.5). The freshly prepared 
substrate solution (100 µL/well) was added to the incubation mixture and the change in 
absorbance was monitored (410 nm, 8 min, RT). For each well, the same amount of 
supernatant was incubated with or without OS and the ratio of ‘activity in presence of OS 
divided by the activity in absence of OS’ was used to evaluate the organic solvent resistance 
of BSLA variants. This ratio was not influenced even when using 2-3 times more BSLA 
supernatant. 
  
 
DMSO TFE 1,4-Dioxane 
Figure 4-1: Chemical structure of the three selected OS: DMSO = dimethyl sulfoxide, TFE = 2,2,2-trifluoroethanol. 
4.5 Results and Discussion 
Many different enzyme classes (e.g. hydrolases, oxidoreductases, transferases, etc.) 
have been successfully tailored for improved OS stability by using protein engineering 
(Carrea and Riva, 2000; Stepankova et al., 2013). These studies also provided initial clues to 
Chapter 4: Nature of Amino Acid Residues Contributing to Organic Solvent Resistance of 
Bacillus subtilis Lipase A 
91 
 
reengineer focused regions of enzymes (e.g. substrate access tunnel and substrate binding 
pocket) and to strengthen the interactions between amino acids (e.g. introducing disulfide 
bridges) for improved OS resistance stability or tolerance. However, in most cases, protein 
engineering strategies for stabilization in OS are usually based on empirical observations 
rather than guided by detailed molecular understanding. In a systematic study through 
screening of a complete saturation mutagenesis library of BSLA (181 SSM-BSLA libraries) 
in the presence of three OS, the following questions were addressed: 1) how many single 
positions can contribute to improved OS resistance of BSLA, 2) what types of amino acid 
substitutions influence the OS resistance of BSLA, and 3) how does the location of amino 
acids (surface exposed or buried) affect the OS resistance of BSLA.  
The SSM-BSLA libraries covered all 181 amino acid positions of BSLA and each of 
the 3620 naturally possible variants were generated and confirmed by extensive sequencing. 
The results in this chapter were analyzed in eight sections as described in chapter 3. The first 
section describes the generation of the SSM libraries for the complete gene encoding the 
BSLA amino sequence. The second section focuses on the conditions used for the screening 
of SSM-BSLA libraries in the presence of the three used OS. The third section deals with the 
analysis of the number of amino acids positions which influence OS resistance of BSLA 
(improved/decreased/unchanged OS resistance and inactivation). In the fourth section, all 
substitutions were analyzed to determine the number of single amino acid substitutions on 
BSLA resistance towards the three OS. The amino acid substitutions were categorized into 
four types (aromatic, aliphatic, polar, and charged) and the influence of each type of amino 
acid on BSLA resistance was elucidated in the fifth section. The sixth section mainly focuses 
on the effect of substituting each type of amino acid with all four types. The seventh section 
discusses the effect of amino acid locations on OS resistance of BSLA. In the last section, 
best variants contributing to highest BSLA resistance in each OS were investigated. The 
results for all variants and positions were categorized as described in chapter 3 to allow 
efficient comparison. 
4.5.1 Screening Conditions for BSLA Libraries in the Presence of Three OS 
All 3620 BSLA variants were screened in the presence of three OS (DMSO, 1,4 
dioxane and TFE). Organic solvent concentrations were selected to obtain a residual BSLA 
WT activity of 30% to 40% (Table 4-1). True standard deviations of 9.6% to 12.0% were 
obtained for the screening system with the three OS as co-solvents. Screening systems with 
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true standard deviations around 12% were commonly used in directed evolution experiments 
(Wong et al., 2007c).  
Table 4-1: OS used for the screening of BSLA libraries. Calculated standard deviations of the screening system are also 
showed. C: concentration, RA: residual activity, stdev: standard deviation, App: apparent. DMSO = Dimethyl sulfoxide, TFE 
= 2,2,2-trifluoroethanol.  
 
Selected OS C [M](%v/v) RWT [%] App stdev [%] True stdev [%] 
DMSO 8.4 ( 60.0 ) 29.0 8.0 10.5 
1,4-dioxane 2.6 (  22.0) 31.0 6.5 9.6 
TFE 2.9 (   12.0) 30.0 7.6 12.0 
 
 
* Concentration used in the incubation steps. 
Table 4-1 shows that BSLA is more resistant to DMSO than to TFE and 1,4-dioxane. 
Indeed, maybe because of its strong acceptor capacity, DMSO (8.4 M) resulted in around 70% 
deactivation effect as well as the weak acceptor 1,4-dioxane (2.6 M) and the weak 
donor/strong acceptor TFE (2.9 M). The dependence of enzyme stability/resistance to the 
hydrophobicity/hydrophilicity of OS has already been established (Carrea and Riva, 2000; 
Klibanov, 1997; Serdakowski and Dordick, 2008). It is well known that the hydrophobic OS 
are less harmful than hydrophilic ones (Zaks and Klibanov, 1988) because of their weak 
ability to remove water from the enzymes. LogP value (defined as the octanol water partition 
of OS and also used as a measure of hydrophobicity) is commonly used to describe the 
hydrophobicity/hydrophilicity of OS (Laane et al., 1987). It is worth mentioning that 
hydrophobicity of OS increases with increased logP and hydrophilicity increased with 
decreased logP. However, the obtained results (Table 4-1) did not correlate with 
hydrophobicity/hydrophilicity of OS (as quantified by logP) (Degn and Zimmermann, 2001; 
Lee et al., 2004) and showed that more improved BSLA variants were obtained for DMSO, 
the most hydrophilic of the three OS. The hydrophilicity order of the selected OS is as 
following: DMSO (-1.12) > 1,4-dioxane (0.17) > TFE (0.31) (Chakravorty et al., 2012; Wu et 
al., 2004). Molecular docking studies predicted that hydrophilic OS (logP < 2, e.g ethanol, 
DMSO, 1,4-dioxane) inactivated the lipase BSLP1 by disrupting the interactions between the 
active sites with water molecules (Chakravorty et al., 2012). Therefore, the inactivation of 
enzymes by OS could be due to multiple reasons. Improved DMSO resistance has been also 
successfully described in other studies: directed evolution of subtilisin E (Chen and Arnold, 
1993), P450 monooxygenase (Wong et al., 2004b), a lipase from Pseudomonas aeruginosa 
(Kawata and Ogino, 2009), and BSLA (Reetz et al., 2010; Yedavalli and Rao, 2013). 
After screening of all 181 SSM-BSLA libraries in buffer and in the presence of each 
of the three OS, residual activity of variant (RV) and the residual activity of WT (RWT) were 
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calculated. Based on the Gaussian distribution curve ( is the true coefficient of variation of 
the screening system see Table 4-1), all the variants were grouped into four categories as 
described previously in chapter 3. 
4.5.2 Influence of the Number of Amino Acid Positions on BSLA’s OS 
Resistance 
Figure 3-2 depicts the number of amino acid positions of BSLA that led to 
improved/unchanged/decreased OS resistance as well as inactivation of BSLA. For the OS 
resistance type “+”, it was found that DMSO (107; 59% of all positions) yields 32 to 33 more 
positions than 1,4-dioxane (75; 41%) and TFE (74; 41%) , respectively. For the OS resistance 
type “=”, at each of the 181 amino acid positions at least one amino acid substitution was 
found that did not influence OS resistance of BSLA. For the OS resistance type “-”, it was 
found that 1,4-dioxane (136, 75% of all positions) yields more positions than TFE (120; 66%) 
~ DMSO (118; 65%). For the resistance type “x”, at least one amino acid substitution was 
found at 99 (55%) amino acid positions which inactivated BSLA already in the buffer 
solution. Detailed analysis of the number of substitutions at each amino acid position of 
BSLA leading to improved/decreased/unchanged OS resistance and inactivation are given in 
Table 7-11 to Table 7-13. 
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Figure 4-2: Number of amino acid positions which lead to improved/unchanged/decreased OS and/or inactivation of 
BSLA in buffer. All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved 
resistance, “=” representing variants with unchanged resistance, “-” representing variants with decreased resistance and “x” 
representing inactive variants in buffer. 
4.5.3 Influence of the Number of Single Amino Acid Substitutions on BSLA´s 
OS Resistance 
The number of variants with improved “+”, unchanged “=”, decreased “-” resistance in 
presence of DMSO, 1,4-dioxane, and TFE as well as ‘‘inactive’’ variants “x” is depicted in 
Figure 4-3. DMSO (371 out of 3620, 10% of all substitutions) yields 190 substitutions more 
than TFE (181, 5%) and 212 more than 1,4-dioxane (159, 4%) for the OS resistance type “+”. 
Among the variants with increased resistance towards TFE, 0.17% showed a resistance 
improvement higher than 2.5-fold, which is 6-fold higher than the values obtained for DMSO 
and 1,4-dioxane (0.03%). Overall, a large majority 61-63% (2212-2288 out of 3620) of all 
substitutions did not influence BSLA resistance type “=” towards the three selected OS. 
Similar results were achieved for the OS resistance type “-” in 1,4-dioxane (675 out of 3620, 
19% of all substitutions) and TFE (664, 18%) in which 136 and 125 more substitutions than 
DMSO (539, 15%) were identified, respectively. BSLA inactivation type “x”, was obtained 
for 498 (14%) substitutions. 
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Figure 4-3: Number of SSM-BSLA variants leading to improved/unchanged/decreased OS resistance and inactivation 
of BSLA. All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, 
“=” representing variants with unchanged resistance, “-” representing variants with decreased resistance and “x” representing 
inactive variants in buffer. 
 
Interestingly, a similar number of positions and substitutions/variants contributing to 
improved BSLA resistance towards 1,4-dioxane and TFE were observed. As strong acceptor, 
DMSO however, displayed around 1.4-fold more positions (59%) for improved resistance 
than 1,4-dioxane (41%) and TFE (41%) (Figure 4-2). Around 2-fold more variants with 
improved OS resistance were obtained for DMSO (10%) than for 1,4-dioxane (4%) and TFE 
(5%) (Figure 4-3). Therefore, there is a higher chance to identify improved variants for 
DMSO resistance than for 1,4-dioxane and TFE from a random mutagenesis library with 
single substitutions. Furthermore, 6-fold more variants with >2.5-fold improved resistance 
were obtained for TFE (0.17%) than for DMSO (0.03%) and for 1,4-dioxane (0.03%), which 
are very difficult to be identified from a random mutagenesis library. This also explains why 
it is feasible to use strategy of accumulating single mutations with modest improvements to 
obtain high improvements by screening iterative rounds of random mutagenesis library. 
4.5.4 Effect of Amino Acid Substitution “Types” (Aromatic, Aliphatic, Charged, 
Polar) on BSLA´s OS Resistance  
The 20 amino acid substitutions were grouped into four “types” in order to be 
consistent with previous reports (Verma et al., 2014; Wong et al., 2006b, 2007a) as 
mentioned before: 15% aromatic (F, Y, and W), 25% aliphatic (A, V, L, I, and G), 25% 
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charged (D, E, H, K, and R) and 35% polar (termed neutral in the cited paper; C, M, P, S, T, 
N, and Q) amino acids. Proline (P), cysteine (C), and glycine (G) are classified elsewhere as 
special amino acids. Figure 4-4 provides information about the effect of each type of amino 
acid substitution on BSLA resistance towards the three OS. Inactive variants were defined as 
the variants which showed no activity in buffer. Supplementing of OS did not in single case 
lead to regain of BSLA activity. Among the 498 inactive BSLA variants (“x” type in buffer), 
charged substitutions harbored 183 (37%), polar 152 (31%), aromatic 87 (17%), and aliphatic 
76 (15%). 
Figure 4-4 A to C provides an overview of improvements for the OS resistance type 
“+” towards DMSO resistance in case of 126 out of 371 to polar amino acids (34%), 117 to 
charged (33%), 88 to aliphatic (24%), and 40 to aromatic (11%). For 1,4-dioxane resistance, 
62 out of 159 to charged (39%), 47 to polar (30%), 26 to aliphatic (16%), and 24 to aromatic 
(15%) were obtained. TFE resulted in 62 out of 181 variants to charged (34%), 57 to polar 
(31%), 34 to aromatic (18%), and 28 to aliphatic (15%). The highest number of improved 
BSLA variants were obtained for DMSO (126) followed by 1,4-dioxane and TFE with each 
62 variants (Figure 4-4 A-C). In summary, BSLA variants with predominantly charged amino 
acid substitutions represented the majority of substitutions that improved resistance in TFE 
and 1,4-dioxane. However, polar amino acids were preferential for improved DMSO 
resistance of BSLA. 
A similar amino acid substitution pattern was observed for all three OS for the organic 
solvent resistance type “=”: 36% polar, 28-29% aliphatic, 20-22% charged, and 14-15% 
aromatic (Table 4-2). 
Table 4-2: Number of each type of amino acid substitution for each resistance type for all three OS. All SSM-
BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” 
representing variants with unchanged resistance, “-” representing variants with decreased resistance and “x” 
representing inactive variants in buffer. 
Resistance type Aromatic [%] Aliphatic [%] Polar [%] Charged [%] 
+ 11-19 15-28 30-34 32-39 
= 14 28-29 36 20-22 
- 15-19 21-23 35-37 24-28 
x 17 15 31 37 
 
The organic solvent resistance type “-” showed 197 polar amino acids (37%), 127 
charged (24%), 111 aliphatic (21%), and 104 aromatic (19%) out of 539 substitutions for 
DMSO. For 1,4-dioxane, 242 polar (36%), 191 charged (28%), 132 aliphatic (20%), and 110 
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(16%) aromatic out of 675 substitutions were obtained. In case of TFE, 230 out of 664 to 
polar (41%), 181 to charged (27%), 153 to aliphatic (23%), and 100 to aromatic (15%) were 
achieved. BSLA variants with polar amino acid substitutions largely led to decreased 
resistance for the three OS and significant difference in the total number was observed (539 
substitutions for DMSO vs 675 in 1,4-dioxane). A similar trend was also observed for the four 
ILs as described in chapter 3. The amino acid composition of BSLA (8.3% aromatic, 43.6% 
aliphatic, 29.8% polar, and 18.2% charged amino acids) was optimized by nature for its 
performance in aqueous solution with a preference for aliphatic amino acids. The 
investigation of individual effect of each type of substitution when replacing each type of 
amino acid in BSLA WT showed that improved variants can be obtained by substitutions with 
aromatic (11-19%), aliphatic (15-28%), polar (30-34%), and charged (32-39%) amino acids. 
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Figure 4-4: Distribution of amino 
acid substitutions of SSM-BSLA 
libraries with improved/unchanged 
/decreased OS resistance. 
A: Resistance towards DMSO, 
B: Resistance towards 1,4-dioxane, 
C: Resistance towards TFE, 
D: Distribution of the 20 amino 
acids, and amino acid composition of 
BSLA WT. Amino acids are grouped 
into: aromatic (F, Y, and W), 
aliphatic (A, V, L, I, and G), charged 
(D, E, H, K, and R), and polar (C, M, 
P, S, T, N, and Q). The X-axis 
represents the extent of resistance 
improvement of BSLA variants 
toward different OS in four 
categories (“+”; “=”; “-“, and “x”). 
The primary Y-axis (on the left) 
displays the total number of variants 
and positions, at which an effect on 
BSLA resistance is observed. The 
secondary Y-axis (on the right) 
represents the chemical distribution 
of the amino acids in categories. All 
SSM-BSLA variants were grouped as 
described in the text: “+” 
representing variants with improved 
resistance, “=” representing variants 
with unchanged resistance, “-” 
representing variants with decreased 
resistance and “x” representing 
inactive variants in buffer. AA: 
amino acid. 
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The number of beneficial substitutions for DMSO (Figure 4-4A) was obtained in the 
order: polar > charged > aliphatic > aromatic. The order for 1,4-dioxane (Figure 4-4B) was 
rather: charged > polar > aliphatic ≥ aromatic and for TFE (Figure 4-4C): charged > polar > 
aromatic > aliphatic. The following order was observed for the variants with OS resistance 
type “=“: polar > aliphatic > charged > aromatic for all three OS. For organic solvent 
resistance type “-”, the number of variants followed this order: polar > charged > aliphatic > 
aromatic in presence of all three OS. Overall, substitutions to charged amino acids mainly led 
to improvements in 1,4-dioxane and TFE. In contrast, substitutions to polar residues mostly 
improved BSLA for DMSO resistance (Table 4-2). Both charged and polar residues have 
been reported to contribute to improved enzymes properties in OS (Chen et al., 1991; Park et 
al., 2012, 2013; Song and Rhee, 2001; Takahashi et al., 2005; Zumárraga et al., 2007a). It is 
likely that charged and polar residues could enable the formation of hydrogen bonds between 
amino acid residues or between surface residues and water molecules which help maintaining 
the enzyme structure intact (Park et al., 2012).  
4.5.5 Effect of Amino Acid Substitution Types on OS Resistance of BSLA: 
Comparison Between WT and SSM-BSLA Variants 
The effect of each type of amino acid substitution (polar, aliphatic, charged and 
aromatic) on organic solvent resistance of BSLA is presented in Table 4-3 in a matrix of 16 
substitution types. In all cases, substitutions to chemically different amino acids led to 
improved OS resistance with significant differences in orders and trends which are reported in 
detail in the following four paragraphs. Table 4-2 provides general trends on amino acid 
substitution patterns and answers in contrast to Figure 4-4 the question what kind of preferred 
types (aromatic, aliphatic, polar and charged) of amino acid exchanges exist. Table 7-14 
shows the effect of charged acidic and charged basic amino acids. 
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Table 4-3: Effect of each amino acid type substitution (polar, aliphatic, charged and aromatic) on OS resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 patterns 
per OS are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and 
R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants with unchanged 
resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer.  
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
  
  Amino acid types in BSLA-WT   
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
   
+ 
(44) 
= 
(193) 
- 
(36) 
x 
(27) 
+ 
(155) 
= 
(843) 
- 
(269) 
x 
(313) 
+ 
(108) 
= 
759) 
- 
(136) 
x 
77) 
+ 
(64) 
= 
(417) 
- 
98) 
x 
81) 
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O
 Aromatic  
7% 20% 8% 0% 9% 14% 17% 19% 8% 14% 24% 19% 22% 12% 21% 15% 
Aliphatic  32% 26% 17% 19% 21% 32% 20% 12% 23% 28% 16% 16% 25% 24% 30% 25% 
Polar 27% 36% 33% 44% 41% 36% 39% 27% 32% 36% 34% 29% 25% 35% 36% 43% 
Charged 34% 18% 42% 37% 29% 18% 24% 42% 36% 22% 26% 36% 28% 29% 13% 17% 
                  
  
+ 
(19) 
= 
195) 
- 
(59) 
x 
(27) 
+ 
(60) 
= 
(827) 
- 
(380) 
x 
(313) 
+ 
(56) 
= 
(780) 
- 
167) 
x 
(77) 
+ 
(24) 
= 
(486) 
- 
(69) 
x 
(81) 
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Aromatic  5% 22% 3% 0% 17% 13% 15% 19% 16% 13% 22% 19% 17% 14% 19% 15% 
Aliphatic  26% 26% 25% 19% 13% 34% 18% 12% 16% 28% 19% 16% 17% 26% 22% 25% 
Polar 21% 35% 34% 44% 32% 37% 39% 27% 32% 37% 32% 29% 25% 35% 32% 43% 
Charged 47% 17% 37% 37% 38% 16% 28% 42% 36% 23% 27% 36% 42% 25% 28% 17% 
  
                
  
+ 
(12) 
= 
(211) 
- 
(50) 
x 
(27) 
+ 
(69) 
= 
836) 
- 
362) 
x 
313) 
+ 
(62) 
= 
(751) 
- 
(190) 
x 
77) 
+ 
(38) 
= 
(479) 
- 
(62) 
x 
(81) 
T
F
E
 
Aromatic  8% 19% 6% 0% 23% 12% 17% 19% 18% 15% 14% 19% 16% 15% 16% 15% 
Aliphatic  0% 27% 28% 19% 14% 33% 20% 12% 19% 26% 28% 16% 16% 26% 23% 25% 
Polar 33% 34% 34% 44% 29% 38% 37% 27% 26% 38% 31% 29% 45% 33% 32% 43% 
Charged 58% 20% 32% 37% 33% 18% 26% 42% 37% 22% 28% 36% 24% 26% 29% 17% 
 
Amino acid types in BS  T
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4.5.5.1 Substitution of Aromatic Amino Acids 
The substitution of aromatic amino acids with chemically different amino acids 
(aliphatic, charged, and polar) led to significantly improved resistance “+” towards all three 
OS. The number of improved variants for DMSO and 1,4-dioxane were obtained in the 
following order of substitution types: charged > aliphatic > polar > aromatic. The order 
obtained in TFE was: charged > polar > aromatic > aliphatic. 
4.5.5.2 Substitution of Aliphatic Amino Acids 
The substitution of aliphatic amino acids with chemically different amino acids (polar 
and charged) led to more variants with improved resistance type “+” towards all three OS. 
The number of improved variants achieved in DMSO was with the substitution types: polar > 
charged > aliphatic > aromatic. The order obtained in 1,4-dioxane and TFE was: charged > 
polar > aromatic > aliphatic. 
4.5.5.3 Substitution of Polar Amino Acids 
The substitution of polar amino acids with chemically different amino acids (charged) 
led to more variants with the resistance type “+” than its own type towards all three OS. The 
order obtained in DMSO was: charged > polar > aliphatic > aromatic. However, in 1,4-
dioxane and TFE, the order was rather: charged > polar > aliphatic = aromatic. 
4.5.5.4 Substitution of Charged Amino Acids 
The substitution of charged amino acids with chemically different amino acids 
(aromatic, aliphatic, and polar) did not yield more variants with resistance type “+” towards 
any of the three OS. For DMSO and 1,4-dioxane, more resitant variants were in many cases 
the results of an exchange from a charged amino acid to a chemically similar amino acid 
(charged amino acid). Accordingly, the obtained order was: charged > polar = aliphatic > 
aromatic for DMSO and charged > polar > aliphatic = aromatic for 1,4-dioxane. TFE was the 
only OS with a preference for substitution with chemically different amino acids: polar > 
charged > aliphatic = aromatic. 
Overall, substitution of aromatic, polar, charged and aliphatic amino acid residues with 
chemically different ones  yielded more improved variants (68-95%) than with its own type 
for all three OS (Table 7-15). Similar trends were also reported for BSLA resistance towards 
ionic liquids (Frauenkron-Machedjou et al., 2015). Chemically different amino acids 
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substitutions were preferred to achieve improved BSLA resistance for four ionic liquids by 
replacement of aromatic, polar and aliphatic amino acids. As described here, charged residues 
were also found to mostly favor replacements with chemically similar residues (Frauenkron-
Machedjou et al., 2015). 
4.5.6  Effect of the Location of Amino Acid Substitution on BSLA´s OS 
Resistance 
About 71% amino acid residues of BSLA are surface exposed and 29% are buried, 
solvent accessible surface for each residue was calculated as described in chapter 3 based on 
the chain A of the BSLA X-ray crystal structure (PDB ID: 1I6W)(van Pouderoyen et al., 
2001). Table 4-4 and Table 7-16 illustrate the effect of amino acid location on OS resistance 
of BSLA. 
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Table 4-4 Effect of amino acid location on organic OS of BSLA when replacing each type of amino acid in BSLA WT. 
16 patterns per OS are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped 
into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and R), and polar (C, M, P, S, T, N, and Q). 
All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” 
representing variants with unchanged resistance, “-” representing variants with decreased resistance and “x” representing 
inactive variants in buffer.  
 
A 
 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is 
not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 18.2% charged, and 8.3% aromatic). Highest values 
among the resistance type “+” are highlighted in blue. Column “x” shows that the number of inactive variants resulted from 
amino acid substitutions. The activity was measured in a buffer plate which was used as reference (absence of OS) for 
comparison. Therefore, the number of inactive variants was the same for three OS. 
 
B 
 
 
AA: amino acid 
The substitutions with charged amino acids on the surface of BSLA yielded to more 
improved variants than the other three type of substitutions for all three OS: DMSO (35%), 
1,4-dioxane (41%), and TFE (34%). In contrast, substitutions with polar amino acids in the 
buried part of BSLA yielded more improved variants than the other kinds of substitutions for 
all three OS: DMSO (44%), 1,4-dioxane (52%), and TFE (38%) (Table 4-4). Substitutions of 
surface located residues were found in numerous cases to contribute to the O resistance of 
enzymes (Kawata and Ogino, 2009; Martinez et al., 1992; Park et al., 2013, 2012). For 
instance, amino acid substitutions located on the surface of a Pseudonomas aeruginosa 
  
  Location of amino acid positions in BSLA   
  Exposed positions (128; 71%) Buried positions (53; 29%) 
   
+ 
(275) 
= 
(1777) 
- 
(319) 
x 
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+ 
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 Aromatic  10% 15% 22% 15% 14% 12% 16% 19% 
Aliphatic  25% 27% 21% 17% 21% 36% 20% 14% 
Polar 31% 36% 33% 38% 44% 36% 41% 26% 
Charged 35% 23% 24% 30% 22% 15% 23% 41% 
  
                
  
+ 
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= 
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(385) 
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e Aromatic  16% 15% 17% 15% 10% 12% 15% 19% 
Aliphatic  17% 27% 19% 17% 14% 39% 20% 14% 
Polar 26% 35% 35% 38% 52% 40% 37% 26% 
Charged 41% 23% 28% 30% 24% 9% 28% 41% 
  
                
  
+ 
(152) 
= 
(1883) 
- 
(336) 
x 
(189) 
+ 
(29) 
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(394) 
- 
(328) 
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(309) 
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Aromatic  19% 15% 15% 15% 17% 12% 15% 19% 
Aliphatic  16% 27% 24% 17% 10% 37% 22% 14% 
Polar 30% 36% 32% 38% 38% 40% 38% 26% 
Charged 34% 23% 29% 30% 34% 11% 26% 41% 
 
Number of each type of amino acids exposed and buried in BSLA. 
Exposed AA residues   
  Aliphatic Aromatic Polar Charged Total 
Number of AA 44 (34%) 12 (9%) 43 (34%) 29 (23%) 128 (100%) 
Buried AA residues   
Number of AA 35 (66%) 3 (6%) 11 (21%) 4 (8%) 53 (100%) 
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LST03 lipase were identified by directed evolution to play an important role in improving its 
organic solvent-stability. Ogino et al. speculated that these substitutions on the surface 
increased enzyme stability in OS because they maybe efficient to prevent the penetration of 
OS inside of the enzyme (Kawata and Ogino, 2009; Ogino et al., 2007). As previously 
reported (Frauenkron-Machedjou et al., 2015), the fraction of polar substitutions resulting in 
inactive BSLA variants (type “x”) was significantly enhanced from 26% (buried positions) to 
38% (exposed positions). Remarkably, charged substitutions at the buried positions rose the 
fraction of inactive variants (type “x”; 41%) and substitutions to polar amino acids 
predominantly lowered activity (type “-”; 32-41% for all three OS). Moreover, substitutions 
that improved OS resistance in this study were mostly located on loops (44% for DMSO, 47% 
for 1,4-dioxane, and 43% for TFE and on helices (34 % for DMSO, 36% for 1,4-dioxane, and 
43% for TFE) as described in Table 7-17. Yedavalli and Rao performed site saturation 
mutagenesis (SSM) of the loop regions of Bacillus subtilis lipase A (BSLA) to find DMSO 
resistant BSLA variants. They identified six mutations that led to 8-fold in higher catalytic 
turnover in 60% DMSO after one round of selection. Additionally, three of the six mutations 
increased the surface polarity suggesting that substitution of more polar amino acids may be 
helpful to improve the stability of a protein in a water-miscible OS (Yedavalli and Rao, 2013). 
Since BSLA shows high sequence identity with the other members of the lipase subfamily I-4, 
the trend observed here can likely be applicable for other members and possibly in all other 
enzymes with an α/β hydrolase fold.  
Figure 4-5 to Figure 4-7 illustrates 3D models of BSLA for visualization of the 
beneficial positions (front and back view of surface/buried positions) found during screening 
with the three OS. Most positions harboring more than eight substitutions (colored in red) 
with improved OS resistance were observed for DMSO. Those beneficial positions were 
gathered located on the back site of the protein surface (Figure 4-5). Interestingly, positions 
harboring more than eight beneficial substitutions in the core were observed only for DMSO 
(Figure 4-5 to Figure 4-7). Positions in the core with only one improved variant (colored blue) 
or no improved variants (colored grey) can be observed for 1,4-dioxane and TFE in Figure 4-
6 and Figure 4-7, respectively implying that the wild type amino acids located in BSLA´s core 
could be weak residues for BSLA resistance. Besides, considering BSLA secondary structure 
elements, 43 to 47% of the beneficial amino acid positions for OS resistance of BSLA were 
localized on the loops of BSLA (Table 7-17). 
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Figure 4-5: 3D model of BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of DMSO in a color scale. Positions at which no substitution led to improvements are colored grey. Positions with 
one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to improvements 
are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more substitutions 
leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, B) Van der 
Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. The two N-
terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
 
 
Figure 4-6: 3D model auf BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of 1,4-dioxane in a color scale. Positions at which no substitution led to improvements are colored grey. Positions 
with one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to 
improvements are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more 
substitutions leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, 
B) Van der Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. 
The two N-terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
A front view (beneficial substitutions) 
 
B surface front view 
 
C buried front view 
 
back view (beneficial substitutions) 
 
surface back view 
 
buried back view 
 
 
A front view (beneficial substitutions) 
 
B surface front view 
 
C buried front view 
 
back view (beneficial substitutions) 
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Figure 4-7: 3D model auf BSLA (Protein Database code: 1I6W) displaying regions which favor BSLA resistance in 
presence of TFE in a color scale. Positions at which no substitution led to improvements are colored grey. Positions with 
one substitution leading to improvements are colored blue. Positions with two to seven substitutions leading to improvements 
are colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more substitutions 
leading to improvements. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, B) Van der 
Waals representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. The two N-
terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization. 
 
4.5.7 The SSM-BSLAVariants Showing Improved OS Resistance ˃2.5-fold 
In contrast to the results presented above 4.5.6, the focus in this section is on the best 
variants with improved BSLA´s organic solvent resistance >2.5-fold. As previously observed, 
highest number of beneficial positions (59%) and substitutions (10%) for improved OS 
resistance were achieved for DMSO whereas a lower number (4%) of variants with 
improvements were obtained in the presence of 1,4-dioxane and TFE. Considering the single 
amino acid substitutions, 6 (0.17%) variants with higher resistance (>2.5-fold improvements) 
were found for DMSO, which represented 5 (0.03%) variants more than for TFE and 
1,4-dioxane (Table 4-5). The highest RV/RWT values (see definition in section 3.5) achieved in 
the OS were 9.0, 7.9, and 3.5 for DMSO, TFE, and 1,4-dioxane, respectively. Variants with 
the highest improvements were obtained at positions Gly21 (helix, exposed) for DMSO, Pro5 
(loop, buried) and Asp91 (loop, exposed) for TFE and at position Val62 (helix, buried) for 
1,4-dioxane. Fewer variants (eight variants) with highest improvements in different organic 
solvents were found than in ionic liquids (61 variants). 
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Table 4-5: Best variants in all three OS. The numbers represents the ratio of residual activity of each variant to the residual 
activity of the wild type. All variants listed have a ratio >2.5-fold. Amino acids are grouped into: aromatic (F, Y, and W), 
aliphatic (A, V, L, I, and G), charged acidic (D, E), charged basic (H, K, and R), and polar (C, M, P, S, T, N, and Q). 
 
RV/RWT values are represented in purple bars for DMSO, in dark blue bars for 1,4-dioxane, and in pink bars TFE. 
The nature of the substitutions that led to the improvement >2.5-fold for all three OS 
were different among the three OS (Table 4-5). Replacement of charged acidic residues with 
aromatic amino acids and polar residues with polar residues resulted in variants with highest 
resistance improvements >2.5-fold for TFE (Figure 4-8). Replacement of polar residues in 
BSLA WT to chemically equivalent residues (polar ones) led to the best variants for DMSO 
resistance. For 1,4-dioxane, replacement of aliphatic residues with charged acidic amino acids 
also led to the best improved variants. These observations implied that polar substitutions 
gave higher improvement while charged substitutions led to higher number of improved 
variants.  
Gly21Gln 9.0 polar --> polar
Val62Glu 3.5 aliphatic --> acidic
Pro5Phe 6.7 Polar --> aromatic
Pro5Asn 7.9 Polar --> polar
Val7Cys 3.6 aliphatic --> polar
Ala81Trp 3.7 aliphatic --> aromatic
Asp91Trp 7.8 acidic --> aromatic
Ile157His 3.7 aliphatic --> acidic
DMSO: 2.5-fold corresponds to a Rv/Rwt of 3.3
1,4-dioxane: 2.5-fold corresponds to a Rv/Rwt of 3.3
TFE: 2.5-fold corresponds to a Rv/Rwt of 3.4
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Figure 4-8: Number of improved variants according to the amino acid substitution of BSLA WT in all three OS. 
Variants with a value ≥2.5-fold are represented here. The nature of the substitution for each variant is also illustrated. Amino 
acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged acidic (D, E), charged basic (H, K, and 
R), and polar (C, M, P, S, T, N, and Q). 
4.6 Conclusion 
In this chapter, all the 181 amino acid positions of the model enzyme BSLA were 
saturated to study the resistance towards three hydrophilic OS. The effect of each position and 
each type of amino acid substitution (charged, polar, aliphatic, and aromatic) on BSLA 
resistance towards the three selected OS was investigated. For the first time, the evolutionary 
potential by single substitution of all amino acid positions of an enzyme to improve its OS 
resistance was shown. Less improved positions and substitutions were found to contribute to 
BSLA OS resistance (41-59%) than ionic liquid resistance (50-69%). In addition, the number 
of substitutions which improved BSLA resistance for OS (4-10%) was slightly lower than for 
ILs (6-13%). Both findings imply that engineering of BSLA for improving IL resistance 
likely is easier than for OS resistance by single amino acid exchanges. For both types of 
solvents, polar and charged amino acids substitutions are more beneficial than aliphatic and 
aromatic substitutions. In contrast to ILs, a clear trend was observed for OS: charged residues 
are more favorable for improved BSLA resistance at the surface and polar substitutions are 
mostly favorable at buried positions. For both kinds of solvents, substitutions of amino acids 
residues with chemically different ones led to significantly more BSLA variants with 
improved solvent resistance than the chemically similar ones. These results explained again as 
reported in chapter 3 why screening of small libraries is often sufficient to find improved 
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variants and confirmed that substitutions with chemically different residues can minimize 
screening effort. Athough chemically different amino acid substitutions preferentially 
dominantly led to improved variants, the variant with highest improvement for DMSO 
showed a substitution from polar amino acid to a polar amino acid (Gly21Gln with 6.9-fold 
improvements). In order to understand this, MD simulation has to be performed in the future. 
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5 Final Summary and Conclusions 
Enzymes have been designed by nature to function in aqueous environment. Very often, 
dramatically loss of enzymatic activity was observed in presence of non-conventional media 
(e.g. ionic liquids (ILs) and organic solvents (OS)) which are often needed in industrial 
applications. Protein engineering has been used to improve the resistance of enzymes towards 
ILs and OS. Despite of the success, geneneral principles for protein engineering are still 
missing. The aim of this PhD project was to conclude some general principles for improving 
the resistance of enzymes toward ILs and OS. Bacillus subtilis lipase A (BSLA) was used as a 
model hydrolase in this work. BSLA is a lipase that does not require interfacial activation and 
belongs to the lipase subfamily I-4 (comprised solely of monomeric enzymes), contains 181 
amino acid residues in their mature forms, have molecular masses close to 19.5 kDa and share 
74-80% sequence identity. The latter characteristic allows drawing more general conclusions 
from the results obtained for BSLA to other members of the subfamily and all hydrolases in 
general. Site saturation mutagenesis (SSM) libraries targeting the complete bsla were 
generated to systematically analyze how much single substitutions can influence the IL/OS 
resistance and what types of amino acid substitution can contribute to the improvement. A 
colorimetric screening assay was optimized based on the detection of p-nitrophenolate 
formation in 96-well MTPs (second chapter). In order to cover the full diversity, 18547 clones 
representing 3620 unique variants were generated and fully sequenced (second chapter). The 
BSLA-SSM libraries were screened and systematically analyzed in the presence of four ILs 
(third chapter) and three OS (fourth chapter). 
The systematic study of all SSM-BSLA variants elucidated first general engineering 
principles for improving IL resistance of BSLA. 6-13% of all substitutions at 50-69% of all 
amino acid positions contributed to the improved BSLA resistance. More than half of the 
amino acid positions contributed to the improved IL resistance. It explained why improved 
enzyme variants can often be identified from small sized random mutant libraries (1000-2000 
clones). Highest number of improved variants were obtained for [BMIM][Cl] among the four 
selected ILs. Moreover, replacement of BSLA WT residues with charged and/or polar 
substitutions led to more improved variants for all four ILs. However, the substitutions for the 
best variants do not show a preference to specific type of amino acid substitution. Among the 
beneficial substitutions, 66-95% of the improved variants were achieved with chemically 
different amino acids (e.g. aromatic amino acids substituted by polar/aliphatic/charged amino 
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acids). The latter indicates that mutagenesis methods that introduce transversions should at 
least for lipases like BSLA be favored to generate variants with improved IL resistance. 
The systematic study of the performance of all SSM-BSLA variants in the presence of 
three OS (fourth chapter) showed that 4-10% substitutions at 41-59% of BSLA positions 
displayed an increased OS resistance. Resistance pattern for TFE and 1,4-dioxane was almost 
similar but different from DMSO resistance pattern of BSLA. In contrast to ILs for which the 
charged and polar amino acid substitution led to improvements, predominantly beneficial 
substitutions for improved OS resistance were charged ones. Lower number of improved 
variants and lower number of variants with higher improvement (>2.5-fold) was obtained for 
OS than that for ILs. In total 61 variants with improvements >2.5-fold were observed for the 
four ILs while only eight variants were obtained for OS. This implies that improving BSLA’s 
OS resistance is more difficult than IL resistance. It was also observed that more improved 
variants were obtained on the surface than in buried region, showing the importance of 
surface residues on improving enzyme stability. Further, analysis of the location of the 
beneficial substitutions on the secondary structure elements indicated that most improvements 
for IL and OS were achieved with substitutions located on the loops. Similar to ILs, high 
number (58-93%) of improved variants were obtained by substitution with chemically 
different amino acids (e.g. aromatic amino acids substituted by polar/aliphatic/charged amino 
acids). 
In summary, an exhaustive set of experimental data to elucidate the general principles 
governing the resistance of BSLA in the presence of four ILs and three OS was used. 
Screening of 181 SSM libraries of BSLA, revealed that ≥50% of amino acid positions 
contributed to improve in four ILs the resistance of BSLA while ≥41% of the positions 
contributed to improved BSLA resistance in OS. The high number of positions which 
improve IL resistance (≥50%) and OS resistance (≥41%) explains for the first time from an 
experimental point of view why often the screening of small sized libraries (1000-2000 
variants) is sufficient to find improved variants. Additionally, screening efforts can be 
minimized by mutagenesis methods, which introduce chemical different amino acids 
substitutions through transversions and consecutive mutations.  
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7 Appendix 
7.1 List of Abbreviations 
AA Amino Acid 
amp Ampicillin (100 µg/µL Finale Concentration) 
AmpR Ampicillin Resistance 
APS Ammonium Persulphate 
Br
-
 Bromide 
BMIM 1-Butyl-3-Methylimidazolium 
bp Base Pair 
BSL  Lipase from Bacillus Subtilis 
BSLA Lipase A from Bacillus Subtilis 
BSLB Lipase B from Bacillus Subtilis 
Cl
-
 Chloride 
CMC Critical Micellar Concentration  
Da Dalton 
ddH2O double-distillated water  
epPCR Error-Prone Polymerase Chain Reaction 
EV Empty Vector 
g Gram 
GRAS Generally Recognized As Safe 
H Hour 
HEPES 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid  
H6 6xhistag 
HTS High-Throughput Screening 
I
-
 Iodide 
IL Ionic Liquid 
k Kilo 
kb Kilobases 
kDa Kilodalton 
Kpi Potassium Phosphate Inorganic 
L Liter  
LB Lysogeny Broth 
LipA Bacillus Subtilis Lipase A 
M Molarity (Mol/L) 
m Mili  
MAIM Modified Auto-Induction Medium 
min Minutes 
MTP Microtiter Plate 
MOPS (N-Morpholino)Propansulfonic Acid Buffer 
OD 
OS 
Optical Density 
Organic Solvent 
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PAGE Polyacrylamid Gel Electrophoresis  
PCR Polymerase Chain Reaction 
pNPB p-Nitrophenyl Butyrate 
pNPC p-Nitrophenyl Caprylate 
pNPP p-Nitrophenyl Palmitate 
rpm Rounds per Minute 
RT Room Temperature 
SDM Side Directed Mutagenesis 
SDS-PAGE Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
SOC Super Optimal Broth with Catabolite Repression 
SS Signal Sequence 
SSM Site Saturation Mutagenesis 
TEA Triethanolamine 
TEMED Tetramethylethylenediamine 
TfO Trifluoromethane Sulfonate 
Tris/HCl
-
 Tris(Hydroxymethyl)Aminomethane Buffer 
U Units 
V Volt 
v/v  Volume per Volume 
w/v Weight per Volume 
WT Wild Type 
 
°C Degree Celsius 
µ Micro 
nm Nanometer 
3D  Three-dimensional 
 
7.2 Nomeclature 
NaOH Sodium Hydroxyde 
HCl Hydrogen Chloride 
[BMIM][Br] 1-Butyl-3-Methylimidazolium Bromide 
[BMIM][Cl] 1-Butyl-3-Methylimidazolium Chloride 
[BMIM][I] 1-Butyl-3-Methylimidazolium Iodide 
[BMIM][Tfo] 1-Butyl-3-Methylimidazolium Trifluoromethanesulfonate 
[BMPy][TFA] 1-Methylpyrrolidinium Trifluoroacetate 
[EMIM][TFA] 1-Ethyl-3-Methylimidazolium Trifluoroacetate 
[EMIM][MESO3] 1-Ethyl-3-Methylimidazolium Methanesulphate 
[EMIM][MeSO4] 1-Ethyl-3-Methylimidazolium Methylsulphate 
[EMIM][AC] 1-Ethyl-3-Methylimidazolium Acetate 
[MMIM][MMPO4] 1,3-Dimethylimidazolium Dimethyl Phosphate 
DMSO Dimethyl Sulfoxide 
TFE 2,2,2-Trifluoroethanol 
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7.5 Vector Maps  
 
 
 
Figure 7-1: Plasmid map of of the expression vector pET22b(+) from Novagen (Cat. No. 69744-3). Ap: ampicillin 
resistance. The black arrow represents the multiple cloning site (MCS). 
 
 
Figure 7-2: Plasmid map of  pET22b(+) BSLA. The expression vector pET22b(+) contains the gene bsla encoding for 
lipase A from Bacillus subtilis. SS: signal sequence, pelB-SS is the sequence responsible for periplasmid localization. AmpR: 
ampicillin resistance. LacI: gene encoding for the lactose repressor. 
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7.6 List of 20 Canonical Amino Acids 
 
7.7 List of Primers 
Protein Sequence of BSLA (181 amino acids) 
 
AGHNPVVMVHGIGGASFNFAGIKSYLVSQGWSRDKLYAVDFWDKTGTNYNNGPVL
SRFVQKVLDETGAKKVDIVAHSMGGANTLYYIKNLDGGNKVANVVTLGGANRLTT
GKALPGTDPNQKILYTSIYSSADMIVMNYLSRLDGARNVQIHGVGHIGLLYSSQVNSL
IKEGLNGGGQNTN 
 
Table 7-1: List of all primers used for the site saturation mutagenesis (SSM). 
Primer name Forward primer Reverse primer 
Ala1-NNS GATGGCCATGGATATCNNSGAACACAATCCAG CTGGATTGTGTTCSNNGATATCCATGGCCATC 
Glu2-NNS CCATGGATATCGCTNNSCACAATCCAGTCG CGACTGGATTGTGSNNAGCGATATCCATGG 
His3-NNS CATGGATATCGCTGAANNSAATCCAGTCGTTATG CATAACGACTGGATTSNNTTCAGCGATATCCATG 
Asn4-NNS GATATCGCTGAACACNNSCCAGTCGTTATGGTT AACCATAACGACTGGSNNGTGTTCAGCGATATC 
Pro5-NNS GATATCGCTGAACACAATNNSGTCGTTATGGTTCAC GTGAACCATAACGACSNNATTGTGTTCAGCGATATC 
Val6-NNS GCTGAACACAATCCANNSGTTATGGTTCACGGT ACCGTGAACCATAACSNNTGGATTGTGTTCAGC 
Val7-NNS GAACACAATCCAGTCNNSATGGTTCACGGTATT AATACCGTGAACCATSNNGACTGGATTGTGTTC 
Met8-NNS CACAATCCAGTCGTTNNSGTTCACGGTATTGGA TCCAATACCGTGAACSNNAACGACTGGATTGTG 
Val9-NNS CAATCCAGTCGTTATGNNSCACGGTATTGGAGGG CCCTCCAATACCGTGSNNCATAACGACTGGATTG 
Types of amino acids One-letter code Three-letter code Full name Polarity 
Aromatic 
F Phe Phenylalanine hydrophobic 
Y Tyr Tyrosine hydrophilic 
W Trp Tryptophan hydrophilic 
Aliphatic 
A Ala Alanine 
hydrophobic 
V Val Valine 
L Leu Leucine 
I Ile Isoleucine 
G Gly Glycine 
Polar 
C Cys Cysteine hydrophilic 
M Met Methionine hydrophilic 
P Pro Proline hydrophobic 
S Ser Serine hydrophilic 
T Thr Threonine hydrophilic 
N Asn Asparagine hydrophilic 
Q Gln Glutamine hydrophilic 
Charged acidic 
D Asp Aspartic Acid 
hydrophilic 
E Glu Glutamic Acid 
H His Histidine 
Charged basic 
K Lys Lysine 
R Arg Arginine 
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Table 7-1: List of all primers used for the site saturation mutagenesis (SSM). 
Primer name Forward primer Reverse primer 
His10-NNS CCAGTCGTTATGGTTNNSGGTATTGGAGGGGCA TGCCCCTCCAATACCSNNAACCATAACGACTGG 
Gly11-NNS GTCGTTATGGTTCACNNSATTGGAGGGGCATCA TGATGCCCCTCCAATSNNGTGAACCATAACGAC 
Ile12-NNS GTTATGGTTCACGGTNNSGGAGGGGCATCATTC GAATGATGCCCCTCCSNNACCGTGAACCATAAC 
Gly13-NNS GTTATGGTTCACGGTATTNNSGGGGCATCATTC GAATGATGCCCCSNNAATACCGTGAACCATAAC 
Gly14-NNS GTTCACGGTATTGGANNSGCATCATTCAATTTT AAAATTGAATGATGCSNNTCCAATACCGTGAAC 
Ala15-NNS CACGGTATTGGAGGGNNSTCATTCAATTTTGCG CGCAAAATTGAATGASNNCCCTCCAATACCGTG 
Ser16-NNS GGTATTGGAGGGGCANNSTTCAATTTTGCGGGA TCCCGCAAAATTGAASNNTGCCCCTCCAATACC 
Phe17-NNS GTATTGGAGGGGCATCANNSAATTTTGCGGGAATT AATTCCCGCAAAATTSNNTGATGCCCCTCCAATAC 
Asn18-NNS GGAGGGGCATCATTCNNSTTTGCGGGAATTAAG CTTAATTCCCGCAAASNNGAATGATGCCCCTCC 
Phe19NNS GGGGCATCATTCAATNNSGCGGGAATTAAGAGC GCTCTTAATTCCCGCSNNATTGAATGATGCCCC 
Ala20-NNS GCATCATTCAATTTTNNSGGAATTAAGAGC GCTCTTAATTCCSNNAAAATTGAATGATGC 
Gly21-NNS GCATCATTCAATTTTGCGNNSATTAAGAGCTAT ATAGCTCTTAATSNNCGCAAAATTGAATGATGC 
Ile22-NNS CAATTTTGCGGGANNSAAGAGCTATCTCGTA TACGAGATAGCTCTTSNNTCCCGCAAAATTG 
Lys23-NNS CAATTTTGCGGGAATTNNSAGCTATCTCGTATCT AGATACGAGATAGCTSNNAATTCCCGCAAAATTG 
Ser24-NNS GCGGGAATTAAGNNSTATCTCGTATCTCAG CTGAGATACGAGATASNNCTTAATTCCCGC 
Tyr25-NNS GCGGGAATTAAGAGCNNSCTCGTATCTCAGGGC GCCCTGAGATACGAGSNNGCTCTTAATTCCCGC 
Leu26-NNS GGAATTAAGAGCTATNNSGTATCTCAGGGCTGG CCAGCCCTGAGATACSNNATAGCTCTTAATTCC 
Val27-NNS GAATTAAGAGCTATCTCNNSTCTCAGGGCTGGTCG CGACCAGCCCTGAGASNNGAGATAGCTCTTAATTC 
Ser28-NNS GAGCTATCTCGTANNSCAGGGCTGGTCGCGG CCGCGACCAGCCCTGSNNTACGAGATAGCTC 
Gln29-NNS AGCTATCTCGTATCTNNSGGCTGGTCGCGGGAC GTCCCGCGACCAGCCSNNAGATACGAGATAGCT 
Gly30-NNS CTATCTCGTATCTCAGNNSTGGTCGCGGGACAAG CTTGTCCCGCGACCASNNCTGAGATACGAGATAG 
Trp31-NNS CTCGTATCTCAGGGCNNSTCGCGGGACAAGCTG CAGCTTGTCCCGCGASNNGCCCTGAGATACGAG 
Ser32-NNS GTATCTCAGGGCTGGNNSCGGGACAAGCTGTAT ATACAGCTTGTCCCGSNNCCAGCCCTGAGATAC 
Leu36-NNS CTGGTCGCGGGACAAGNNSTATGCAGTTGATTTT AAAATCAACTGCATASNNCTTGTCCCGCGACCAG 
Tyr37-NNS GTCGCGGGACAAGCTGNNSGCAGTTGATTTTTGG CCAAAAATCAACTGCSNNCAGCTTGTCCCGCGAC 
Ala38-NNS CGGGACAAGCTGTATNNSGTTGATTTTTGGGAC GTCCCAAAAATCAACSNNATACAGCTTGTCCCG 
Val39-NNS GACAAGCTGTATGCANNSGATTTTTGGGACAAG CTTGTCCCAAAAATCSNNTGCATACAGCTTGTC 
Asp40-NNS AAGCTGTATGCAGTTNNSTTTTGGGACAAGACA TGTCTTGTCCCAAAASNNAACTGCATACAGCTT 
Phe41-NNS CTGTATGCAGTTGATNNSTGGGACAAGACAGGC GCCTGTCTTGTCCCASNNATCAACTGCATACAG 
Trp42-NNS TATGCAGTTGATTTTNNSGACAAGACAGGCACA TGTGCCTGTCTTGTCSNNAAAATCAACTGCATA 
Asp43-NNS GCAGTTGATTTTTGGNNSAAGACAGGCACAAAT ATTTGTGCCTGTCTTSNNCCAAAAATCAACTGC 
Lys44-NNS GTTGATTTTTGGGACNNSACAGGCACAAATTAT ATAATTTGTGCCTGTSNNGTCCCAAAAATCAAC 
Thr45-NNS GATTTTTGGGACAAGNNSGGCACAAATTATAAC GTTATAATTTGTGCCSNNCTTGTCCCAAAAATC 
Gly46-NNS GATTTTTGGGACAAGACANNSACAAATTATAACAAT ATTGTTATAATTTGTSNNTGTCTTGTCCCAAAAATC 
Thr47-NNS 
GATTTTTGGGACAAGACAGGCNNSAATTATAACAATG
GA 
TCCATTGTTATAATTSNNGCCTGTCTTGTCCCAAAAAT
C 
Asn48-NNS GACAAGACAGGCACANNSTATAACAATGGACCG CGGTCCATTGTTATASNNTGTGCCTGTCTTGTC 
Tyr49-NNS AAGACAGGCACAAATNNSAACAATGGACCGGTA TACCGGTCCATTGTTSNNATTTGTGCCTGTCTT 
Asn50-NNS ACAGGCACAAATTATNNSAATGGACCGGTATTA TAATACCGGTCCATTSNNATAATTTGTGCCTGT 
Asn51-NNS GGCACAAATTATAACNNSGGACCGGTATTATCA TGATAATACCGGTCCSNNGTTATAATTTGTGCC 
Gly52-NNS CACAAATTATAACAATNNSCCGGTATTATCACGA TCGTGATAATACCGGSNNATTGTTATAATTTGTG 
Pro53-NNS AATTATAACAATGGANNSGTATTATCACGATTT AAATCGTGATAATACSNNTCCATTGTTATAATT 
Val54-NNS TATAACAATGGACCGNNSTTATCACGATTTGTG CACAAATCGTGATAASNNCGGTCCATTGTTATA 
Leu55-NNS CAATGGACCGGTANNSTCACGATTTGTGCAA TTGCACAAATCGTGASNNTACCGGTCCATTG 
Ser56-NNS CAATGGACCGGTATTANNSCGATTTGTGCAAAAG CTTTTGCACAAATCGSNNTAATACCGGTCCATTG 
Arg57-NNS GGACCGGTATTATCANNSTTTGTGCAAAAGGTT AACCTTTTGCACAAASNNTGATAATACCGGTCC 
Phe58-NNS CCGGTATTATCACGANNSGTGCAAAAGGTTTTA TAAAACCTTTTGCACSNNTCGTGATAATACCGG 
Val59-NNS GTATTATCACGATTTNNSCAAAAGGTTTTAGAT ATCTAAAACCTTTTGSNNAAATCGTGATAATAC 
Gln60-NNS TTATCACGATTTGTGNNSAAGGTTTTAGATGAA TTCATCTAAAACCTTSNNCACAAATCGTGATAA 
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Table 7-1: List of all primers used for the site saturation mutagenesis (SSM). 
Primer name Forward primer Reverse primer 
Lys61-NNS CACGATTTGTGCAANNSGTTTTAGATGAAACG CGTTTCATCTAAAACSNNTTGCACAAATCGTG 
Val62-NNS CGATTTGTGCAAAAGNNSTTAGATGAAACGGGT ACCCGTTTCATCTAASNNCTTTTGCACAAATCG 
Leu63-NNS GATTTGTGCAAAAGGTTNNSGATGAAACGGGTGCG CGCACCCGTTTCATCSNNAACCTTTTGCACAAATC 
Asp64-NNS GTGCAAAAGGTTTTANNSGAAACGGGTGCGAAA TTTCGCACCCGTTTCSNNTAAAACCTTTTGCAC 
Glu65-NNS CAAAAGGTTTTAGATNNSACGGGTGCGAAAAAA TTTTTTCGCACCCGTSNNATCTAAAACCTTTTG 
Thr66-NNS GGTTTTAGATGAANNSGGTGCGAAAAAAGTG CACTTTTTTCGCACCSNNTTCATCTAAAACC 
Gly67-NNS GTTTTAGATGAAACGNNSGCGAAAAAAGTGGAT ATCCACTTTTTTCGCSNNCGTTTCATCTAAAAC 
Lys69-NNS GATGAAACGGGTGCGNNSAAAGTGGATATTGTC GACAATATCCACTTTSNNCGCACCCGTTTCATC 
Lys70-NNS GAAACGGGTGCGAAANNSGTGGATATTGTCGCT AGCGACAATATCCACSNNTTTCGCACCCGTTTC 
Asp72-NNS GGTGCGAAAAAAGTGNNSATTGTCGCTCACAGC GCTGTGAGCGACAATSNNCACTTTTTTCGCACC 
Ile73-NNS GCGAAAAAAGTGGATNNSGTCGCTCACAGCATG CATGCTGTGAGCGACSNNATCCACTTTTTTCGC 
Val74-NNS GAAAAAAGTGGATATTNNSGCTCACAGCATGGGG CCCCATGCTGTGAGCSNNAATATCCACTTTTTTC 
Ala75-NNS GAAAAAAGTGGATATTGTCNNSCACAGCATGGGGGGC GCCCCCCATGCTGTGSNNGACAATATCCACTTTTTTC 
His76-NNS GTGGATATTGTCGCTNNSAGCATGGGGGGCGCG CGCGCCCCCCATGCTSNNAGCGACAATATCCAC 
Ser77-NNS GATATTGTCGCTCACNNSATGGGGGGCGCGAAC GTTCGCGCCCCCCATSNNGTGAGCGACAATATC 
Met78-NNS GATATTGTCGCTCACAGCNNSGGGGGCGCGAACACA TGTGTTCGCGCCCCCSNNGCTGTGAGCGACAATATC 
Gly79-NNS GTCGCTCACAGCATGNNSGGCGCGAACACACTT AAGTGTGTTCGCGCCSNNCATGCTGTGAGCGAC 
Gly80-NNS GCTCACAGCATGGGGNNSGCGAACACACTTTAC GTAAAGTGTGTTCGCSNNCCCCATGCTGTGAGC 
Ala81-NNS CACAGCATGGGGGGCNNSAACACACTTTACTAC GTAGTAAAGTGTGTTSNNGCCCCCCATGCTGTG 
Asn82-NNS CAGCATGGGGGGCGCGNNSACACTTTACTACATA TATGTAGTAAAGTGTSNNCGCGCCCCCCATGCTG 
Thr83-NNS CATGGGGGGCGCGAACNNSCTTTACTACATAAAA TTTTATGTAGTAAAGSNNGTTCGCGCCCCCCATG 
Leu84-NNS GGGGGCGCGAACACANNSTACTACATAAAAAAT ATTTTTTATGTAGTASNNTGTGTTCGCGCCCCC 
Tyr85-NNS GGCGCGAACACACTTNNSTACATAAAAAATCTG CAGATTTTTTATGTASNNAAGTGTGTTCGCGCC 
Tyr86-NNS GCGAACACACTTTACNNSATAAAAAATCTGGAC GTCCAGATTTTTTATSNNGTAAAGTGTGTTCGC 
Ile87-NNS GAACACACTTTACTACNNSAAAAATCTGGACGGC GCCGTCCAGATTTTTSNNGTAGTAAAGTGTGTTC 
Lys88-NNS CACACTTTACTACATANNSAATCTGGACGGCGGA TCCGCCGTCCAGATTSNNTATGTAGTAAAGTGTG 
Asn89-NNS CTTTACTACATAAAANNSCTGGACGGCGGAAAT ATTTCCGCCGTCCAGSNNTTTTATGTAGTAAAG 
Leu90-NNS CTTTACTACATAAAAAATNNSGACGGCGGAAATAAA TTTATTTCCGCCGTCSNNATTTTTTATGTAGTAAAG 
Asp91-NNS CTACATAAAAAATCTGNNSGGCGGAAATAAAGTT AACTTTATTTCCGCCSNNCAGATTTTTTATGTAG 
Gly92-NNS TGCAACTTTATTTCCSNNGTCCAGATTTTTTATG CATAAAAAATCTGGACNNSGGAAATAAAGTTGCA 
Gly93-NNS GTTTGCAACTTTATTSNNGCCGTCCAGATTTTTTATG CATAAAAAATCTGGACGGCNNSAATAAAGTTGCAAAC 
Asn94-NNS 
GACGTTTGCAACTTTSNNTCCGCCGTCCAGATTTTTTA
TG 
TAAAAAATCTGGACGGCGGANNSAAAGTTGCAAACGT
C 
Lys95-NNS CACGACGTTTGCAACSNNATTTCCGCCGTCCAG CTGGACGGCGGAAATNNSGTTGCAAACGTCGTG 
Val96-NNS CGTCACGACGTTTGCSNNTTTATTTCCGCCGTC GACGGCGGAAATAAANNSGCAAACGTCGTGACG 
Ala97-NNS AAGCGTCACGACGTTSNNAACTTTATTCCTGCC GGCAGGAATAAAGTTNNSAACGTCGTGACGCTT 
Asn98-NNS GCCAAGCGTCACGACSNNTGCAACTTTATTTCC GGAAATAAAGTTGCANNSGTCGTGACGCTTGGC 
Val99-NNS GCCGCCAAGCGTCACSNNGTTTGCAACTTTATTTC GAAATAAAGTTGCAAACNNSGTGACGCTTGGCGGC 
Val100-NNS CGCGCCGCCAAGCGTSNNGACGTTTGCAAC GTTGCAAACGTCNNSACGCTTGGCGGCGCG 
Thr101-NNS GTTCGCGCCGCCAAGSNNCACGACGTTTGCAAC GTTGCAAACGTCGTGNNSCTTGGCGGCGCGAAC 
Leu102-NNS ACGGTTCGCGCCGCCSNNCGTCACGACGTTTGC GCAAACGTCGTGACGNNSGGCGGCGCGAACCGT 
Gly103-NNS TAAACGGTTCGCGCCSNNAAGCGTCACGACGTT AACGTCGTGACGCTTNNSGGCGCGAACCGTTTA 
Gly104-NNS CGTTAAACGGTTCGCSNNGCCAAGCGTCACGAC GTCGTGACGCTTGGCNNSGCGAACCGTTTAACG 
Ala105-NNS TGTCGTTAAACGGTTSNNGCCGCCAAGCGTCAC GTGACGCTTGGCGGCNNSAACCGTTTAACGACA 
Asn106-NNS GGCGGCGCGNNSCGTTTGACGACAGGC CAAACGSNNCGCGCCGCCAAGCGTCACGAC 
Arg107-NNS CTTGGCGGCGCGAACNNSTTGACGACAGGCAAG CTTGCCTGTCGTCAASNNGTTCGCGCCGCCAAG 
Leu108-NNS CGCCTTGCCTGTCGTSNNACGGTTCGCGCCGCC GGCGGCGCGAACCGTNNSACGACAGGCAAGGCG 
Thr109-NNS AAGCGCCTTGCCTGTSNNCAAACGGTTCGCGCC GGCGCGAACCGTTTGNNSACAGGCAAGGCGCTT 
Thr110-NNS GCGAACCGTTTGACGNNSGGCAAGGCGCTTCCG CGGAAGCGCCTTGCCSNNCGTCAAACGGTTCGC 
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Table 7-1: List of all primers used for the site saturation mutagenesis (SSM). 
Primer name Forward primer Reverse primer 
Gly111-NNS GAACCGTTTGACGACANNSAAGGCGCTTCCGGG CCCGGAAGCGCCTTSNNTGTCGTCAAACGGTTC 
Lys112-NNS TGTTCCCCGAAGCGCSNNGCCTGTCGTCAAACG CGTTTGACGACAGGCNNSGCGCTTCGGGGAACA 
Ala113-NNS ATCTGTTCCCGGAAGSNNCTTGCCTGTCGTTAAAC GTTTAACGACAGGCAAGNNSCTTCCGGGAACAGAT 
Leu114-NNS TGGATCTGTTCCCGGSNNCGCCTTGCCTGTCG CGACAGGCAAGGCGNNSCCGGGAACAGATCCA 
Pro115-NNS ATTTGGATCTGTTCCSNNAAGCGCCTTGCCTGTC GACAGGCAAGGCGCTTNNSGGAACAGATCCAAAT 
Gly116-NNS TTGATTTGGATCTGTSNNCGGAAGCGCCTTGCC GGCAAGGCGCTTCCGNNSACAGATCCAAATCAA 
Thr117-NNS CTTTTGATTTGGATCSNNTCCCGGAAGCGCCTTG CAAGGCGCTTCCGGGANNSGATCCAAATCAAAAG 
Asp118-NNS AATCTTTTGATTTGGSNNTGTTCCCGGAAGCGC GCGCTTCCGGGAACANNSCCAAATCAAAAGATT 
Pro119-NNS TAAAATCTTTTGATTSNNATCTGTTCCCGGAAG CTTCCGGGAACAGATNNSAATCAAAAGATTTTA 
Asn120-NNS CCGGGAACAGATCCANNSCAAAAGATTTTATAC GTATAAAATCTTTTGSNNTGGATCTGTTCCCGG 
Gln121-NNS TGTGTATAAAATCTTSNNATTTGGATCTGTTCC GGAACAGATCCAAATNNSAAGATTTTATACACA 
Lys122-NNS GGATGTGTATAAAATSNNTTGATTTGGATCTG CAGATCCAAATCAANNSATTTTATACACATCC 
Ile123-NNS AATGGATGTGTATAASNNCTTTTGATTTGGATC GATCCAAATCAAAAGNNSTTATACACATCCATT 
Leu124-NNS CCAAATCAAAAGATTNNSTACACATCCATTTAC GTAAATGGATGTGTASNNAATCTTTTGATTTGG 
Tyr125-NNS GCTGTAAATGGATGTSNNTAAAATCTTTTGATTTG CAAATCAAAAGATTTTANNSACATCCATTTACAGC 
Thr126-NNS ACTGCTGTAAATGGASNNGTATAAAATCTTTTG CAAAAGATTTTATACNNSTCCATTTACAGCAGT 
Ser127-NNS GGCACTGCTGTAAATSNNTGTGTATAAAATCTT AAGATTTTATACACANNSATTTACAGCAGTGCC 
Ile128-NNS ATCGGCACTGCTGTASNNGGATGTGTATAAAATC GATTTTATACACATCCNNSTACAGCAGTGCCGAT 
Tyr129-NNS CATATCGGCACTGCTSNNAATGGATGTGTATAAAATC GATTTTATACACATCCATTNNSAGCAGTGCCGATATG 
Ser130-NNS AATCATATCGGCACTSNNGTAAATGGATGTG CACATCCATTTACNNSAGTGCCGATATGATT 
Ser131-NNS ACATCCATTTACAGCNNSGCCGATATGATTGTC GACAATCATATCGGCSNNGCTGTAAATGGATGT 
Ala132-NNS CATGACAATCATATCSNNACTGCTGTAAATGG CCATTTACAGCAGTNNSGATATGATTGTCATG 
Asp133-NNS ATTCATGACAATCATSNNGGCACTGCTGTAAATG CATTTACAGCAGTGCCNNSATGATTGTCATGAAT 
Met134-NNS GTAATTCATGACAATSNNATCGGCACTGCTGTAAATG CATTTACAGCAGTGCCGATNNSATTGTCATGAATTAC 
Ile135-NNS TAAGTAATTCATGACSNNCATATCGGCACTGCTG CAGCAGTGCCGATATGNNSGTCATGAATTACTTA 
Val136-NNS TGATAAGTAATTCATSNNAATCATATCGGCACTG CAGTGCCGATATGATTNNSATGAATTACTTATCA 
Met137-NNS TCTTGATAAGTAATTSNNGACAATCATATCGGC GCCGATATGATTGTCNNSAATTACTTATCAAGA 
Asn138-NNS TAATCTTGATAAGTASNNCATGACAATCATATC GATATGATTGTCATGNNSTACTTATCAAGATTA 
Tyr139-NNS 
ATCTAATCTTGATAASNNATTCATGACAATCATATCGG
C 
GCCGATATGATTGTCATGAATNNSTTATCAAGATTAGA
T 
Leu140-NNS ACCATCTAATCTTGASNNGTAATTCATGACAATC GATTGTCATGAATTACNNSTCAAGATTAGATGGT 
Ser141-NNS AGCACCATCTAATCTSNNTAAGTAATTCATGAC GTCATGAATTACTTANNSAGATTAGATGGTGCT 
Arg142-NNS TCTAGCACCATCTAASNNTGATAAGTAATTCATG CATGAATTACTTATCANNSTTAGATGGTGCTAGA 
Leu143-NNS GTTTCTAGCACCATCSNNTCTTGATAAGTAATTC GAATTACTTATCAAGANNSGATGGTGCTAGAAAC 
Asp144-NNS AACGTTTCTAGCACCSNNTAATCTTGATAAGTAATT AATTACTTATCAAGATTANNSGGTGCTAGAAACGTT 
Gly145-NNS TTGAACGTTTCTAGCSNNATCTAATCTTGATAAG CTTATCAAGATTAGATNNSGCTAGAAACGTTCAA 
Ala146-NNS TCAAGATTAGATGGTNNSAGAAACGTTCAAATC GATTTGAACGTTTCTSNNACCATCTAATCTTGA 
Arg147-NNS ATGGATTTGAACGTTSNNAGCACCATCTAATCTTG CAAGATTAGATGGTGCTNNSAACGTTCAAATCCAT 
Asn148-NNS GCCATGGATTTGAACSNNTCTAGCACCATCTAATC GATTAGATGGTGCTAGANNSGTTCAAATCCATGGC 
Val149-NNS AACGCCATCGATTTGSNNGTTTCTAGCACCATC GATGGTGCTAGAAACNNSCAAATCGATGGCGTT 
Gln150-NNS TCCAACGCCATGGATSNNAACGTTTCTAGCACC GGTGCTAGAAACGTTNNSATCCATGGCGTTGGA 
Ile151-NNS GTGTCCAACGCCATGSNNTTGAACGTTTCTAGC GCTAGAAACGTTCAANNSCATGGCGTTGGACAC 
His152-NNS GATGTGTCCAACGCCSNNGATTTGAACGTTTCTAG CTAGAAACGTTCAAATCNNSGGCGTTGGACACATC 
Gly153-NNS GCCGATGTGTCCAACSNNATGGATTTGAACGTTTC GAAACGTTCAAATCCATNNSGTTGGACACATCGGC 
Val154-NNS AAGGCCGATGTGTCCSNNGCCATGGATTTGAAC GTTCAAATCCATGGCNNSGGACACATCGGCCTT 
Gly155-NNS CAGAAGGCCGATGTGSNNAACGCCATGGATTTG CAAATCCATGGCGTTNNSCACATCGGCCTTCTG 
His156-NNS GTACAGAAGGCCGATSNNTCCAACGCCATGGATTTG CAAATCCATGGCGTTGGANNSATCGGCCTTCTGTAC 
Ile157-NNS GCTGTACAGAAGGCCSNNGTGTCCAACGCCATG CATGGCGTTGGACACNNSGGCCTTCTGTACAGC 
Gly158-NNS GCTGCTGTACAGAAGSNNGATGTGTCCAACGCC GGCGTTGGACACATCNNSCTTCTGTACAGCAGC 
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Table 7-1: List of all primers used for the site saturation mutagenesis (SSM). 
Primer name Forward primer Reverse primer 
Leu159-NNS TTGGCTGCTGTACAGSNNGCCGATGTGTCCAAC GTTGGACACATCGGCNNSCTGTACAGCAGCCAA 
Leu160-NNS GACTTGGCTGCTGTASNNAAGGCCGATGTGTCC GGACACATCGGCCTTNNSTACAGCAGCCAAGTC 
Tyr161-NNS GTTGACTTGGCTGCTSNNCAGAAGGCCGATGTG CACATCGGCCTTCTGNNSAGCAGCCAAGTCAAC 
Ser162-NNS GCTGTTGACTTGGCTSNNGTACAGAAGGCCGATG CATCGGCCTTCTGTACNNSAGCCAAGTCAACAGC 
Ser163-NNS CAGGCTGTTGACTTGSNNGCTGTACAGAAGGCC GGCCTTCTGTACAGCNNSCAAGTCAACAGCCTG 
Gln164-NNS AATCAGGCTGTTGACSNNGCTGCTGTACAGAAG CTTCTGTACAGCAGCNNSGTCAACAGCCTGATT 
Val165-NNS TTTAATCAGGCTGTTSNNTTGGCTGCTGTACAG CTGTACAGCAGCCAANNSAACAGCCTGATTAAA 
Asn166-NNS TTCTTTAATCAGGCTSNNGACTTGGCTGCTGTAC GTACAGCAGCCAAGTCNNSAGCCTGATTAAAGAA 
Ser167-NNS CCCTCCTTTAATCAGSNNGTTGACTTGGCTGCTG CAGCAGCCAAGTCAACNNSCTGATTAAAGGAGGG 
Leu168-NNS CAGCCCTTCTTTAATSNNGCTGTTGACTTGGCTGCTG CAGCAGCCAAGTCAACAGCNNSATTAAAGAAGGGCTG 
Ile169-NNS GTTCAGCCCTTCTTTSNNCAGGCTGTTGACTTG CAAGTCAACAGCCTGNNSAAAGAAGGGCTGAAC 
Lys170-NNS GCCGTTCAGCCCTTCSNNAATCAGGCTGTTGAC GTCAACAGCCTGATTNNSGAAGGGCTGAACGGC 
Glu171-NNS CCCGCCGTTCAGCCCSNNTTTAATCAGGCTGTT AACAGCCTGATTAAANNSGGGCTGAACGGCGGG 
Gly172-NNS AGCCTGATTAAAGAANNSCTGAACGGCGGGGGC GCCCCCGCCGTTCAGSNNTTCTTTAATCAGGCT 
Leu173-NNS CTGATTAAAGAAGGGNNSAACGGCGGGGGCCAG CTGGCCCCCGCCGTTSNNCCCTTCTTTAATCAG 
Asn174-NNS AATCAGGCTGTTGACSNNGCTGCTGTACAGAAG GAAGGGCTGNNSGGCGGGGGCGAGAATACGAAT 
Gly175-NNS AAAGAAGGGCTGAACNNSGGGGGCCAGAATACG CGTATTCTGGCCCCCSNNGTTCAGCCCTTCTTT 
Gly176-NNS GAAGGGCTGAACGGCNNSGGCCAGAATACGAAT ATTCGTATTCTGGCCSNNGCCGTTCAGCCCTTC 
Gly177-NNS GGGCTGAACGGCGGGNNSCAGAATACGAATTAA TTAATTCGTATTCTGSNNCCCGCCGTTCAGCCC 
Gln178-NNS GCTTGTCGACGGAGCTCTCATTAATTCGTATTSNNGCC 
GGCNNSAATACGAATTAATGAGAGCTCCGTCGACAAG
C 
Asn179-NNS GCTTGTCGACGGAGCTCTCATTAATTCGTSNNCTC GAGNNSACGAATTAATGAGAGCTCCGTCGACAAGC 
Thr180-NNS GGCGGGGGCCAGAATNNSAATTAATGAGAGCTC GAGCTCTCATTAATTSNNATTCTGGCCCCCGCC 
Asn181-NNS GCTTGTCGACGGAGCTCTCATTASNNCGT ACGNNSTAATGAGAGCTCCGTCGACAAGC 
 
 
Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Ala1phe GATGGCCATGGATATCTTTGAACACAATCCAG CTGGATTGTGTTCAAAGATATCCATGGCCATC 
Ala1Asp GATGGCCATGGATATCGATGAACACAATCCAG CTGGATTGTGTTCATCGATATCCATGGCCATC 
Glu2Lys CCATGGATATCGCTAAACACAATCCAGTCG CGACTGGATTGTGTTTAGCGATATCCATGG 
Gly2Tyr CCATGGATATCGCTTATCACAATCCAGTCG CGACTGGATTGTGATAAGCGATATCCATGG 
Glu2Gln CCATGGATATCGCTCAGCACAATCCAGTCG CGACTGGATTGTGCTGAGCGATATCCATGG 
Glu2Cys CCATGGATATCGCTTGCCACAATCCAGTCG CGACTGGATTGTGGCAAGCGATATCCATGG 
His3Lys CATGGATATCGCTGAAAAGAATCCAGTCGTTATG CATAACGACTGGATTCTTTTCAGCGATATCCATG 
His3Met CATGGATATCGCTGAAATGAATCCAGTCGTTATG CATAACGACTGGATTCATTTCAGCGATATCCATG 
His3Gln CATGGATATCGCTGAACAGAATCCAGTCGTTATG CATAACGACTGGATTCTGTTCAGCGATATCCATG 
His3Cys CATGGATATCGCTGAATGCAATCCAGTCGTTATG CATAACGACTGGATTGCATTCAGCGATATCCATG 
Asn4Phe GATATCGCTGAACACTTTCCAGTCGTTATGGTT AACCATAACGACTGGAAAGTGTTCAGCGATATC 
Val6Lys GCTGAACACAATCCAAAAGTTATGGTTCACGGT ACCGTGAACCATAACTTTTGGATTGTGTTCAGC 
Val6lle GCTGAACACAATCCAATTGTTATGGTTCACGGT ACCGTGAACCATAACAATTGGATTGTGTTCAGC 
Met8Lys CACAATCCAGTCGTTAAGGTTCACGGTATTGGA TCCAATACCGTGAACCTTAACGACTGGATTGTG 
Met8Phe CACAATCCAGTCGTTTTTGTTCACGGTATTGGA TCCAATACCGTGAACAAAAACGACTGGATTGTG 
Val9Glu CAATCCAGTCGTTATGGAACACGGTATTGGAGGG CCCTCCAATACCGTGTTCCATAACGACTGGATTG 
Val9His CAATCCAGTCGTTATGCACCACGGTATTGGAGGG CCCTCCAATACCGTGGTGCATAACGACTGGATTG 
Val9Met CAATCCAGTCGTTATGATGCACGGTATTGGAGGG CCCTCCAATACCGTGCATCATAACGACTGGATTG 
Val9Trp CAATCCAGTCGTTATGTGGCACGGTATTGGAGGG CCCTCCAATACCGTGCCACATAACGACTGGATTG 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Gly11Asp GTCGTTATGGTTCACGATATTGGAGGGGCATCA TGATGCCCCTCCAATATCGTGAACCATAACGAC 
lle12Glu GTTATGGTTCACGGTGAAGGAGGGGCATCATTC GAATGATGCCCCTCCTTCACCGTGAACCATAAC 
lle12His GTTATGGTTCACGGTCACGGAGGGGCATCATTC GAATGATGCCCCTCCGTGACCGTGAACCATAAC 
Gly14lle GTTCACGGTATTGGAATTGCATCATTCAATTTT AAAATTGAATGATGCAATTCCAATACCGTGAAC 
Gly14Tyr GTTCACGGTATTGGATATGCATCATTCAATTTT AAAATTGAATGATGCATATCCAATACCGTGAAC 
Gly14Ser GTTCACGGTATTGGAAGCGCATCATTCAATTTT AAAATTGAATGATGCGCTTCCAATACCGTGAAC 
Gly14Cys GTTCACGGTATTGGATGCGCATCATTCAATTTT AAAATTGAATGATGCGCATCCAATACCGTGAAC 
Ala15lle CACGGTATTGGAGGGATTTCATTCAATTTTGCG CGCAAAATTGAATGAAATCCCTCCAATACCGTG 
Ser16His GGTATTGGAGGGGCACACTTCAATTTTGCGGGA TCCCGCAAAATTGAAGTGTGCCCCTCCAATACC 
Ser16lle GGTATTGGAGGGGCAATTTTCAATTTTGCGGGA TCCCGCAAAATTGAAAATTGCCCCTCCAATACC 
Ser16Phe GGTATTGGAGGGGCATTTTTCAATTTTGCGGGA TCCCGCAAAATTGAAAAATGCCCCTCCAATACC 
Asn18Trp GGAGGGGCATCATTCTGGTTTGCGGGAATTAAG CTTAATTCCCGCAAACCAGAATGATGCCCCTCC 
Phe19Lys GGGGCATCATTCAATAAGGCGGGAATTAAGAGC GCTCTTAATTCCCGCCTTATTGAATGATGCCCC 
Phe19lle GGGGCATCATTCAATATTGCGGGAATTAAGAGC GCTCTTAATTCCCGCAATATTGAATGATGCCCC 
Phe19Gln GGGGCATCATTCAATCAGGCGGGAATTAAGAGC GCTCTTAATTCCCGCCTGATTGAATGATGCCCC 
Ala20-Met GCATCATTCAATTTTATGGGAATTAAGAGC GCTCTTAATTCCCATAAAATTGAATGATGC 
Ala20-Phe GCATCATTCAATTTTTTTGGAATTAAGAGC GCTCTTAATTCCAAAAAAATTGAATGATGC 
Gly21Asp GCATCATTCAATTTTGCGGATATTAAGAGCTAT ATAGCTCTTAATATCCGCAAAATTGAATGATGC 
Gly21Phe GCATCATTCAATTTTGCGTTTATTAAGAGCTAT ATAGCTCTTAATAAACGCAAAATTGAATGATGC 
Gly21Gln GCATCATTCAATTTTGCGCAGATTAAGAGCTAT ATAGCTCTTAATCTGCGCAAAATTGAATGATGC 
Lys23-Asp CAATTTTGCGGGAATTGATAGCTATCTCGTATCT AGATACGAGATAGCTATCAATTCCCGCAAAATTG 
Ser24-Met GCGGGAATTAAGATGTATCTCGTATCTCAG CTGAGATACGAGATACATCTTAATTCCCGC 
Ser24lle GCGGGAATTAAGATTTATCTCGTATCTCAG CTGAGATACGAGATAAATCTTAATTCCCGC 
Ser24Phe GCGGGAATTAAGTTTTATCTCGTATCTCAG CTGAGATACGAGATAAAACTTAATTCCCGC 
Ser24Cys GCGGGAATTAAGTGCTATCTCGTATCTCAG CTGAGATACGAGATAGCACTTAATTCCCGC 
Tyr25Asp GCGGGAATTAAGAGCGATCTCGTATCTCAGGGC GCCCTGAGATACGAGATCGCTCTTAATTCCCGC 
Leu26lle GGAATTAAGAGCTATATTGTATCTCAGGGCTGG CCAGCCCTGAGATACAATATAGCTCTTAATTCC 
Leu26Tyr GGAATTAAGAGCTATTATGTATCTCAGGGCTGG CCAGCCCTGAGATACATAATAGCTCTTAATTCC 
Leu26Trp GGAATTAAGAGCTATTGGGTATCTCAGGGCTGG CCAGCCCTGAGATACCCAATAGCTCTTAATTCC 
Val27Asp GAATTAAGAGCTATCTCGATTCTCAGGGCTGGTCG CGACCAGCCCTGAGAATCGAGATAGCTCTTAATTC 
Val27lle GAATTAAGAGCTATCTCATTTCTCAGGGCTGGTCG CGACCAGCCCTGAGAAATGAGATAGCTCTTAATTC 
Val27Tyr GAATTAAGAGCTATCTCTATTCTCAGGGCTGGTCG CGACCAGCCCTGAGAATAGAGATAGCTCTTAATTC 
Ser28Asp GAGCTATCTCGTAGATCAGGGCTGGTCGCGG CCGCGACCAGCCCTGATCTACGAGATAGCTC 
Ser28His GAGCTATCTCGTACACCAGGGCTGGTCGCGG CCGCGACCAGCCCTGGTGTACGAGATAGCTC 
Ser28Trp GAGCTATCTCGTATGGCAGGGCTGGTCGCGG CCGCGACCAGCCCTGCCATACGAGATAGCTC 
Gly29His AGCTATCTCGTATCTCACGGCTGGTCGCGGGAC GTCCCGCGACCAGCCGTGAGATACGAGATAGCT 
Gly29Phe AGCTATCTCGTATCTTTTGGCTGGTCGCGGGAC GTCCCGCGACCAGCCAAAAGATACGAGATAGCT 
Gly30His CTATCTCGTATCTCAGCACTGGTCGCGGGACAAG CTTGTCCCGCGACCAGTGCTGAGATACGAGATAG 
Trp31Tyr CTCGTATCTCAGGGCTATTCGCGGGACAAGCTG CAGCTTGTCCCGCGAATAGCCCTGAGATACGAG 
Trp31-Ile CTCGTATCTCAGGGCATTTCGCGGGACAAGCTG CAGCTTGTCCCGCGAAATGCCCTGAGATACGAG 
Trp31-His CTCGTATCTCAGGGCCACTCGCGGGACAAGCTG CAGCTTGTCCCGCGAGTGGCCCTGAGATACGAG 
Trp31-Cys CTCGTATCTCAGGGCTGCTCGCGGGACAAGCTG CAGCTTGTCCCGCGAGCAGCCCTGAGATACGAG 
Trp31-Pro CTCGTATCTCAGGGCCCGTCGCGGGACAAGCTG CAGCTTGTCCCGCGACGGGCCCTGAGATACGAG 
Ser32Trp GTATCTCAGGGCTGGTGGCGGGACAAGCTGTAT ATACAGCTTGTCCCGCCACCAGCCCTGAGATAC 
Ser32Gln GTATCTCAGGGCTGGCAGCGGGACAAGCTGTAT ATACAGCTTGTCCCGCTGCCAGCCCTGAGATAC 
Leu36His CTGGTCGCGGGACAAGCACTATGCAGTTGATTTT AAAATCAACTGCATAGTGCTTGTCCCGCGACCAG 
Leu36Met CTGGTCGCGGGACAAGATGTATGCAGTTGATTTT AAAATCAACTGCATACATCTTGTCCCGCGACCAG 
Tyr37His GTCGCGGGACAAGCTGCACGCAGTTGATTTTTGG CCAAAAATCAACTGCGTGCAGCTTGTCCCGCGAC 
Tyr37Met GTCGCGGGACAAGCTGATGGCAGTTGATTTTTGG CCAAAAATCAACTGCCATCAGCTTGTCCCGCGAC 
Tyr37Gln GTCGCGGGACAAGCTGCAGGCAGTTGATTTTTGG CCAAAAATCAACTGCCTGCAGCTTGTCCCGCGAC 
Ala38Asp CGGGACAAGCTGTATGATGTTGATTTTTGGGAC GTCCCAAAAATCAACATCATACAGCTTGTCCCG 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Ala38Arg CGGGACAAGCTGTATCGGGTTGATTTTTGGGAC GTCCCAAAAATCAACCCGATACAGCTTGTCCCG 
Val39Cys GACAAGCTGTATGCATGCGATTTTTGGGACAAG CTTGTCCCAAAAATCGCATGCATACAGCTTGTC 
Asp40Tyr AAGCTGTATGCAGTTTATTTTTGGGACAAGACA TGTCTTGTCCCAAAAATAAACTGCATACAGCTT 
Asp40lle AAGCTGTATGCAGTTATTTTTTGGGACAAGACA TGTCTTGTCCCAAAAAATAACTGCATACAGCTT 
Phy41Val CTGTATGCAGTTGATGTTTGGGACAAGACAGGC GCCTGTCTTGTCCCAAACATCAACTGCATACAG 
Trp42Asp TATGCAGTTGATTTTGATGACAAGACAGGCACA TGTGCCTGTCTTGTCATCAAAATCAACTGCATA 
Trp42Glu TATGCAGTTGATTTTGAAGACAAGACAGGCACA TGTGCCTGTCTTGTCTTCAAAATCAACTGCATA 
Trp42Ala TATGCAGTTGATTTTGCGGACAAGACAGGCACA TGTGCCTGTCTTGTCCGCAAAATCAACTGCATA 
Trp42Gln TATGCAGTTGATTTTCAGGACAAGACAGGCACA TGTGCCTGTCTTGTCCTGAAAATCAACTGCATA 
Asp43-Gln GCAGTTGATTTTTGGCAGAAGACAGGCACAAAT ATTTGTGCCTGTCTTCTGCCAAAAATCAACTGC 
Lys44-Asp GTTGATTTTTGGGACGATACAGGCACAAATTAT ATAATTTGTGCCTGTATCGTCCCAAAAATCAAC 
Lys44-Glu GTTGATTTTTGGGACGAAACAGGCACAAATTAT ATAATTTGTGCCTGTTTCGTCCCAAAAATCAAC 
Lys44-Ile GTTGATTTTTGGGACATTACAGGCACAAATTAT ATAATTTGTGCCTGTAATGTCCCAAAAATCAAC 
Lys44-Tyr GTTGATTTTTGGGACTATACAGGCACAAATTAT ATAATTTGTGCCTGTATAGTCCCAAAAATCAAC 
Thr45lle GATTTTTGGGACAAGATTGGCACAAATTATAAC GTTATAATTTGTGCCAATCTTGTCCCAAAAATC 
Thr47Asp 
GATTTTTGGGACAAGACAGGCGATAATTATAACAAT
GGA 
TCCATTGTTATAATTATCGCCTGTCTTGTCCCAAAAAT
C 
Thr47Ala 
GATTTTTGGGACAAGACAGGCGCGAATTATAACAAT
GGA 
TCCATTGTTATAATTCGCGCCTGTCTTGTCCCAAAAAT
C 
Thr47Gln 
GATTTTTGGGACAAGACAGGCCAGAATTATAACAAT
GGA 
TCCATTGTTATAATTCTGGCCTGTCTTGTCCCAAAAAT
C 
Thr47-Ile 
GATTTTTGGGACAAGACAGGCATTAATTATAACAAT
GGA 
TCCATTGTTATAATTAATGCCTGTCTTGTCCCAAAAAT
C 
Asn50Met ACAGGCACAAATTATATGAATGGACCGGTATTA TAATACCGGTCCATTCATATAATTTGTGCCTGT 
Asn51Asp GGCACAAATTATAACGATGGACCGGTATTATCA TGATAATACCGGTCCATCGTTATAATTTGTGCC 
Asn51Cys GGCACAAATTATAACTGCGGACCGGTATTATCA TGATAATACCGGTCCGCAGTTATAATTTGTGCC 
Gly52Met CACAAATTATAACAATATGCCGGTATTATCACGA TCGTGATAATACCGGCATATTGTTATAATTTGTG 
Gly52Asn CACAAATTATAACAATAATCCGGTATTATCACGA TCGTGATAATACCGGATTATTGTTATAATTTGTG 
Gly52Cys CACAAATTATAACAATTGCCCGGTATTATCACGA TCGTGATAATACCGGGCAATTGTTATAATTTGTG 
Pro53lle 
ACAAATTATAACAATGGAATTGTATTATCACGATTT
GTG 
CACAAATCGTGATAATACAATTCCATTGTTATAATTTG
T 
Val54lle TATAACAATGGACCGATTTTATCACGATTTGTG CACAAATCGTGATAAAATCGGTCCATTGTTATA 
Leu55Asp CAATGGACCGGTAGATTCACGATTTGTGCAA TTGCACAAATCGTGAATCTACCGGTCCATTG 
Leu55lle CAATGGACCGGTAATTTCACGATTTGTGCAA TTGCACAAATCGTGAAATTACCGGTCCATTG 
Leu55Met CAATGGACCGGTAATGTCACGATTTGTGCAA TTGCACAAATCGTGACATTACCGGTCCATTG 
Arg57-Met GGACCGGTATTATCAATGTTTGTGCAAAAGGTT AACCTTTTGCACAAACATTGATAATACCGGTCC 
Arg57-Trp GGACCGGTATTATCATGGTTTGTGCAAAAGGTT AACCTTTTGCACAAACCATGATAATACCGGTCC 
Phe58-Asp CCGGTATTATCACGAGATGTGCAAAAGGTTTTA TAAAACCTTTTGCACATCTCGTGATAATACCGG 
Phe58-Ala CCGGTATTATCACGAGCGGTGCAAAAGGTTTTA TAAAACCTTTTGCACCGCTCGTGATAATACCGG 
Phe58-Gln CCGGTATTATCACGACAGGTGCAAAAGGTTTTA TAAAACCTTTTGCACCTGTCGTGATAATACCGG 
Val59Asp GTATTATCACGATTTGATCAAAAGGTTTTAGAT ATCTAAAACCTTTTGATCAAATCGTGATAATAC 
Val59Tyr GTATTATCACGATTTTATCAAAAGGTTTTAGAT ATCTAAAACCTTTTGATAAAATCGTGATAATAC 
Gly60Asp TTATCACGATTTGTGGATAAGGTTTTAGATGAA TTCATCTAAAACCTTATCCACAAATCGTGATAA 
Lys61lle CACGATTTGTGCAAATTGTTTTAGATGAAACG CGTTTCATCTAAAACAATTTGCACAAATCGTG 
Val62Asp CGATTTGTGCAAAAGGATTTAGATGAAACGGGT ACCCGTTTCATCTAAATCCTTTTGCACAAATCG 
Val62Trp CGATTTGTGCAAAAGTGGTTAGATGAAACGGGT ACCCGTTTCATCTAACCACTTTTGCACAAATCG 
Val62Cys CGATTTGTGCAAAAGTGCTTAGATGAAACGGGT ACCCGTTTCATCTAAGCACTTTTGCACAAATCG 
Leu63lle GATTTGTGCAAAAGGTTATTGATGAAACGGGTGCG CGCACCCGTTTCATCAATAACCTTTTGCACAAATC 
Leu63Gln GATTTGTGCAAAAGGTTCAGGATGAAACGGGTGCG CGCACCCGTTTCATCCTGAACCTTTTGCACAAATC 
Asp64lle GTGCAAAAGGTTTTAATTGAAACGGGTGCGAAA TTTCGCACCCGTTTCAATTAAAACCTTTTGCAC 
Glu65Asp CAAAAGGTTTTAGATGATACGGGTGCGAAAAAA TTTTTTCGCACCCGTATCATCTAAAACCTTTTG 
Glu65Tyr CAAAAGGTTTTAGATTATACGGGTGCGAAAAAA TTTTTTCGCACCCGTATAATCTAAAACCTTTTG 
Thr66Asp GGTTTTAGATGAAGATGGTGCGAAAAAAGTG CACTTTTTTCGCACCATCTTCATCTAAAACC 
Thr66Cys GGTTTTAGATGAATGCGGTGCGAAAAAAGTG CACTTTTTTCGCACCGCATTCATCTAAAACC 
Gly67Asp GTTTTAGATGAAACGGATGCGAAAAAAGTGGAT ATCCACTTTTTTCGCATCCGTTTCATCTAAAAC 
Gly67Gln GTTTTAGATGAAACGCAGGCGAAAAAAGTGGAT ATCCACTTTTTTCGCCTGCGTTTCATCTAAAAC 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Ala68-Lys 
AGATGAAACGGGTAAGAAAAAAGTGGATATTGTCG
C GCGACAATATCCACTTTTTTCTTACCCGTTTCATCT 
Ala68-Met 
AGATGAAACGGGTATGAAAAAAGTGGATATTGTCG
C GCGACAATATCCACTTTTTTCATACCCGTTTCATCT 
Lys69Trp GATGAAACGGGTGCGTGGAAAGTGGATATTGTC GACAATATCCACTTTCCACGCACCCGTTTCATC 
Lys69Cys GATGAAACGGGTGCGTGCAAAGTGGATATTGTC GACAATATCCACTTTGCACGCACCCGTTTCATC 
Lys70Asp GAAACGGGTGCGAAAGATGTGGATATTGTCGCT AGCGACAATATCCACATCTTTCGCACCCGTTTC 
Lys70Ile GAAACGGGTGCGAAAATTGTGGATATTGTCGCT AGCGACAATATCCACAATTTTCGCACCCGTTTC 
Lys70Met GAAACGGGTGCGAAAATGGTGGATATTGTCGCT AGCGACAATATCCACCATTTTCGCACCCGTTTC 
Val71Asp CGGGTGCGAAAAAAGATGATATTGTCGCTCACAG CTGTGAGCGACAATATCATCTTTTTTCGCACCCG 
His76Gln GTGGATATTGTCGCTCAGAGCATGGGGGGCGCG CGCGCCCCCCATGCTCTGAGCGACAATATCCAC 
Ser77His GATATTGTCGCTCACCACATGGGGGGCGCGAAC GTTCGCGCCCCCCATGTGGTGAGCGACAATATC 
Ser77Tyr GATATTGTCGCTCACTATATGGGGGGCGCGAAC GTTCGCGCCCCCCATATAGTGAGCGACAATATC 
Ser77Cys GATATTGTCGCTCACTGCATGGGGGGCGCGAAC GTTCGCGCCCCCCATGCAGTGAGCGACAATATC 
Met78Trp 
GATATTGTCGCTCACAGCTGGGGGGGCGCGAACAC
A TGTGTTCGCGCCCCCCCAGCTGTGAGCGACAATATC 
Met78Cys GATATTGTCGCTCACAGCTGCGGGGGCGCGAACACA TGTGTTCGCGCCCCCGCAGCTGTGAGCGACAATATC 
Gly79Asp GTCGCTCACAGCATGGATGGCGCGAACACACTT AAGTGTGTTCGCGCCATCCATGCTGTGAGCGAC 
Gly79His GTCGCTCACAGCATGCACGGCGCGAACACACTT AAGTGTGTTCGCGCCGTGCATGCTGTGAGCGAC 
Gly79lle GTCGCTCACAGCATGATTGGCGCGAACACACTT AAGTGTGTTCGCGCCAATCATGCTGTGAGCGAC 
Gly79Trp GTCGCTCACAGCATGTGGGGCGCGAACACACTT AAGTGTGTTCGCGCCCCACATGCTGTGAGCGAC 
Gly80Glu GCTCACAGCATGGGGGAAGCGAACACACTTTAC GTAAAGTGTGTTCGCTTCCCCCATGCTGTGAGC 
Gly80lle GCTCACAGCATGGGGATTGCGAACACACTTTAC GTAAAGTGTGTTCGCAATCCCCATGCTGTGAGC 
Gly80Met GCTCACAGCATGGGGATGGCGAACACACTTTAC GTAAAGTGTGTTCGCCATCCCCATGCTGTGAGC 
Ala81Asp CACAGCATGGGGGGCGATAACACACTTTACTAC GTAGTAAAGTGTGTTATCGCCCCCCATGCTGTG 
Ala81Gln CACAGCATGGGGGGCCAGAACACACTTTACTAC GTAGTAAAGTGTGTTCTGGCCCCCCATGCTGTG 
Ala81cys CACAGCATGGGGGGCTGCAACACACTTTACTAC GTAGTAAAGTGTGTTGCAGCCCCCCATGCTGTG 
Ala81-Phe CACAGCATGGGGGGCTTTAACACACTTTACTAC GTAGTAAAGTGTGTTAAAGCCCCCCATGCTGTG 
Thr83Ala CATGGGGGGCGCGAACGCGCTTTACTACATAAAA TTTTATGTAGTAAAGCGCGTTCGCGCCCCCCATG 
Thr83lle CATGGGGGGCGCGAACATTCTTTACTACATAAAA TTTTATGTAGTAAAGAATGTTCGCGCCCCCCATG 
Thr83Ser CATGGGGGGCGCGAACAGCCTTTACTACATAAAA TTTTATGTAGTAAAGGCTGTTCGCGCCCCCCATG 
Thr83Gln CATGGGGGGCGCGAACCAGCTTTACTACATAAAA TTTTATGTAGTAAAGCTGGTTCGCGCCCCCCATG 
Thr83Cys CATGGGGGGCGCGAACTGCCTTTACTACATAAAA TTTTATGTAGTAAAGGCAGTTCGCGCCCCCCATG 
Tyr85Met GGCGCGAACACACTTATGTACATAAAAAATCTG CAGATTTTTTATGTACATAAGTGTGTTCGCGCC 
Tyr85Gln GGCGCGAACACACTTCAGTACATAAAAAATCTG CAGATTTTTTATGTACTGAAGTGTGTTCGCGCC 
Tyr85Glu GGCGCGAACACACTTGAATACATAAAAAATCTG CAGATTTTTTATGTATTCAAGTGTGTTCGCGCC 
Tyr85Ile GGCGCGAACACACTTATTTACATAAAAAATCTG CAGATTTTTTATGTAAATAAGTGTGTTCGCGCC 
Tyr86Phe GCGAACACACTTTACTTTATAAAAAATCTGGAC GTCCAGATTTTTTATAAAGTAAAGTGTGTTCGC 
Tyr86Gln GCGAACACACTTTACCAGATAAAAAATCTGGAC GTCCAGATTTTTTATCTGGTAAAGTGTGTTCGC 
Ile87Gln GAACACACTTTACTACCAGAAAAATCTGGACGGC GCCGTCCAGATTTTTCTGGTAGTAAAGTGTGTTC 
Lys88Trp CACACTTTACTACATATGGAATCTGGACGGCGGA TCCGCCGTCCAGATTCCATATGTAGTAAAGTGTG 
Asn89Cys CTTTACTACATAAAATGCCTGGACGGCGGAAAT ATTTCCGCCGTCCAGGCATTTTATGTAGTAAAG 
Asp91Lys CTACATAAAAAATCTGAAGGGCGGAAATAAAGTT AACTTTATTTCCGCCCTTCAGATTTTTTATGTAG 
Gly92Gln AAAAATCTGGACCAGGGAAATAAAGTT AACTTTATTTCCCTGGTCCAGATTTTT 
Gly92Cys AAAAATCTGGACTGCGGAAATAAAGTT AACTTTATTTCCGCAGTCCAGATTTTT 
Gly93Asp AATCTGGACGGCGATAATAAAGTTGCA TGCAACTTTATTATCGCCGTCCAGATT 
Gly93Glu AATCTGGACGGCGAAAATAAAGTTGCA TGCAACTTTATTTTCGCCGTCCAGATT 
Gly93Lys AATCTGGACGGCAAAAATAAAGTTGCA TGCAACTTTATTTTTGCCGTCCAGATT 
Gly93Ile AATCTGGACGGCATTAATAAAGTTGCA TGCAACTTTATTAATGCCGTCCAGATT 
Gly93Gln AATCTGGACGGCCAGAATAAAGTTGCA TGCAACTTTATTCTGGCCGTCCAGATT 
Gly93Cys AATCTGGACGGCTGCAATAAAGTTGCA TGCAACTTTATTGCAGCCGTCCAGATT 
Asn94Cys CTGGACGGCGGATGCAAAGTTGCAAAC GTTTGCAACTTTGCATCCGCCGTCCAG 
Asn94Glu CTGGACGGCGGAGAAAAAGTTGCAAAC GTTTGCAACTTTTTCTCCGCCGTCCAG 
Asn94Lys CTGGACGGCGGAAAAAAAGTTGCAAAC GTTTGCAACTTTTTTTCCGCCGTCCAG 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Asn94Trp CTGGACGGCGGATGGAAAGTTGCAAAC GTTTGCAACTTTCCATCCGCCGTCCAG 
Asn94Thr GGACGGCGGAACCAAAGTTGCAA TTGCAACTTTGGTTCCGCCGTCC 
Lys95His GACGGCGGAAATCATGTTGCAAACGTC GACGTTTGCAACATGATTTCCGCCGTC 
Lys95Ile GACGGCGGAAATATTGTTGCAAACGTC GACGTTTGCAACAATATTTCCGCCGTC 
Lys95Gln GACGGCGGAAATCAGGTTGCAAACGTC GACGTTTGCAACCTGATTTCCGCCGTC 
Val96Asp GGCGGAAATAAAGATGCAAACGTCGTG CACGACGTTTGCATCTTTATTTCCGCC 
Val96Lys GGCGGAAATAAAAAAGCAAACGTCGTG CACGACGTTTGCTTTTTTATTTCCGCC 
Val96Gln GGCGGAAATAAACAGGCAAACGTCGTG CACGACGTTTGCCTGTTTATTTCCGCC 
Ala97Asp GGAAATAAAGTTGATAACGTCGTGACG CGTCACGACGTTATCAACTTTATTTCC 
Ala97His GGAAATAAAGTTCATAACGTCGTGACG CGTCACGACGTTATGAACTTTATTTCC 
Ala97Asn GGAAATAAAGTTAACAACGTCGTGACG CGTCACGACGTTGTTAACTTTATTTCC 
Asn98Lys AATAAAGTTGCAAAAGTCGTGACGCTT AAGCGTCACGACTTTTGCAACTTTATT 
Asn98Thr AATAAAGTTGCAACCGTCGTGACGCTT AAGCGTCACGACGGTTGCAACTTTATT 
Asn98Gln AATAAAGTTGCACAGGTCGTGACGCTT AAGCGTCACGACCTGTGCAACTTTATT 
Val100His GTTGCAAACGTCCATACGCTTGGCGGC GCCGCCAAGCGTATGGACGTTTGCAAC 
Val100Ala GTTGCAAACGTCGCCACGCTTGGCGGC GCCGCCAAGCGTGGCGACGTTTGCAAC 
Val100Ile GTTGCAAACGTCATTACGCTTGGCGGC GCCGCCAAGCGTAATGACGTTTGCAAC 
Thr101His GCAAACGTCGTGCATCTTGGCGGCGCG CGCGCCGCCAAGATGCACGACGTTTGC 
Leu102Lys CGTCGTGACGAAAGGCGGCGCGA TCGCGCCGCCTTTCGTCACGACG 
Ala105Cys ACGCTTGGCGGCTGCAACCGTTTGACG CGTCAAACGGTTGCAGCCGCCAAGCGT 
Thr109Glu GCGAACCGTTTGGAAACAGGCAAGGCG CGCCTTGCCTGTTTCCAAACGGTTCGC 
Thr109Lys GCGAACCGTTTGAAAACAGGCAAGGCG CGCCTTGCCTGTTTTCAAACGGTTCGC 
Thr109Ile GCGAACCGTTTGATTACAGGCAAGGCG CGCCTTGCCTGTAATCAAACGGTTCGC 
Thr109Asn GAACCGTTTGAACACAGGCAAGG CCTTGCCTGTGTTCAAACGGTTC 
Lys112Asp TTGACGACAGGCGATGCGCTTCCGGGA TCCCGGAAGCGCATCGCCTGTCGTCAA 
Lys112Glu TTGACGACAGGCGAAGCGCTTCCGGGA TCCCGGAAGCGCTTCGCCTGTCGTCAA 
Ala113Cys ACGACAGGCAAGTGCCTTCCGGGAACA TGTTCCCGGAAGGCACTTGCCTGTCGT 
Ala113His ACGACAGGCAAGCATCTTCCGGGAACA TGTTCCCGGAAGATGCTTGCCTGTCGT 
Ala113Asn ACGACAGGCAAGAACCTTCCGGGAACA TGTTCCCGGAAGGTTCTTGCCTGTCGT 
Ala113Gln ACGACAGGCAAGCAGCTTCCGGGAACA TGTTCCCGGAAGCTGCTTGCCTGTCGT 
Leu114Glu ACAGGCAAGGCGGAACCGGGAACAGAT ATCTGTTCCCGGTTCCGCCTTGCCTGT 
Leu114Trp ACAGGCAAGGCGTGGCCGGGAACAGAT ATCTGTTCCCGGCCACGCCTTGCCTGT 
Pro115Trp GGCAAGGCGCTTTGGGGAACAGATCCA TGGATCTGTTCCCCAAAGCGCCTTGCC 
Gly116Met AAGGCGCTTCCGATGACAGATCCAAAT ATTTGGATCTGTCATCGGAAGCGCCTT 
Thr117Tyr GCGCTTCCGGGATATGATCCAAATCAA TTGATTTGGATCATATCCCGGAAGCGC 
Asp118Ile CTTCCGGGAACAATTCCAAATCAAAAG CTTTTGATTTGGAATTGTTCCCGGAAG 
Asp118Tyr CTTCCGGGAACATATCCAAATCAAAAG CTTTTGATTTGGATATGTTCCCGGAAG 
Pro119Cys CCGGGAACAGATTGCAATCAAAAGATT AATCTTTTGATTGCAATCTGTTCCCGG 
Asn120Glu GGAACAGATCCAGAACAAAAGATTTTA TAAAATCTTTTGTTCTGGATCTGTTCC 
Asn120Arg GGAACAGATCCACGCCAAAAGATTTTA TAAAATCTTTTGGCGTGGATCTGTTCC 
Gln121Ala ACAGATCCAAATGCCAAGATTTTATAC GTATAAAATCTTGGCATTTGGATCTGT 
Gln121Met ACAGATCCAAATATGAAGATTTTATAC GTATAAAATCTTCATATTTGGATCTGT 
Lys122Tyr GATCCAAATCAATATATTTTATACACA TGTGTATAAAATATATTGATTTGGATC 
Lys122Cys GATCCAAATCAATGCATTTTATACACA TGTGTATAAAATGCATTGATTTGGATC 
Lys122Asp GATCCAAATCAAGATATTTTATACACA TGTGTATAAAATATCTTGATTTGGATC 
Lys122Ile GATCCAAATCAAATTATTTTATACACA TGTGTATAAAATAATTTGATTTGGATC 
Lys122Phe GATCCAAATCAATTTATTTTATACACA TGTGTATAAAATAAATTGATTTGGATC 
Ile123Tyr CCAAATCAAAAGTATTTATACACATCC GGATGTGTATAAATACTTTTGATTTGG 
Leu124Trp AATCAAAAGATTTGGTACACATCCATT AATGGATGTGTACCAAATCTTTTGATT 
Leu124Gln AATCAAAAGATTCAGTACACATCCATT AATGGATGTGTACTGAATCTTTTGATT 
Leu124Glu AATCAAAAGATTGAATACACATCCATT AATGGATGTGTATTCAATCTTTTGATT 
Leu124Val AATCAAAAGATTGTGTACACATCCATT AATGGATGTGTACACAATCTTTTGATT 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Leu124Tyr AATCAAAAGATTTATTACACATCCATT AATGGATGTGTAATAAATCTTTTGATT 
Tyr125Ile CAAAAGATTTTAATTACATCCATTTAC GTAAATGGATGTAATTAAAATCTTTTG 
Tyr125Met CAAAAGATTTTAATGACATCCATTTAC GTAAATGGATGTCATTAAAATCTTTTG 
Tyr125Gln CAAAAGATTTTACAGACATCCATTTAC GTAAATGGATGTCTGTAAAATCTTTTG 
Thr126Asp AAGATTTTATACGATTCCATTTACAGC GCTGTAAATGGAATCGTATAAAATCTT 
Thr126Met AAGATTTTATACATGTCCATTTACAGC GCTGTAAATGGACATGTATAAAATCTT 
Thr126Phe AAGATTTTATACTTTTCCATTTACAGC GCTGTAAATGGAAAAGTATAAAATCTT 
Thr126Lys GATTTTATACAAATCCATTTACA TGTAAATGGATTTGTATAAAATC 
Thr126Cys GATTTTATACTGCTCCATTTACA TGTAAATGGAGCAGTATAAAATC 
Ser127Gln ATTTTATACACACAGATTTACAGCAGT ACTGCTGTAAATCTGTGTGTATAAAAT 
Ser127Glu ATTTTATACACAGAAATTTACAGCAGT ACTGCTGTAAATTTCTGTGTATAAAAT 
Ser127Met ATTTTATACACAATGATTTACAGCAGT ACTGCTGTAAATCATTGTGTATAAAAT 
Ser127Trp ATTTTATACACATGGATTTACAGCAGT ACTGCTGTAAATCCATGTGTATAAAAT 
Ile128Asp TTATACACATCCGATTACAGCAGTGCC GGCACTGCTGTAATCGGATGTGTATAA 
Ile128Cys TTATACACATCCTGCTACAGCAGTGCC GGCACTGCTGTAGCAGGATGTGTATAA 
Tyr129His TACACATCCATTCATAGCAGTGCCGAT ATCGGCACTGCTATGAATGGATGTGTA 
Tyr129Asn TACACATCCATTAACAGCAGTGCCGAT ATCGGCACTGCTGTTAATGGATGTGTA 
Tyr129Cys TACACATCCATTTGCAGCAGTGCCGAT ATCGGCACTGCTGCAAATGGATGTGTA 
Ser130Asp ACATCCATTTACGATAGTGCCGATATG CATATCGGCACTATCGTAAATGGATGT 
Ser130Trp ACATCCATTTACTGGAGTGCCGATATG CATATCGGCACTCCAGTAAATGGATGT 
Ser131Gln TCCATTTACAGCCAGGCCGATATGATT AATCATATCGGCCTGGCTGTAAATGGA 
Ser131Ala CATTTACAGCGCCGCCGATATGA TCATATCGGCGGCGCTGTAAATG 
Ala132Gln ATTTACAGCAGTCAGGATATGATTGTC GACAATCATATCCTGACTGCTGTAAAT 
Ala132Lys ATTTACAGCAGTAAAGATATGATTGTC GACAATCATATCTTTACTGCTGTAAAT 
Ala132Ile ATTTACAGCAGTATTGATATGATTGTC GACAATCATATCAATACTGCTGTAAAT 
Ala132Met ATTTACAGCAGTATGGATATGATTGTC GACAATCATATCCATACTGCTGTAAAT 
Met134Phe AGCAGTGCCGATTTTATTGTCATGAAT ATTCATGACAATAAAATCGGCACTGCT 
Met134Tyr AGCAGTGCCGATTATATTGTCATGAAT ATTCATGACAATATAATCGGCACTGCT 
Ile135Gln AGTGCCGATATGCAGGTCATGAATTAC GTAATTCATGACCTGCATATCGGCACT 
Val136Trp GCCGATATGATTTGGATGAATTACTTA TAAGTAATTCATCCAAATCATATCGGC 
Val136Cys GCCGATATGATTTGCATGAATTACTTA TAAGTAATTCATGCAAATCATATCGGC 
Val136His CGATATGATTCATATGAATTACT AGTAATTCATATGAATCATATCG 
Met137Asn GATATGATTGTCAACAATTACTTATCA TGATAAGTAATTGTTGACAATCATATC 
Met137Cys GATATGATTGTCTGCAATTACTTATCA TGATAAGTAATTGCAGACAATCATATC 
Met137Pro GATATGATTGTCCCGAATTACTTATCA TGATAAGTAATTCGGGACAATCATATC 
Met137Asp GATATGATTGTCGATAATTACTTATCA TGATAAGTAATTATCGACAATCATATC 
Met137His GATATGATTGTCCATAATTACTTATCA TGATAAGTAATTATGGACAATCATATC 
Met137Tyr GATATGATTGTCTATAATTACTTATCA TGATAAGTAATTATAGACAATCATATC 
Asn138Cys ATGATTGTCATGTGCTACTTATCAAGA TCTTGATAAGTAGCACATGACAATCAT 
Tyr139Phe ATTGTCATGAATTTTTTATCAAGATTA TAATCTTGATAAAAAATTCATGACAAT 
Tyr139Gln ATTGTCATGAATCAGTTATCAAGATTA TAATCTTGATAACTGATTCATGACAAT 
Tyr139Pro TGTCATGAATCCGTTATCAAGAT ATCTTGATAACGGATTCATGACA 
Tyr139Ile TGTCATGAATATTTTATCAAGAT ATCTTGATAAAATATTCATGACA 
Tyr139Met TGTCATGAATATGTTATCAAGAT ATCTTGATAACATATTCATGACA 
Leu140Gln GTCATGAATTACCAGTCAAGATTAGAT ATCTAATCTTGACTGGTAATTCATGAC 
Arg142Phe AATTACTTATCATTTTTAGATGGTGCT AGCACCATCTAAAAATGATAAGTAATT 
Leu143Asp TACTTATCAAGAGATGATGGTGCTAGA TCTAGCACCATCATCTCTTGATAAGTA 
Asp144Phe TTATCAAGATTATTTGGTGCTAGAAAC GTTTCTAGCACCAAATAATCTTGATAA 
Gly145Phe TCAAGATTAGATTTTGCTAGAAACGTT AACGTTTCTAGCAAAATCTAATCTTGA 
Gly145Gln TCAAGATTAGATCAGGCTAGAAACGTT AACGTTTCTAGCCTGATCTAATCTTGA 
Arg147Trp TTAGATGGTGCTTGGAACGTTCAAATC GATTTGAACGTTCCAAGCACCATCTAA 
Arg147Glu TTAGATGGTGCTGAAAACGTTCAAATC GATTTGAACGTTTTCAGCACCATCTAA 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Arg147Lys TTAGATGGTGCTAAAAACGTTCAAATC GATTTGAACGTTTTTAGCACCATCTAA 
Arg147Met TTAGATGGTGCTATGAACGTTCAAATC GATTTGAACGTTCATAGCACCATCTAA 
Asn148Trp GATGGTGCTAGATGGGTTCAAATCCAT ATGGATTTGAACCCATCTAGCACCATC 
Asn148Val TGGTGCTAGAGTGGTTCAAATCC GGATTTGAACCACTCTAGCACCA 
Val149Gln GGTGCTAGAAACCAGCAAATCCATGGC GCCATGGATTTGCTGGTTTCTAGCACC 
Gln150Asn GCTAGAAACGTTAACATCCATGGCGTT AACGCCATGGATGTTAACGTTTCTAGC 
Ile151Glu AGAAACGTTCAAGAACATGGCGTTGGA TCCAACGCCATGTTCTTGAACGTTTCT 
Ile151Arg AGAAACGTTCAACGCCATGGCGTTGGA TCCAACGCCATGGCGTTGAACGTTTCT 
Ile151Cys AGAAACGTTCAATGCCATGGCGTTGGA TCCAACGCCATGGCATTGAACGTTTCT 
His152Asp AACGTTCAAATCGATGGCGTTGGACAC GTGTCCAACGCCATCGATTTGAACGTT 
His152Cys AACGTTCAAATCTGCGGCGTTGGACAC GTGTCCAACGCCGCAGATTTGAACGTT 
Val154His AATCCATGGCCATGGACACATCG CGATGTGTCCATGGCCATGGATT 
His156Met CATGGCGTTGGAATGATCGGCCTTCTG CAGAAGGCCGATCATTCCAACGCCATG 
His156Cys CATGGCGTTGGATGCATCGGCCTTCTG CAGAAGGCCGATGCATCCAACGCCATG 
Ile157Gln GGCGTTGGACACCAGGGCCTTCTGTAC GTACAGAAGGCCCTGGTGTCCAACGCC 
Ile157Asp GGCGTTGGACACGATGGCCTTCTGTAC GTACAGAAGGCCATCGTGTCCAACGCC 
Ile157Glu GGCGTTGGACACGAAGGCCTTCTGTAC GTACAGAAGGCCTTCGTGTCCAACGCC 
Ile157Met GGCGTTGGACACATGGGCCTTCTGTAC GTACAGAAGGCCCATGTGTCCAACGCC 
Gly158Met GTTGGACACATCATGCTTCTGTACAGC GCTGTACAGAAGCATGATGTGTCCAAC 
Gly158Phe GTTGGACACATCTTTCTTCTGTACAGC GCTGTACAGAAGAAAGATGTGTCCAAC 
Gly158Asn GTTGGACACATCAACCTTCTGTACAGC GCTGTACAGAAGGTTGATGTGTCCAAC 
Leu159Ile GGACACATCGGCATTCTGTACAGCAGC GCTGCTGTACAGAATGCCGATGTGTCC 
Leu160Asp CACATCGGCCTTGATTACAGCAGCCAA TTGGCTGCTGTAATCAAGGCCGATGTG 
Tyr161Asp ATCGGCCTTCTGGATAGCAGCCAAGTC GACTTGGCTGCTATCCAGAAGGCCGAT 
Tyr161Val ATCGGCCTTCTGGTGAGCAGCCAAGTC GACTTGGCTGCTCACCAGAAGGCCGAT 
Ser163Phe CTTCTGTACAGCTTTCAAGTCAACAGC GCTGTTGACTTGAAAGCTGTACAGAAG 
Ser163Gln CTTCTGTACAGCCAGCAAGTCAACAGC GCTGTTGACTTGCTGGCTGTACAGAAG 
Ser163Cys CTTCTGTACAGCTGCCAAGTCAACAGC GCTGTTGACTTGGCAGCTGTACAGAAG 
Gln164Asp CTGTACAGCAGCGATGTCAACAGCCTG CAGGCTGTTGACATCGCTGCTGTACAG 
Gln164Ile CTGTACAGCAGCATTGTCAACAGCCTG CAGGCTGTTGACAATGCTGCTGTACAG 
Gln164Trp CTGTACAGCAGCTGGGTCAACAGCCTG CAGGCTGTTGACCCAGCTGCTGTACAG 
Val165Gln TACAGCAGCCAACAGAACAGCCTGATT AATCAGGCTGTTCTGTTGGCTGCTGTA 
Val165Cys TACAGCAGCCAATGCAACAGCCTGATT AATCAGGCTGTTGCATTGGCTGCTGTA 
Asn166Glu AGCAGCCAAGTCGAAAGCCTGATTAAA TTTAATCAGGCTTTCGACTTGGCTGCT 
Asn166Met AGCAGCCAAGTCATGAGCCTGATTAAA TTTAATCAGGCTCATGACTTGGCTGCT 
Asn166Tyr AGCAGCCAAGTCTATAGCCTGATTAAA TTTAATCAGGCTATAGACTTGGCTGCT 
Ser167Val AGCCAAGTCAACGTGCTGATTAAAGAA TTCTTTAATCAGCACGTTGACTTGGCT 
Ser167Trp AGCCAAGTCAACTGGCTGATTAAAGAA TTCTTTAATCAGCCAGTTGACTTGGCT 
Ser167Gln AGCCAAGTCAACCAGCTGATTAAAGAA TTCTTTAATCAGCTGGTTGACTTGGCT 
Ser167Met CCAAGTCAACATGCTGATTAAAG CTTTAATCAGCATGTTGACTTGG 
Leu168Thr CAAGTCAACAGCACCATTAAAGAAGGG CCCTTCTTTAATGGTGCTGTTGACTTG 
Leu168Asn CAAGTCAACAGCAACATTAAAGAAGGG CCCTTCTTTAATGTTGCTGTTGACTTG 
Ile169Glu GTCAACAGCCTGGAAAAAGAAGGGCTG CAGCCCTTCTTTTTCCAGGCTGTTGAC 
Lys170Cys AACAGCCTGATTTGCGAAGGGCTGAAC GTTCAGCCCTTCGCAAATCAGGCTGTT 
Lys170Gly AACAGCCTGATTGGCGAAGGGCTGAAC GTTCAGCCCTTCGCCAATCAGGCTGTT 
Glu171Trp AGCCTGATTAAATGGGGGCTGAACGGC GCCGTTCAGCCCCCATTTAATCAGGCT 
Glu171Gln AGCCTGATTAAACAGGGGCTGAACGGC GCCGTTCAGCCCCTGTTTAATCAGGCT 
Gly172Phe CTGATTAAAGAATTTCTGAACGGCGGG CCCGCCGTTCAGAAATTCTTTAATCAG 
Leu173Asp ATTAAAGAAGGGGATAACGGCGGGGGC GCCCCCGCCGTTATCCCCTTCTTTAAT 
Leu173Lys ATTAAAGAAGGGAAAAACGGCGGGGGC GCCCCCGCCGTTTTTCCCTTCTTTAAT 
Gly175Lys GAAGGGCTGAACAAAGGGGGCCAGAAT ATTCTGGCCCCCTTTGTTCAGCCCTTC 
Gly175Asn GAAGGGCTGAACAACGGGGGCCAGAAT ATTCTGGCCCCCGTTGTTCAGCCCTTC 
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Table 7-2: List of all primers used for the site directed mutagenesis (SDM). 
Primer name Forward primer Reverse primer 
Gly176Lys GGGCTGAACGGCAAAGGCCAGAATACG CGTATTCTGGCCTTTGCCGTTCAGCCC 
Gly176Cys GGGCTGAACGGCTGCGGCCAGAATACG CGTATTCTGGCCGCAGCCGTTCAGCCC 
Gly177Asp CTGAACGGCGGGGATCAGAATACGAAT ATTCGTATTCTGATCCCCGCCGTTCAG 
Gly177Gln CTGAACGGCGGGCAGCAGAATACGAAT ATTCGTATTCTGCTGCCCGCCGTTCAG 
Gly177Cys CTGAACGGCGGGTGCCAGAATACGAAT ATTCGTATTCTGGCACCCGCCGTTCAG 
Gly177His GAACGGCGGGCATCAGAATACGA TCGTATTCTGATGCCCGCCGTTC 
Gln178His AACGGCGGGGGCCATAATACGAATTAA TTAATTCGTATTATGGCCCCCGCCGTT 
Asn179Ala GGCGGGGGCCAGGCCACGAATTAATGA TCATTAATTCGTGGCCTGGCCCCCGCC 
Asn179Met GGCGGGGGCCAGATGACGAATTAATGA TCATTAATTCGTCATCTGGCCCCCGCC 
Thr180Gln GGGGGCCAGAATCAGAATTAATGAGAG CTCTCATTAATTCTGATTCTGGCCCCC 
Thr180Gly GGGGGCCAGAATGGCAATTAATGAGAG CTCTCATTAATTGCCATTCTGGCCCCC 
Asn181Glu GGCCAGAATACGGAATAATGAGAGCTC GAGCTCTCATTATTCCGTATTCTGGCC 
Asn181Met GGCCAGAATACGATGTAATGAGAGCTC GAGCTCTCATTACATCGTATTCTGGCC 
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Table 7-3: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards [BMIM][Cl] and inactivation 
of BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in 
light grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: 
unchanged resistance; “-”: decreased resistance and “x” inactivated. 
  
BSLA
 secondary
structure
BSLA amino
acid positions
+ = - x
loop Ala1 2 18 0 0
loop Glu2 0 19 1 0
loop HIS3 0 19 1 0
loop ASN4 1 18 1 0
loop PRO5 5 8 5 2
Sheet VAL6 2 11 2 5
Sheet VAL7 3 2 0 15
Sheet MET8 1 8 7 4
Sheet VAL9 2 9 4 5
loop HIS10 7 5 8 0
loop GLY11 0 1 1 18
loop ILE12 10 5 1 4
loop GLY13 0 8 12 0
loop GLY14 8 5 4 3
loop ALA15 0 17 2 1
Helix H1 SER16 0 19 1 0
Helix H1 PHE17 15 5 0 0
Helix H1 ASN18 6 11 2 1
Helix H1 PHE19 0 8 11 1
Helix H1 ALA20 0 15 5 0
Helix H1 GLY21 0 17 3 0
Helix H1 ILE22 5 13 0 2
Helix H1 LYS23 7 9 3 1
Helix H1 SER24 0 17 3 0
Helix H1 TYR25 0 18 1 1
Helix H1 LEU26 0 7 3 10
Helix H1 VAL27 2 16 1 1
Helix H1 SER28 2 14 4 0
loop GLN29 1 18 0 1
loop GLY30 0 3 15 2
loop TRP31 1 16 1 2
loop SER32 1 18 1 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 2 7 10 1
Helix H3 LYS35 0 16 1 3
Sheet LEU36 4 12 2 2
Sheet TYR37 0 19 1 0
Sheet ALA38 0 18 2 0
loop VAL39 1 19 0 0
loop ASP40 0 18 2 0
loop PHE41 4 4 10 2
loop TRP42 0 19 1 0
loop ASP43 0 20 0 0
loop LYS44 1 19 0 0
loop THR45 1 19 0 0
loop GLY46 4 12 4 0
loop THR47 4 16 0 0
Helix H4 ASN48 4 16 0 0
Helix H4 TYR49 1 19 0 0
Helix H4 ASN50 1 19 0 0
Helix H4 ASN51 2 17 1 0
loop GLY52 1 3 16 0
Helix H4 PRO53 0 20 0 0
Helix H4 VAL54 13 6 0 1
Helix H4 LEU55 4 7 0 9
Helix H4 SER56 0 18 2 0
Helix H4 ARG57 2 10 8 0
Helix H4 PHE58 12 7 0 1
Helix H4 VAL59 1 3 4 12
Helix H4 GLN60 0 8 12 0
Helix H4 LYS61 2 15 2 1
Helix H4 VAL62 0 8 10 2
Helix H4 LEU63 1 15 3 1
Helix H4 ASP64 6 11 2 1
Helix H4 GLU65 2 14 4 0
Helix H4 THR66 3 15 1 1
loop GLY67 0 15 4 1
loop ALA68 1 14 5 0
loop LYS69 0 20 0 0
loop LYS70 9 6 4 1
Sheet VAL71 0 1 8 11
Sheet ASP72 0 8 6 6
Sheet ILE73 0 2 2 16
Sheet VAL74 0 6 1 13
Sheet ALA75 0 8 2 10
Sheet HIS76 0 1 1 18
loop SER77 0 1 0 19
Helix H5 MET78 6 6 0 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 2 3 1 14
Helix H5 ALA81 9 8 2 1
Helix H5 ASN82 0 9 9 2
Helix H5 THR83 1 14 2 3
Helix H5 LEU84 7 11 0 2
Helix H5 TYR85 0 18 1 1
Helix H5 TYR86 0 16 0 4
Helix H5 ILE87 2 9 1 8
Helix H5 LYS88 1 15 3 1
loop ASN89 3 9 4 4
loop LEU90 14 3 3 0
loop ASP91 3 10 5 2
Number of amino acid substitutions with
[BMIM][Cl]
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
Helix H6 GLY92 0 7 13 0
Helix H6 GLY93 1 19 0 0
Helix H6 ASN94 3 17 0 0
loop LYS95 9 10 1 0
Sheet VAL96 0 10 2 8
Sheet ALA97 2 16 1 1
Sheet ASN98 3 15 2 0
Sheet VAL99 3 12 1 4
Sheet VAL100 0 10 2 8
Sheet THR101 4 14 1 1
Sheet LEU102 2 8 1 9
loop GLY103 0 2 3 15
loop GLY104 6 7 1 6
loop ALA105 7 10 1 2
Helix H7 ASN106 1 14 4 1
Helix H7 ARG107 8 9 0 3
Helix H7 LEU108 2 15 2 1
loop THR109 4 13 3 0
loop THR110 1 17 2 0
loop GLY111 1 13 6 0
loop LYS112 2 17 1 0
loop ALA113 0 19 1 0
loop LEU114 3 17 0 0
loop PRO115 0 20 0 0
loop GLY116 2 18 0 0
loop THR117 1 12 4 3
loop ASP118 1 19 0 0
loop PRO119 12 7 1 0
loop ASN120 1 19 0 0
loop GLN121 1 19 0 0
loop LYS122 1 18 0 1
loop ILE123 0 11 5 4
Sheet LEU124 12 8 0 0
Sheet TYR125 0 11 2 7
Sheet THR126 1 12 5 2
Sheet SER127 3 12 1 4
Sheet ILE128 1 11 1 7
Sheet TYR129 5 10 2 3
Sheet SER130 2 12 4 2
loop SER131 0 20 0 0
loop ALA132 4 16 0 0
loop ASP133 1 1 0 18
loop MET134 4 16 0 0
loop ILE135 5 14 1 0
loop VAL136 1 11 2 6
loop MET137 7 13 0 0
Helix H8 ASN138 6 13 0 1
Helix H8 TYR139 1 13 2 4
Helix H8 LEU140 4 16 0 0
Helix H8 SER141 2 4 5 9
loop ARG142 1 19 0 0
loop LEU143 3 4 6 7
loop ASP144 3 17 0 0
loop GLY145 7 13 0 0
loop ALA146 0 17 2 1
Sheet ARG147 4 15 0 1
Sheet ASN148 0 14 5 1
Sheet VAL149 0 20 0 0
Sheet GLN150 3 17 0 0
Sheet ILE151 7 11 2 0
loop HIS152 5 14 0 1
loop GLY153 0 19 1 0
loop VAL154 5 10 5 0
loop GLY155 17 3 0 0
loop HIS156 0 1 0 19
loop ILE157 2 11 3 4
Helix H9 GLY158 1 19 0 0
Helix H9 LEU159 7 12 0 1
Helix H9 LEU160 1 10 3 6
Helix H9 TYR161 3 16 0 1
loop SER162 1 18 1 0
Helix H10 SER163 1 19 0 0
Helix H10 GLN164 3 14 3 0
Helix H10 VAL165 7 10 0 3
Helix H10 ASN166 1 2 11 6
Helix H10 SER167 5 12 2 1
Helix H10 LEU168 3 4 3 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 18 0 1
Helix H10 GLU171 6 12 0 2
Helix H10 GLY172 1 19 0 0
Helix H10 LEU173 0 8 6 6
loop ASN174 2 18 0 0
loop GLY175 0 20 0 0
loop GLY176 0 19 1 0
loop GLY177 0 20 0 0
loop GLN178 1 17 2 0
loop ASN179 3 16 0 1
loop THR180 0 20 0 0
loop ASN181 3 17 0 0
Total 124 181 117 99
[BMIM][Cl]
Number of amino acid substitutions with
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Table 7-4: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards [BMIM][Br] and inactivation 
of BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in 
light grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: 
unchanged resistance; “-”: decreased resistance and “x” inactivated. 
  
BSLA
 secondary
structure
BSLA amino
acid positions + = - x
loop Ala1 1 19 0 0
loop Glu2 0 20 0 0
loop HIS3 0 20 0 0
loop ASN4 0 20 0 0
loop PRO5 4 10 4 2
Sheet VAL6 1 11 3 5
Sheet VAL7 1 4 0 15
Sheet MET8 0 8 8 4
Sheet VAL9 0 5 10 5
loop HIS10 1 8 11 0
loop GLY11 0 1 1 18
loop ILE12 8 8 0 4
loop GLY13 0 18 2 0
loop GLY14 0 11 6 3
loop ALA15 0 18 1 1
Helix H1 SER16 0 20 0 0
Helix H1 PHE17 5 15 0 0
Helix H1 ASN18 1 17 1 1
Helix H1 PHE19 0 7 12 1
Helix H1 ALA20 0 20 0 0
Helix H1 GLY21 2 18 0 0
Helix H1 ILE22 0 14 4 2
Helix H1 LYS23 3 16 0 1
Helix H1 SER24 0 20 0 0
Helix H1 TYR25 0 19 0 1
Helix H1 LEU26 0 10 0 10
Helix H1 VAL27 0 19 0 1
Helix H1 SER28 1 18 1 0
loop GLN29 1 18 0 1
loop GLY30 0 17 1 2
loop TRP31 0 18 0 2
loop SER32 0 20 0 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 2 11 6 1
Helix H3 LYS35 0 17 0 3
Sheet LEU36 0 17 1 2
Sheet TYR37 0 20 0 0
Sheet ALA38 0 19 1 0
loop VAL39 1 19 0 0
loop ASP40 0 20 0 0
loop PHE41 1 5 12 2
loop TRP42 0 20 0 0
loop ASP43 0 20 0 0
loop LYS44 0 20 0 0
loop THR45 0 20 0 0
loop GLY46 3 16 1 0
loop THR47 3 17 0 0
Helix H4 ASN48 1 19 0 0
Helix H4 TYR49 2 18 0 0
Helix H4 ASN50 1 19 0 0
Helix H4 ASN51 1 19 0 0
loop GLY52 0 10 10 0
Helix H4 PRO53 0 20 0 0
Helix H4 VAL54 6 13 0 1
Helix H4 LEU55 1 10 0 9
Helix H4 SER56 0 18 2 0
Helix H4 ARG57 1 15 4 0
Helix H4 PHE58 5 14 0 1
Helix H4 VAL59 0 5 3 12
Helix H4 GLN60 0 15 5 0
Helix H4 LYS61 0 18 1 1
Helix H4 VAL62 0 4 14 2
Helix H4 LEU63 0 15 4 1
Helix H4 ASP64 1 18 0 1
Helix H4 GLU65 2 18 0 0
Helix H4 THR66 0 18 1 1
loop GLY67 0 18 1 1
loop ALA68 0 20 0 0
loop LYS69 0 20 0 0
loop LYS70 1 18 0 1
Sheet VAL71 0 1 8 11
Sheet ASP72 0 9 5 6
Sheet ILE73 1 1 2 16
Sheet VAL74 1 5 1 13
Sheet ALA75 0 6 4 10
Sheet HIS76 1 1 0 18
loop SER77 0 1 0 19
Helix H5 MET78 4 8 0 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 1 5 0 14
Helix H5 ALA81 5 13 1 1
Helix H5 ASN82 0 8 10 2
Helix H5 THR83 0 13 4 3
Helix H5 LEU84 1 11 6 2
Helix H5 TYR85 0 19 0 1
Helix H5 TYR86 0 10 6 4
Helix H5 ILE87 0 10 2 8
Helix H5 LYS88 1 18 0 1
loop ASN89 2 14 0 4
loop LEU90 3 15 2 0
loop ASP91 6 11 1 2
[BMIM][Br]
Number of amino acid substitutions with
BSLA
 secondary
structure
BSLA amino
acid positions
+ = - x
Helix H6 GLY92 0 4 16 0
Helix H6 GLY93 1 19 0 0
Helix H6 ASN94 1 19 0 0
loop LYS95 9 11 0 0
Sheet VAL96 0 11 1 8
Sheet ALA97 1 18 0 1
Sheet ASN98 1 19 0 0
Sheet VAL99 0 9 7 4
Sheet VAL100 0 9 3 8
Sheet THR101 0 18 1 1
Sheet LEU102 0 10 1 9
loop GLY103 0 3 2 15
loop GLY104 0 8 6 6
loop ALA105 1 16 1 2
Helix H7 ASN106 1 15 3 1
Helix H7 ARG107 7 10 0 3
Helix H7 LEU108 1 17 1 1
loop THR109 3 16 1 0
loop THR110 1 18 1 0
loop GLY111 0 20 0 0
loop LYS112 2 18 0 0
loop ALA113 0 19 1 0
loop LEU114 1 19 0 0
loop PRO115 0 20 0 0
loop GLY116 0 20 0 0
loop THR117 3 14 0 3
loop ASP118 1 19 0 0
loop PRO119 1 16 3 0
loop ASN120 1 19 0 0
loop GLN121 0 19 1 0
loop LYS122 1 18 0 1
loop ILE123 0 10 6 4
Sheet LEU124 8 11 1 0
Sheet TYR125 0 10 3 7
Sheet THR126 1 14 3 2
Sheet SER127 0 15 1 4
Sheet ILE128 1 6 6 7
Sheet TYR129 4 7 6 3
Sheet SER130 2 9 7 2
loop SER131 0 20 0 0
loop ALA132 2 18 0 0
loop ASP133 1 1 0 18
loop MET134 2 18 0 0
loop ILE135 5 15 0 0
loop VAL136 1 10 3 6
loop MET137 3 17 0 0
Helix H8 ASN138 6 6 7 1
Helix H8 TYR139 5 10 1 4
Helix H8 LEU140 2 18 0 0
Helix H8 SER141 1 5 5 9
loop ARG142 0 18 2 0
loop LEU143 1 7 5 7
loop ASP144 0 20 0 0
loop GLY145 1 18 1 0
loop ALA146 0 18 1 1
Sheet ARG147 1 18 0 1
Sheet ASN148 0 15 4 1
Sheet VAL149 0 20 0 0
Sheet GLN150 0 20 0 0
Sheet ILE151 1 17 2 0
loop HIS152 4 15 0 1
loop GLY153 0 19 1 0
loop VAL154 1 17 2 0
loop GLY155 9 11 0 0
loop HIS156 0 1 0 19
loop ILE157 0 14 2 4
Helix H9 GLY158 2 18 0 0
Helix H9 LEU159 2 17 0 1
Helix H9 LEU160 0 12 2 6
Helix H9 TYR161 3 16 0 1
loop SER162 0 20 0 0
Helix H10 SER163 1 19 0 0
Helix H10 GLN164 0 19 1 0
Helix H10 VAL165 1 15 1 3
Helix H10 ASN166 1 7 6 6
Helix H10 SER167 2 17 0 1
Helix H10 LEU168 0 9 1 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 18 0 1
Helix H10 GLU171 3 15 0 2
Helix H10 GLY172 1 17 2 0
Helix H10 LEU173 0 6 8 6
loop ASN174 0 20 0 0
loop GLY175 0 20 0 0
loop GLY176 0 20 0 0
loop GLY177 0 20 0 0
loop GLN178 1 18 1 0
loop ASN179 2 17 0 1
loop THR180 0 20 0 0
loop ASN181 0 20 0 0
Total 91 181 89 99
[BMIM][Br]
Number of amino acid substitutions with
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Table 7-5: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards [BMIM][I] and inactivation 
of BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in 
light grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: 
unchanged resistance; “-”: decreased resistance and “x” inactivated. 
  
BSLA
 secondary
structure
BSLA amino
acid positions + = - x
loop Ala1 3 17 0 0
loop Glu2 0 19 1 0
loop HIS3 0 20 0 0
loop ASN4 0 20 0 0
loop PRO5 2 13 3 2
Sheet VAL6 0 8 7 5
Sheet VAL7 1 4 0 15
Sheet MET8 0 4 12 4
Sheet VAL9 0 4 11 5
loop HIS10 0 1 19 0
loop GLY11 0 1 1 18
loop ILE12 7 7 2 4
loop GLY13 0 8 12 0
loop GLY14 0 5 12 3
loop ALA15 4 14 1 1
Helix H1 SER16 0 19 1 0
Helix H1 PHE17 3 16 1 0
Helix H1 ASN18 0 15 4 1
Helix H1 PHE19 0 5 14 1
Helix H1 ALA20 0 20 0 0
Helix H1 GLY21 0 19 1 0
Helix H1 ILE22 0 12 6 2
Helix H1 LYS23 3 16 0 1
Helix H1 SER24 1 17 2 0
Helix H1 TYR25 0 18 1 1
Helix H1 LEU26 0 3 7 10
Helix H1 VAL27 0 18 1 1
Helix H1 SER28 2 16 2 0
loop GLN29 2 16 1 1
loop GLY30 0 7 11 2
loop TRP31 0 10 8 2
loop SER32 0 20 0 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 2 10 7 1
Helix H3 LYS35 0 16 1 3
Sheet LEU36 0 8 10 2
Sheet TYR37 0 18 2 0
Sheet ALA38 1 16 3 0
loop VAL39 1 19 0 0
loop ASP40 0 17 3 0
loop PHE41 0 5 13 2
loop TRP42 0 20 0 0
loop ASP43 0 20 0 0
loop LYS44 2 18 0 0
loop THR45 1 19 0 0
loop GLY46 2 15 3 0
loop THR47 9 11 0 0
Helix H4 ASN48 3 17 0 0
Helix H4 TYR49 3 17 0 0
Helix H4 ASN50 4 16 0 0
Helix H4 ASN51 2 16 2 0
loop GLY52 1 5 14 0
Helix H4 PRO53 1 19 0 0
Helix H4 VAL54 10 9 0 1
Helix H4 LEU55 0 7 4 9
Helix H4 SER56 0 18 2 0
Helix H4 ARG57 1 15 4 0
Helix H4 PHE58 5 14 0 1
Helix H4 VAL59 2 5 1 12
Helix H4 GLN60 0 8 12 0
Helix H4 LYS61 0 18 1 1
Helix H4 VAL62 0 4 14 2
Helix H4 LEU63 0 13 6 1
Helix H4 ASP64 0 19 0 1
Helix H4 GLU65 1 19 0 0
Helix H4 THR66 0 17 2 1
loop GLY67 0 15 4 1
loop ALA68 0 18 2 0
loop LYS69 0 20 0 0
loop LYS70 2 15 2 1
Sheet VAL71 0 1 8 11
Sheet ASP72 0 6 8 6
Sheet ILE73 0 2 2 16
Sheet VAL74 0 5 2 13
Sheet ALA75 0 4 6 10
Sheet HIS76 1 1 0 18
loop SER77 0 1 0 19
Helix H5 MET78 4 7 1 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 0 3 3 14
Helix H5 ALA81 3 13 3 1
Helix H5 ASN82 0 12 6 2
Helix H5 THR83 0 11 6 3
Helix H5 LEU84 0 12 6 2
Helix H5 TYR85 0 18 1 1
Helix H5 TYR86 0 7 9 4
Helix H5 ILE87 0 9 3 8
Helix H5 LYS88 1 18 0 1
loop ASN89 1 15 0 4
loop LEU90 2 16 2 0
loop ASP91 6 10 2 2
[BMIM][I]
Number of amino acid substitutions with
BSLA
 secondary
structure
BSLA amino
acid positions + = - x
Helix H6 GLY92 0 3 17 0
Helix H6 GLY93 2 15 3 0
Helix H6 ASN94 4 16 0 0
loop LYS95 9 10 1 0
Sheet VAL96 0 8 4 8
Sheet ALA97 3 16 0 1
Sheet ASN98 3 16 1 0
Sheet VAL99 0 7 9 4
Sheet VAL100 0 9 3 8
Sheet THR101 2 13 4 1
Sheet LEU102 0 5 6 9
loop GLY103 0 2 3 15
loop GLY104 0 3 11 6
loop ALA105 1 10 7 2
Helix H7 ASN106 0 11 8 1
Helix H7 ARG107 10 7 0 3
Helix H7 LEU108 0 10 9 1
loop THR109 3 16 1 0
loop THR110 1 18 1 0
loop GLY111 1 19 0 0
loop LYS112 2 18 0 0
loop ALA113 0 11 9 0
loop LEU114 2 18 0 0
loop PRO115 0 20 0 0
loop GLY116 0 16 4 0
loop THR117 0 14 3 3
loop ASP118 1 19 0 0
loop PRO119 4 13 3 0
loop ASN120 1 19 0 0
loop GLN121 0 19 1 0
loop LYS122 4 15 0 1
loop ILE123 0 8 8 4
Sheet LEU124 10 10 0 0
Sheet TYR125 0 8 5 7
Sheet THR126 1 13 4 2
Sheet SER127 0 13 3 4
Sheet ILE128 0 6 7 7
Sheet TYR129 3 6 8 3
Sheet SER130 1 10 7 2
loop SER131 2 17 1 0
loop ALA132 4 16 0 0
loop ASP133 1 1 0 18
loop MET134 8 12 0 0
loop ILE135 8 12 0 0
loop VAL136 1 9 4 6
loop MET137 6 14 0 0
Helix H8 ASN138 3 16 0 1
Helix H8 TYR139 1 13 2 4
Helix H8 LEU140 1 19 0 0
Helix H8 SER141 2 3 6 9
loop ARG142 0 20 0 0
loop LEU143 1 6 6 7
loop ASP144 2 18 0 0
loop GLY145 2 14 4 0
loop ALA146 0 17 2 1
Sheet ARG147 2 17 0 1
Sheet ASN148 0 14 5 1
Sheet VAL149 1 19 0 0
Sheet GLN150 2 18 0 0
Sheet ILE151 2 16 2 0
loop HIS152 7 12 0 1
loop GLY153 0 19 1 0
loop VAL154 1 17 2 0
loop GLY155 9 11 0 0
loop HIS156 0 1 0 19
loop ILE157 0 13 3 4
Helix H9 GLY158 3 17 0 0
Helix H9 LEU159 2 15 2 1
Helix H9 LEU160 0 6 8 6
Helix H9 TYR161 3 16 0 1
loop SER162 1 19 0 0
Helix H10 SER163 1 19 0 0
Helix H10 GLN164 2 17 1 0
Helix H10 VAL165 0 16 1 3
Helix H10 ASN166 4 6 4 6
Helix H10 SER167 1 17 1 1
Helix H10 LEU168 1 8 1 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 18 0 1
Helix H10 GLU171 4 14 0 2
Helix H10 GLY172 1 16 3 0
Helix H10 LEU173 0 5 9 6
loop ASN174 1 19 0 0
loop GLY175 0 20 0 0
loop GLY176 0 20 0 0
loop GLY177 2 18 0 0
loop GLN178 1 16 3 0
loop ASN179 1 18 0 1
loop THR180 1 19 0 0
loop ASN181 0 20 0 0
Total 95 181 115 99
[BMIM][I]
Number of amino acid substitutions with
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Table 7-6: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards [BMIM][TfO] and 
inactivation of BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white 
and helix in light grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved 
resistance; “=”: unchanged resistance; “-”: decreased resistance and “x” inactivated. 
  
BSLA
 secondary
structure
BSLA amino
acid positions + = - x
loop Ala1 2 18 0 0
loop Glu2 0 19 1 0
loop HIS3 0 20 0 0
loop ASN4 0 20 0 0
loop PRO5 5 9 4 2
Sheet VAL6 2 11 2 5
Sheet VAL7 1 4 0 15
Sheet MET8 0 15 1 4
Sheet VAL9 0 5 10 5
loop HIS10 0 6 14 0
loop GLY11 0 1 1 18
loop ILE12 6 10 0 4
loop GLY13 0 17 3 0
loop GLY14 0 12 5 3
loop ALA15 1 17 1 1
Helix H1 SER16 0 20 0 0
Helix H1 PHE17 5 15 0 0
Helix H1 ASN18 3 15 1 1
Helix H1 PHE19 0 7 12 1
Helix H1 ALA20 0 18 2 0
Helix H1 GLY21 0 20 0 0
Helix H1 ILE22 0 13 5 2
Helix H1 LYS23 5 13 1 1
Helix H1 SER24 0 20 0 0
Helix H1 TYR25 0 18 1 1
Helix H1 LEU26 3 7 0 10
Helix H1 VAL27 1 18 0 1
Helix H1 SER28 0 20 0 0
loop GLN29 2 17 0 1
loop GLY30 0 15 3 2
loop TRP31 0 15 3 2
loop SER32 3 17 0 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 3 15 1 1
Helix H3 LYS35 0 17 0 3
Sheet LEU36 2 15 1 2
Sheet TYR37 0 20 0 0
Sheet ALA38 0 18 2 0
loop VAL39 1 19 0 0
loop ASP40 0 19 1 0
loop PHE41 1 9 8 2
loop TRP42 0 20 0 0
loop ASP43 0 20 0 0
loop LYS44 2 18 0 0
loop THR45 0 20 0 0
loop GLY46 4 13 3 0
loop THR47 6 14 0 0
Helix H4 ASN48 3 17 0 0
Helix H4 TYR49 2 18 0 0
Helix H4 ASN50 1 19 0 0
Helix H4 ASN51 2 17 1 0
loop GLY52 1 6 13 0
Helix H4 PRO53 0 20 0 0
Helix H4 VAL54 9 10 0 1
Helix H4 LEU55 1 10 0 9
Helix H4 SER56 0 18 2 0
Helix H4 ARG57 3 17 0 0
Helix H4 PHE58 3 16 0 1
Helix H4 VAL59 0 5 3 12
Helix H4 GLN60 0 17 3 0
Helix H4 LYS61 0 18 1 1
Helix H4 VAL62 0 11 7 2
Helix H4 LEU63 0 15 4 1
Helix H4 ASP64 3 15 1 1
Helix H4 GLU65 2 18 0 0
Helix H4 THR66 0 18 1 1
loop GLY67 2 17 0 1
loop ALA68 0 20 0 0
loop LYS69 0 20 0 0
loop LYS70 2 15 2 1
Sheet VAL71 0 1 8 11
Sheet ASP72 0 6 8 6
Sheet ILE73 0 3 1 16
Sheet VAL74 0 5 2 13
Sheet ALA75 0 7 3 10
Sheet HIS76 1 1 0 18
loop SER77 0 1 0 19
Helix H5 MET78 3 9 0 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 1 5 0 14
Helix H5 ALA81 3 15 1 1
Helix H5 ASN82 1 11 6 2
Helix H5 THR83 1 12 4 3
Helix H5 LEU84 1 16 1 2
Helix H5 TYR85 0 19 0 1
Helix H5 TYR86 0 8 8 4
Helix H5 ILE87 1 9 2 8
Helix H5 LYS88 1 18 0 1
loop ASN89 0 14 2 4
loop LEU90 10 8 2 0
loop ASP91 10 7 1 2
[BMIM][TfO]
Number of amino acid substitutions with
BSLA
 secondary
structure
BSLA amino
acid positions + = - x
Helix H6 GLY92 0 1 19 0
Helix H6 GLY93 2 17 1 0
Helix H6 ASN94 5 15 0 0
loop LYS95 10 5 5 0
Sheet VAL96 1 10 1 8
Sheet ALA97 3 16 0 1
Sheet ASN98 3 16 1 0
Sheet VAL99 0 8 8 4
Sheet VAL100 0 9 3 8
Sheet THR101 3 11 5 1
Sheet LEU102 0 7 4 9
loop GLY103 0 2 3 15
loop GLY104 0 4 10 6
loop ALA105 1 13 4 2
Helix H7 ASN106 0 11 8 1
Helix H7 ARG107 8 9 0 3
Helix H7 LEU108 0 10 9 1
loop THR109 3 12 5 0
loop THR110 0 16 4 0
loop GLY111 0 20 0 0
loop LYS112 2 18 0 0
loop ALA113 0 11 9 0
loop LEU114 1 19 0 0
loop PRO115 0 20 0 0
loop GLY116 0 12 8 0
loop THR117 0 16 1 3
loop ASP118 1 19 0 0
loop PRO119 2 17 1 0
loop ASN120 1 19 0 0
loop GLN121 0 20 0 0
loop LYS122 4 15 0 1
loop ILE123 0 9 7 4
Sheet LEU124 13 6 1 0
Sheet TYR125 2 6 5 7
Sheet THR126 1 9 8 2
Sheet SER127 2 10 4 4
Sheet ILE128 1 5 7 7
Sheet TYR129 3 11 3 3
Sheet SER130 0 6 12 2
loop SER131 3 17 0 0
loop ALA132 5 15 0 0
loop ASP133 1 1 0 18
loop MET134 3 17 0 0
loop ILE135 5 14 1 0
loop VAL136 1 10 3 6
loop MET137 7 13 0 0
Helix H8 ASN138 5 14 0 1
Helix H8 TYR139 3 9 4 4
Helix H8 LEU140 4 16 0 0
Helix H8 SER141 1 5 5 9
loop ARG142 0 20 0 0
loop LEU143 1 10 2 7
loop ASP144 2 18 0 0
loop GLY145 3 16 1 0
loop ALA146 0 17 2 1
Sheet ARG147 4 15 0 1
Sheet ASN148 0 12 7 1
Sheet VAL149 1 18 1 0
Sheet GLN150 3 17 0 0
Sheet ILE151 2 15 3 0
loop HIS152 6 13 0 1
loop GLY153 0 19 1 0
loop VAL154 1 17 2 0
loop GLY155 4 16 0 0
loop HIS156 0 1 0 19
loop ILE157 2 10 4 4
Helix H9 GLY158 3 17 0 0
Helix H9 LEU159 2 16 1 1
Helix H9 LEU160 0 11 3 6
Helix H9 TYR161 2 17 0 1
loop SER162 0 20 0 0
Helix H10 SER163 1 19 0 0
Helix H10 GLN164 2 17 1 0
Helix H10 VAL165 1 14 2 3
Helix H10 ASN166 1 3 10 6
Helix H10 SER167 2 17 0 1
Helix H10 LEU168 3 5 2 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 17 1 1
Helix H10 GLU171 0 18 0 2
Helix H10 GLY172 1 13 6 0
Helix H10 LEU173 0 5 9 6
loop ASN174 1 19 0 0
loop GLY175 0 20 0 0
loop GLY176 1 19 0 0
loop GLY177 4 16 0 0
loop GLN178 0 17 3 0
loop ASN179 2 17 0 1
loop THR180 0 20 0 0
loop ASN181 1 19 0 0
Total 104 181 102 99
[BMIM][TfO]
Number of amino acid substitutions with
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Table 7-7: Effect of each amino acid type substitution (polar, aliphatic, charged and aromatic) on IL resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 patterns 
per IL are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and 
R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants with unchanged 
resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer. 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
 
 
 
  
  Amino acid types in BSLA-WT   
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
   
+ 
(42) 
= 
(199) 
- 
(32) 
X 
(27) 
+ 
(215) 
= 
(852) 
- 
(200) 
x 
(313) 
+ 
(121) 
= 
(771) 
- 
(111) 
x 
(77) 
+ 
(84) 
= 
(432) 
- 
(63) 
x 
(81) 
[B
M
IM
][
C
l]
 
Aromatic  14% 19% 6% 0% 13% 13% 20% 19% 14% 14% 22% 19% 25% 13% 17% 15% 
Aliphatic  26% 25% 28% 19% 20% 33% 18% 12% 21% 26% 32% 16% 24% 25% 25% 25% 
Polar 40% 32% 41% 44% 35% 37% 39% 27% 28% 38% 28% 29% 26% 34% 41% 43% 
Charged 19% 25% 25% 37% 33% 17% 24% 42% 37% 23% 18% 36% 25% 28% 16% 17% 
acidic 7% 10% 13% 15% 14% 6% 14% 15% 13% 10% 6% 10% 12% 10% 10% 6% 
basic 12% 15% 13% 22% 19% 11% 11% 27% 24% 13% 12% 26% 13% 17% 6% 11% 
                  
  
+ 
(25) 
= 
(208) 
- 
(40) 
x 
(27) 
+ 
(79) 
= 
(1014) 
- 
(174) 
x 
(313) 
+ 
(53) 
= 
(869) 
- 
(81) 
x 
(77) 
+ 
(49) 
= 
(500) 
- 
(30) 
x 
(81) 
[B
M
IM
][
B
r]
 
Aromatic  20% 18% 8% 0% 14% 14% 17% 19% 13% 14% 17% 19% 18% 14% 20% 15% 
Aliphatic  28% 25% 25% 19% 20% 31% 17% 12% 26% 26% 21% 16% 22% 25% 23% 25% 
Polar 36% 34% 35% 44% 29% 37% 40% 27% 32% 36% 36% 29% 27% 34% 43% 43% 
Charged 16% 23% 33% 37% 37% 19% 27% 42% 28% 24% 26% 36% 33% 26% 13% 17% 
acidic 8% 9% 15% 15% 15% 7% 16% 15% 9% 10% 12% 10% 16% 10% 7% 6% 
basic 8% 14% 18% 22% 22% 12% 11% 27% 19% 14% 14% 26% 16% 16% 7% 11% 
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Table 7-7: Effect of each amino acid type substitution (polar, aliphatic, charged and aromatic) on IL resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 patterns 
per IL are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and 
R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants with unchanged 
resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer. 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
 
  
  Amino acid types in BSLA-WT   
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
  
+ 
(18) 
= 
(191) 
- 
(64) 
x 
(27) 
+ 
(95) 
= 
(854) 
- 
(318) 
x 
(313) 
+ 
(88) 
= 
(802) 
- 
(113) 
x 
(77) 
+ 
(62) 
= 
(468) 
- 
(49) 
x 
(81) 
[B
M
IM
][
I]
 
Aromatic  22% 20% 5% 0% 16% 14% 14% 19% 15% 14% 16% 19% 27% 13% 22% 15% 
Aliphatic  17% 27% 23% 19% 19% 32% 20% 12% 22% 27% 22% 16% 21% 26% 24% 25% 
Polar 33% 32% 41% 44% 33% 35% 43% 27% 28% 36% 35% 29% 19% 35% 39% 43% 
Charged 28% 21% 31% 37% 33% 19% 23% 42% 35% 23% 27% 36% 32% 26% 14% 17% 
acidic 17% 6% 17% 15% 15% 6% 13% 15% 14% 9% 12% 10% 15% 10% 6% 6% 
basic 11% 15% 14% 22% 18% 12% 10% 27% 22% 13% 14% 26% 18% 16% 8% 11% 
                  
  
+ 
(21) 
= 
(208) 
- 
(44) 
x 
(27) 
+ 
(118) 
= 
(925) 
- 
(224) 
x 
(313) 
+ 
(82) 
= 
(821) 
- 
(100) 
x 
(77) 
+ 
(71) 
= 
(471) 
- 
(37) 
x 
(81) 
B
M
IM
][
T
fO
] 
Aromatic  5% 20% 5% 0% 14% 13% 17% 19% 16% 14% 19% 19% 28% 13% 19% 15% 
Aliphatic  33% 24% 30% 19% 15% 32% 19% 12% 18% 27% 21% 16% 20% 26% 27% 25% 
Polar 38% 33% 39% 44% 37% 37% 38% 27% 34% 36% 29% 29% 28% 35% 32% 43% 
Charged 24% 23% 27% 37% 33% 18% 25% 42% 32% 23% 31% 36% 24% 27% 22% 17% 
acidic 14% 9% 11% 15% 14% 7% 13% 15% 16% 9% 12% 10% 11% 10% 19% 6% 
basic 10% 14% 16% 22% 19% 11% 12% 27% 16% 13% 19% 26% 13% 17% 3% 11% 
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Table 7-8: Chemical diversity for improved variants in all four ILs. The percentage values were calculated by addition of 
the values for the chemically different amino acids in each case. In case of [BMIM][Cl] for example, 86% (addition of values 
from aliphatic, polar, and charged) of the aromatic WT residues preferred substitutions with chemically different amino acids. 
Lowest and highest values are in bold. 
Amino acid types in BSLA WT 
 Aromatic [%] Aliphatic [%] Polar [%] Charged [%] 
[BMIM][Cl] 86 80  72  75  
[BMIM][Br] 80  80  68  67  
[BMIM][I] 78  81  72  68  
[BMIM][TfO] 95  85  66  76  
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Table 7-9. Effect of amino acid location (exposed, buried) on IL resistance of BSLA when replacing each type of 
amino acid in BSLA WT. 16 patterns per IL are shown. The absolute number of BSLA variants per type is shown in 
bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged acidic (D and E), 
charged basic (H, K, and R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the 
text: “+” representing variants with improved resistance, “=” representing variants with unchanged resistance, “-” 
representing variants with decreased resistance and “x” representing inactive variants in buffer. 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is 
not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 18.2% charged, and, 8.3% aromatic). Highest values 
among the resistance type “+” are highlighted in blue. Column “x” shows that the number of inactive variants resulted from 
amino acid substitutions. The activity was measured in a buffer plate which was used as reference (absence of IL) for 
comparison. Therefore, the number of inactive variants was the same for three OS. 
 
  
  Location of amino acid positions in BSLA   
  Exposed positions (128; 71%) Buried positions (53; 29%) 
   
+ 
(343) 
= 
(1781) 
- 
(247) 
x 
(189) 
+ 
(119) 
= 
(473) 
- 
(159) 
x 
(309) 
[B
M
IM
][
C
l]
 
Aromatic  15% 14% 22% 15% 16% 12% 14% 19% 
Aliphatic  22% 27% 23% 17% 18% 34% 25% 14% 
Polar 30% 36% 34% 38% 38% 39% 40% 26% 
Charged 32% 24% 21% 30% 28% 15% 22% 41% 
 acidic 13% 9% 11% 11% 13% 6% 11% 14% 
 basic 20% 14% 10% 19% 15% 9% 11% 27% 
  
                
  
+ 
(172) 
= 
(2077) 
- 
(122) 
x 
(189) 
+ 
(34) 
= 
(514) 
- 
(203) 
x 
(309) 
[B
M
IM
][
B
r]
 
Aromatic  16% 15% 20% 15% 12% 13% 14% 19% 
Aliphatic  23% 26% 17% 17% 26% 33% 21% 14% 
Polar 30% 35% 38% 38% 32% 39% 39% 26% 
Charged 31% 24% 25% 30% 29% 14% 27% 41% 
 acidic 12% 10% 14% 11% 18% 5% 14% 14% 
 basic 19% 14% 11% 19% 12% 9% 12% 27% 
  
                
  
+ 
(236) 
= 
(1897) 
- 
(238) 
x 
(189) 
+ 
(27) 
= 
(418) 
- 
(306) 
x 
(309) 
[B
M
IM
][
I]
 Aromatic  19% 15% 15% 15% 15% 13% 13% 19% 
Aliphatic  19% 27% 22% 17% 26% 37% 20% 14% 
Polar 27% 35% 37% 38% 37% 35% 44% 26% 
Charged 34% 23% 26% 30% 22% 15% 22% 41% 
 acidic 14% 9% 14% 11% 15% 5% 12% 14% 
 basic 20% 14% 12% 19% 7% 10% 10% 27% 
                  
  
+ 
(248) 
= 
(1962) 
- 
(161) 
x 
(189) 
+ 
(44) 
= 
(463) 
- 
(244) 
x 
(309) 
B
M
IM
][
T
fO
] 
Aromatic  19% 14% 17% 15% 11% 12% 16% 19% 
Aliphatic  19% 27% 22% 17% 14% 36% 21% 14% 
Polar 33% 35% 31% 38% 43% 38% 39% 26% 
Charged 29% 24% 29% 30% 32% 14% 25% 41% 
 acidic 14% 9% 14% 11% 14% 5% 13% 14% 
 basic 15% 15% 16% 19% 18% 8% 12% 27% 
 
 
dfbgvnbmn 
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Table 7-10: Overall number of amino acid substitutions on different secondary elements of BSLA (loop, helix and β-
sheet) contributing to increased/unchanged/decreased resistance towards all four ILs and inactivation of BSLA. “+”: 
improved resistance; “=”: unchanged resistance; “-”: decreased resistance and “x” inactivated. 
 
Highest values among the resistance type “+” are highlighted in blue. 
 
 
 
 [BMIM][Cl] 
 
+ 
(124) 
= 
(181) 
- 
(117) 
x 
(99) 
Loops 44% 44% 39% 28% 
Sheets 15% 18% 23% 25% 
Helices 40% 39% 38% 46% 
Total 100% 100% 100% 100% 
 
 [BMIM][Br] 
 
+ 
(91) 
= 
(181) 
- 
(89) 
x 
(99) 
Loops 41% 44% 35% 28% 
Sheets 15% 18% 27% 25% 
Helices 44% 39% 38% 46% 
Total 100% 100% 100% 100% 
 
 [BMIM][I] 
 
+ 
(95) 
= 
(181) 
- 
(115) 
x 
(99) 
Loops 47% 44% 36% 28% 
Sheets 15% 18% 22% 25% 
Helices 38% 39% 43% 46% 
Total 100% 100% 100% 100% 
 
 [BMIM][TfO] 
 
+ 
(104) 
= 
(181) 
- 
(112) 
x 
(99) 
Loops 42% 44% 36% 28% 
Sheets 17% 18% 25% 25% 
Helices 40% 39% 38% 46% 
Total 100% 100% 100% 100% 
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Table 7-11: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards DMSO and inactivation of 
BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in light 
grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: unchanged 
resistance; “-”: decreased resistance and “x” inactivated. 
 
 
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
loop Ala1 0 20 0 0
loop Glu2 0 15 5 0
loop HIS3 0 20 0 0
loop ASN4 9 9 2 0
loop PRO5 0 3 15 2
Sheet VAL6 0 9 6 5
Sheet VAL7 0 3 2 15
Sheet MET8 1 4 11 4
Sheet VAL9 0 8 7 5
loop HIS10 0 4 16 0
loop GLY11 0 1 1 18
loop ILE12 6 7 3 4
loop GLY13 0 14 6 0
loop GLY14 2 6 9 3
loop ALA15 4 13 2 1
Helix H1 SER16 0 14 6 0
Helix H1 PHE17 5 14 1 0
Helix H1 ASN18 0 16 3 1
Helix H1 PHE19 0 11 8 1
Helix H1 ALA20 1 18 1 0
Helix H1 GLY21 2 15 3 0
Helix H1 ILE22 0 11 7 2
Helix H1 LYS23 0 13 6 1
Helix H1 SER24 0 17 3 0
Helix H1 TYR25 0 19 0 1
Helix H1 LEU26 0 7 3 10
Helix H1 VAL27 0 19 0 1
Helix H1 SER28 2 16 2 0
loop GLN29 1 15 3 1
loop GLY30 0 10 8 2
loop TRP31 0 6 12 2
loop SER32 5 13 2 0
Helix H3 ARG33 0 16 4 0
Helix H3 ASP34 0 9 10 1
Helix H3 LYS35 0 7 10 3
Sheet LEU36 0 9 9 2
Sheet TYR37 7 11 2 0
Sheet ALA38 3 17 0 0
loop VAL39 1 17 2 0
loop ASP40 0 19 1 0
loop PHE41 2 12 4 2
loop TRP42 2 18 0 0
loop ASP43 0 15 5 0
loop LYS44 0 11 9 0
loop THR45 0 13 7 0
loop GLY46 1 13 6 0
loop THR47 0 20 0 0
Helix H4 ASN48 0 17 3 0
Helix H4 TYR49 0 17 3 0
Helix H4 ASN50 1 15 4 0
Helix H4 ASN51 1 13 6 0
loop GLY52 0 16 4 0
Helix H4 PRO53 1 18 1 0
Helix H4 VAL54 3 16 0 1
Helix H4 LEU55 0 6 5 9
Helix H4 SER56 0 19 1 0
Helix H4 ARG57 1 11 8 0
Helix H4 PHE58 9 10 0 1
Helix H4 VAL59 0 4 4 12
Helix H4 GLN60 0 11 9 0
Helix H4 LYS61 0 18 1 1
Helix H4 VAL62 0 4 14 2
Helix H4 LEU63 0 9 10 1
Helix H4 ASP64 1 18 0 1
Helix H4 GLU65 2 15 3 0
Helix H4 THR66 1 18 0 1
loop GLY67 0 16 3 1
loop ALA68 1 17 2 0
loop LYS69 1 18 1 0
loop LYS70 7 12 0 1
Sheet VAL71 0 1 8 11
Sheet ASP72 0 8 6 6
Sheet ILE73 0 3 1 16
Sheet VAL74 3 3 1 13
Sheet ALA75 0 7 3 10
Sheet HIS76 1 1 0 18
loop SER77 0 1 0 19
Helix H5 MET78 1 6 5 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 0 3 3 14
Helix H5 ALA81 1 14 4 1
Helix H5 ASN82 0 6 12 2
Helix H5 THR83 0 14 3 3
Helix H5 LEU84 7 8 3 2
Helix H5 TYR85 0 19 0 1
Helix H5 TYR86 0 12 4 4
Helix H5 ILE87 0 12 0 8
Helix H5 LYS88 1 16 2 1
loop ASN89 3 10 3 4
loop LEU90 0 4 16 0
loop ASP91 1 12 5 2
Number of amino acid substitutions with
DMSO
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
Helix H6 GLY92 5 15 0 0
Helix H6 GLY93 6 13 1 0
Helix H6 ASN94 6 14 0 0
loop LYS95 14 6 0 0
Sheet VAL96 2 7 3 8
Sheet ALA97 1 18 0 1
Sheet ASN98 5 15 0 0
Sheet VAL99 5 11 0 4
Sheet VAL100 1 8 3 8
Sheet THR101 1 14 4 1
Sheet LEU102 1 7 3 9
loop GLY103 0 3 2 15
loop GLY104 0 2 12 6
loop ALA105 2 7 9 2
Helix H7 ASN106 1 13 5 1
Helix H7 ARG107 7 9 1 3
Helix H7 LEU108 0 4 15 1
loop THR109 5 11 4 0
loop THR110 1 13 6 0
loop GLY111 1 18 1 0
loop LYS112 1 19 0 0
loop ALA113 2 9 9 0
loop LEU114 4 16 0 0
loop PRO115 0 20 0 0
loop GLY116 1 8 11 0
loop THR117 5 12 0 3
loop ASP118 7 13 0 0
loop PRO119 0 18 2 0
loop ASN120 5 15 0 0
loop GLN121 0 20 0 0
loop LYS122 3 16 0 1
loop ILE123 0 14 2 4
Sheet LEU124 10 9 1 0
Sheet TYR125 6 7 0 7
Sheet THR126 4 14 0 2
Sheet SER127 5 8 3 4
Sheet ILE128 4 9 0 7
Sheet TYR129 6 11 0 3
Sheet SER130 2 14 2 2
loop SER131 0 20 0 0
loop ALA132 2 18 0 0
loop ASP133 1 1 0 18
loop MET134 0 19 1 0
loop ILE135 0 15 5 0
loop VAL136 2 9 3 6
loop MET137 5 15 0 0
Helix H8 ASN138 7 11 1 1
Helix H8 TYR139 3 11 2 4
Helix H8 LEU140 5 15 0 0
Helix H8 SER141 2 8 1 9
loop ARG142 1 14 5 0
loop LEU143 5 5 3 7
loop ASP144 6 14 0 0
loop GLY145 7 12 1 0
loop ALA146 0 17 2 1
Sheet ARG147 3 16 0 1
Sheet ASN148 4 13 2 1
Sheet VAL149 2 18 0 0
Sheet GLN150 5 15 0 0
Sheet ILE151 9 11 0 0
loop HIS152 5 14 0 1
loop GLY153 1 18 1 0
loop VAL154 1 15 4 0
loop GLY155 4 16 0 0
loop HIS156 0 1 0 19
loop ILE157 0 7 9 4
Helix H9 GLY158 2 16 2 0
Helix H9 LEU159 3 13 3 1
Helix H9 LEU160 4 10 0 6
Helix H9 TYR161 4 15 0 1
loop SER162 3 17 0 0
Helix H10 SER163 2 18 0 0
Helix H10 GLN164 0 18 2 0
Helix H10 VAL165 0 17 0 3
Helix H10 ASN166 1 12 1 6
Helix H10 SER167 2 17 0 1
Helix H10 LEU168 4 5 1 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 18 0 1
Helix H10 GLU171 0 18 0 2
Helix H10 GLY172 10 10 0 0
Helix H10 LEU173 0 9 5 6
loop ASN174 1 18 1 0
loop GLY175 5 15 0 0
loop GLY176 0 20 0 0
loop GLY177 9 11 0 0
loop GLN178 1 19 0 0
loop ASN179 6 13 0 1
loop THR180 0 20 0 0
loop ASN181 3 17 0 0
Total 107 181 118 99
DMSO
Number of amino acid substitutions with
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Table 7-12: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards 1,4-dioxane and inactivation 
of BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in 
light grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: 
unchanged resistance; “-”: decreased resistance and “x” inactivated. 
 
 
BSLA
secondary
structure
BSLA 
amino
acid 
positions
+ = - x
loop Ala1 0 20 0 0
loop Glu2 0 20 0 0
loop HIS3 0 16 4 0
loop ASN4 0 18 2 0
loop PRO5 0 10 8 2
Sheet VAL6 0 6 9 5
Sheet VAL7 0 5 0 15
Sheet MET8 0 9 7 4
Sheet VAL9 0 7 8 5
loop HIS10 3 3 14 0
loop GLY11 0 1 1 18
loop ILE12 8 7 1 4
loop GLY13 4 14 2 0
loop GLY14 2 11 4 3
loop ALA15 2 17 0 1
Helix H1 SER16 0 18 2 0
Helix H1 PHE17 6 14 0 0
Helix H1 ASN18 1 12 6 1
Helix H1 PHE19 1 12 6 1
Helix H1 ALA20 0 20 0 0
Helix H1 GLY21 0 19 1 0
Helix H1 ILE22 0 8 10 2
Helix H1 LYS23 0 19 0 1
Helix H1 SER24 0 18 2 0
Helix H1 TYR25 1 17 1 1
Helix H1 LEU26 1 5 4 10
Helix H1 VAL27 0 18 1 1
Helix H1 SER28 0 17 3 0
loop GLN29 0 19 0 1
loop GLY30 0 4 14 2
loop TRP31 0 10 8 2
loop SER32 2 17 1 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 1 14 4 1
Helix H3 LYS35 0 16 1 3
Sheet LEU36 0 9 9 2
Sheet TYR37 0 15 5 0
Sheet ALA38 1 18 1 0
loop VAL39 0 18 2 0
loop ASP40 1 19 0 0
loop PHE41 0 15 3 2
loop TRP42 2 16 2 0
loop ASP43 2 18 0 0
loop LYS44 0 10 10 0
loop THR45 0 19 1 0
loop GLY46 0 15 5 0
loop THR47 8 12 0 0
Helix H4 ASN48 0 18 2 0
Helix H4 TYR49 1 19 0 0
Helix H4 ASN50 3 17 0 0
Helix H4 ASN51 0 15 5 0
loop GLY52 0 9 11 0
Helix H4 PRO53 0 19 1 0
Helix H4 VAL54 1 18 0 1
Helix H4 LEU55 0 4 7 9
Helix H4 SER56 0 19 1 0
Helix H4 ARG57 2 13 5 0
Helix H4 PHE58 1 16 2 1
Helix H4 VAL59 0 5 3 12
Helix H4 GLN60 0 17 3 0
Helix H4 LYS61 0 14 5 1
Helix H4 VAL62 1 3 14 2
Helix H4 LEU63 0 11 8 1
Helix H4 ASP64 0 19 0 1
Helix H4 GLU65 1 18 1 0
Helix H4 THR66 0 17 2 1
loop GLY67 0 16 3 1
loop ALA68 0 16 4 0
loop LYS69 0 19 1 0
loop LYS70 0 16 3 1
Sheet VAL71 0 3 6 11
Sheet ASP72 0 8 6 6
Sheet ILE73 0 3 1 16
Sheet VAL74 1 4 2 13
Sheet ALA75 0 5 5 10
Sheet HIS76 0 1 1 18
loop SER77 0 1 0 19
Helix H5 MET78 2 5 5 8
Helix H5 GLY79 0 1 2 17
Helix H5 GLY80 0 4 2 14
Helix H5 ALA81 0 11 8 1
Helix H5 ASN82 1 12 5 2
Helix H5 THR83 0 10 7 3
Helix H5 LEU84 0 9 9 2
Helix H5 TYR85 0 15 4 1
Helix H5 TYR86 0 5 11 4
Helix H5 ILE87 0 4 8 8
Helix H5 LYS88 1 15 3 1
loop ASN89 0 16 0 4
loop LEU90 0 17 3 0
loop ASP91 1 16 1 2
Number of amino acid substitutions with
1,4-dioxane
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
Helix H6 GLY92 0 15 5 0
Helix H6 GLY93 0 14 6 0
Helix H6 ASN94 2 18 0 0
loop LYS95 1 15 4 0
Sheet VAL96 0 10 2 8
Sheet ALA97 0 19 0 1
Sheet ASN98 1 14 5 0
Sheet VAL99 0 11 5 4
Sheet VAL100 5 5 2 8
Sheet THR101 2 11 6 1
Sheet LEU102 0 6 5 9
loop GLY103 0 1 4 15
loop GLY104 0 2 12 6
loop ALA105 0 8 10 2
Helix H7 ASN106 0 7 12 1
Helix H7 ARG107 0 15 2 3
Helix H7 LEU108 0 7 12 1
loop THR109 2 8 10 0
loop THR110 0 8 12 0
loop GLY111 3 14 3 0
loop LYS112 0 19 1 0
loop ALA113 0 8 12 0
loop LEU114 3 17 0 0
loop PRO115 0 20 0 0
loop GLY116 0 3 17 0
loop THR117 5 12 0 3
loop ASP118 1 19 0 0
loop PRO119 0 17 3 0
loop ASN120 2 18 0 0
loop GLN121 0 18 2 0
loop LYS122 1 18 0 1
loop ILE123 0 6 10 4
Sheet LEU124 4 15 1 0
Sheet TYR125 0 5 8 7
Sheet THR126 1 9 8 2
Sheet SER127 0 7 9 4
Sheet ILE128 0 4 9 7
Sheet TYR129 1 11 5 3
Sheet SER130 1 4 13 2
loop SER131 0 20 0 0
loop ALA132 3 16 1 0
loop ASP133 0 2 0 18
loop MET134 2 18 0 0
loop ILE135 1 14 5 0
loop VAL136 1 7 6 6
loop MET137 4 16 0 0
Helix H8 ASN138 3 15 1 1
Helix H8 TYR139 4 8 4 4
Helix H8 LEU140 2 17 1 0
Helix H8 SER141 1 5 5 9
loop ARG142 0 17 3 0
loop LEU143 0 7 6 7
loop ASP144 3 17 0 0
loop GLY145 1 11 8 0
loop ALA146 2 13 4 1
Sheet ARG147 1 18 0 1
Sheet ASN148 0 10 9 1
Sheet VAL149 1 17 2 0
Sheet GLN150 2 18 0 0
Sheet ILE151 1 11 8 0
loop HIS152 5 14 0 1
loop GLY153 0 19 1 0
loop VAL154 1 15 4 0
loop GLY155 4 15 1 0
loop HIS156 0 1 0 19
loop ILE157 0 6 10 4
Helix H9 GLY158 0 18 2 0
Helix H9 LEU159 1 9 9 1
Helix H9 LEU160 0 6 8 6
Helix H9 TYR161 2 17 0 1
loop SER162 3 16 1 0
Helix H10 SER163 2 18 0 0
Helix H10 GLN164 0 19 1 0
Helix H10 VAL165 1 12 4 3
Helix H10 ASN166 2 6 6 6
Helix H10 SER167 0 18 1 1
Helix H10 LEU168 1 7 2 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 0 19 0 1
Helix H10 GLU171 0 18 0 2
Helix H10 GLY172 0 13 7 0
Helix H10 LEU173 0 9 5 6
loop ASN174 0 20 0 0
loop GLY175 0 20 0 0
loop GLY176 0 19 1 0
loop GLY177 4 15 1 0
loop GLN178 0 20 0 0
loop ASN179 1 18 0 1
loop THR180 2 18 0 0
loop ASN181 1 19 0 0
Total 75 181 136 99
1,4-dioxane
Number of amino acid substitutions with
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Table 7-13: Number of amino acid substitutions in BSLA which lead to increased/unchanged/decreased resistance towards TFE and inactivation of 
BSLA. The secondary structure characteristic (loop, helix and β-sheet) of every position is shown. Loops are labelled in black, sheets in white and helix in light 
grey. The results in the table are given with a color scale from dark grey (highest values) to light grey (lowest values.). “+”: improved resistance; “=”: unchanged 
resistance; “-”: decreased resistance and “x” inactivated. 
 
 
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
loop Ala1 0 20 0 0
loop Glu2 0 20 0 0
loop HIS3 0 20 0 0
loop ASN4 0 20 0 0
loop PRO5 8 9 1 2
Sheet VAL6 3 12 0 5
Sheet VAL7 1 4 0 15
Sheet MET8 0 15 1 4
Sheet VAL9 0 6 9 5
loop HIS10 2 7 11 0
loop GLY11 0 1 1 18
loop ILE12 5 11 0 4
loop GLY13 1 16 3 0
loop GLY14 3 11 3 3
loop ALA15 3 16 0 1
Helix H1 SER16 0 20 0 0
Helix H1 PHE17 1 18 1 0
Helix H1 ASN18 3 13 3 1
Helix H1 PHE19 0 9 10 1
Helix H1 ALA20 0 19 1 0
Helix H1 GLY21 1 17 2 0
Helix H1 ILE22 0 8 10 2
Helix H1 LYS23 4 15 0 1
Helix H1 SER24 0 17 3 0
Helix H1 TYR25 0 16 3 1
Helix H1 LEU26 1 9 0 10
Helix H1 VAL27 0 19 0 1
Helix H1 SER28 0 20 0 0
loop GLN29 1 18 0 1
loop GLY30 0 17 1 2
loop TRP31 0 18 0 2
loop SER32 2 18 0 0
Helix H3 ARG33 0 20 0 0
Helix H3 ASP34 2 15 2 1
Helix H3 LYS35 0 17 0 3
Sheet LEU36 2 13 3 2
Sheet TYR37 0 20 0 0
Sheet ALA38 0 19 1 0
loop VAL39 1 18 1 0
loop ASP40 0 20 0 0
loop PHE41 4 12 2 2
loop TRP42 2 18 0 0
loop ASP43 3 17 0 0
loop LYS44 0 19 1 0
loop THR45 1 19 0 0
loop GLY46 0 17 3 0
loop THR47 10 10 0 0
Helix H4 ASN48 0 20 0 0
Helix H4 TYR49 1 19 0 0
Helix H4 ASN50 1 19 0 0
Helix H4 ASN51 2 17 1 0
loop GLY52 3 7 10 0
Helix H4 PRO53 0 20 0 0
Helix H4 VAL54 4 15 0 1
Helix H4 LEU55 0 11 0 9
Helix H4 SER56 0 20 0 0
Helix H4 ARG57 1 13 6 0
Helix H4 PHE58 0 15 4 1
Helix H4 VAL59 0 5 3 12
Helix H4 GLN60 0 20 0 0
Helix H4 LYS61 0 17 2 1
Helix H4 VAL62 0 16 2 2
Helix H4 LEU63 0 13 6 1
Helix H4 ASP64 2 16 1 1
Helix H4 GLU65 2 18 0 0
Helix H4 THR66 0 19 0 1
loop GLY67 0 18 1 1
loop ALA68 0 20 0 0
loop LYS69 0 20 0 0
loop LYS70 0 14 5 1
Sheet VAL71 0 6 3 11
Sheet ASP72 0 4 10 6
Sheet ILE73 0 2 2 16
Sheet VAL74 0 5 2 13
Sheet ALA75 0 8 2 10
Sheet HIS76 1 1 0 18
loop SER77 0 1 0 19
Helix H5 MET78 4 7 1 8
Helix H5 GLY79 0 2 1 17
Helix H5 GLY80 0 4 2 14
Helix H5 ALA81 2 11 6 1
Helix H5 ASN82 0 9 9 2
Helix H5 THR83 1 11 5 3
Helix H5 LEU84 1 6 11 2
Helix H5 TYR85 1 18 0 1
Helix H5 TYR86 0 13 3 4
Helix H5 ILE87 0 6 6 8
Helix H5 LYS88 1 18 0 1
loop ASN89 0 16 0 4
loop LEU90 10 9 1 0
loop ASP91 9 7 2 2
TFE
Number of amino acid substitutions with
BSLA
 secondary
structure
BSLA 
amino
acid 
positions
+ = - x
Helix H6 GLY92 0 5 15 0
Helix H6 GLY93 0 9 11 0
Helix H6 ASN94 0 19 1 0
loop LYS95 4 14 2 0
Sheet VAL96 0 12 0 8
Sheet ALA97 4 15 0 1
Sheet ASN98 1 15 4 0
Sheet VAL99 0 11 5 4
Sheet VAL100 2 9 1 8
Sheet THR101 0 10 9 1
Sheet LEU102 0 6 5 9
loop GLY103 0 3 2 15
loop GLY104 0 3 11 6
loop ALA105 1 13 4 2
Helix H7 ASN106 0 4 15 1
Helix H7 ARG107 0 7 10 3
Helix H7 LEU108 0 5 14 1
loop THR109 2 2 16 0
loop THR110 0 2 18 0
loop GLY111 0 19 1 0
loop LYS112 1 18 1 0
loop ALA113 0 4 16 0
loop LEU114 2 15 3 0
loop PRO115 0 19 1 0
loop GLY116 0 1 19 0
loop THR117 1 16 0 3
loop ASP118 0 17 3 0
loop PRO119 4 15 1 0
loop ASN120 1 19 0 0
loop GLN121 0 18 2 0
loop LYS122 0 17 2 1
loop ILE123 0 4 12 4
Sheet LEU124 0 15 5 0
Sheet TYR125 0 2 11 7
Sheet THR126 0 10 8 2
Sheet SER127 0 4 12 4
Sheet ILE128 0 4 9 7
Sheet TYR129 0 4 13 3
Sheet SER130 0 3 15 2
loop SER131 1 17 2 0
loop ALA132 1 17 2 0
loop ASP133 0 1 1 18
loop MET134 6 14 0 0
loop ILE135 0 17 3 0
loop VAL136 0 10 4 6
loop MET137 4 16 0 0
Helix H8 ASN138 0 13 6 1
Helix H8 TYR139 2 11 3 4
Helix H8 LEU140 7 12 1 0
Helix H8 SER141 0 1 10 9
loop ARG142 0 20 0 0
loop LEU143 0 3 10 7
loop ASP144 1 19 0 0
loop GLY145 0 2 18 0
loop ALA146 0 14 5 1
Sheet ARG147 2 15 2 1
Sheet ASN148 0 1 18 1
Sheet VAL149 1 17 2 0
Sheet GLN150 1 19 0 0
Sheet ILE151 0 7 13 0
loop HIS152 1 18 0 1
loop GLY153 0 18 2 0
loop VAL154 0 9 11 0
loop GLY155 0 20 0 0
loop HIS156 0 1 0 19
loop ILE157 4 10 2 4
Helix H9 GLY158 0 17 3 0
Helix H9 LEU159 1 7 11 1
Helix H9 LEU160 1 3 10 6
Helix H9 TYR161 1 18 0 1
loop SER162 0 12 8 0
Helix H10 SER163 2 18 0 0
Helix H10 GLN164 2 18 0 0
Helix H10 VAL165 1 13 3 3
Helix H10 ASN166 1 3 10 6
Helix H10 SER167 3 15 1 1
Helix H10 LEU168 3 7 0 10
Helix H10 ILE169 0 1 1 18
Helix H10 LYS170 1 18 0 1
Helix H10 GLU171 1 16 1 2
Helix H10 GLY172 0 10 10 0
Helix H10 LEU173 0 7 7 6
loop ASN174 0 19 1 0
loop GLY175 0 20 0 0
loop GLY176 0 19 1 0
loop GLY177 0 6 14 0
loop GLN178 0 17 3 0
loop ASN179 0 14 5 1
loop THR180 0 20 0 0
loop ASN181 0 20 0 0
Total 74 181 120 99
TFE
Number of amino acid substitutions with
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Table 7-14: Effect of each type of amino acid substitution (polar, aliphatic, charged and aromatic) on OS resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 
patterns per OS are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, 
E, H, K, and R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants 
with unchanged resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer. 
 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
 
 
 
  
  Amino acid types in BSLA-WT   
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
   
+ 
(44) 
= 
(193) 
- 
(36) 
x 
(27) 
+ 
(155) 
= 
(843) 
- 
(269) 
x 
(313) 
+ 
(108) 
= 
759) 
- 
(136) 
x 
77) 
+ 
(64) 
= 
(417) 
- 
98) 
x 
81) 
D
M
S
O
 
Aromatic  7% 20% 8% 0% 9% 14% 17% 19% 8% 14% 24% 19% 22% 12% 21% 15% 
Aliphatic  32% 26% 17% 19% 21% 32% 20% 12% 23% 28% 16% 16% 25% 24% 30% 25% 
Polar 27% 36% 33% 44% 41% 36% 39% 27% 32% 36% 34% 29% 25% 35% 36% 43% 
Charged 34% 18% 42% 37% 29% 18% 24% 42% 36% 22% 26% 36% 28% 29% 13% 17% 
acidic 11% 6% 25% 15% 8% 8% 10% 15% 11% 9% 16% 10% 11% 12% 6% 6% 
basic 23% 12% 17% 22% 21% 10% 13% 27% 25% 13% 10% 26% 17% 17% 7% 11% 
                  
  
+ 
(19) 
= 
195) 
- 
(59) 
x 
(27) 
+ 
(60) 
= 
(827) 
- 
(380) 
x 
(313) 
+ 
(56) 
= 
(780) 
- 
167) 
x 
(77) 
+ 
(24) 
= 
(486) 
- 
(69) 
x 
(81) 
1
,4
-d
io
x
a
n
e 
Aromatic  5% 22% 3% 0% 17% 13% 15% 19% 16% 13% 22% 19% 17% 14% 19% 15% 
Aliphatic  26% 26% 25% 19% 13% 34% 18% 12% 16% 28% 19% 16% 17% 26% 22% 25% 
Polar 21% 35% 34% 44% 32% 37% 39% 27% 32% 37% 32% 29% 25% 35% 32% 43% 
Charged 47% 17% 37% 37% 38% 16% 28% 42% 36% 23% 27% 36% 42% 25% 28% 17% 
acidic 11% 5% 24% 15% 8% 6% 15% 15% 4% 9% 15% 10% 4% 9% 23% 6% 
basic 37% 12% 14% 22% 30% 10% 13% 27% 32% 13% 12% 26% 38% 16% 4% 11% 
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Table 7-14: Effect of each type of amino acid substitution (polar, aliphatic, charged and aromatic) on OS resistance of BSLA when replacing each type of amino acid in BSLA WT. 16 
patterns per OS are shown. The absolute number of BSLA variants per type is shown in bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, 
H, K, and R), and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants with improved resistance, “=” representing variants with 
unchanged resistance, “-” representing variants with decreased resistance and “x” representing inactive variants in buffer. 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is not equally distributed (43.6% aliphatic, 29.8% polar amino acids, 
18.2% charged, and, 8.3% aromatic). Highest values among the resistance type “+” are highlighted in blue and dark red represents the values of substitutions preferring exchange with similar 
residues. 
 
  
 
 
 
 
 
 
 
 
 
 
1  
 
Amino acid types in BSLA-WT 
  BSLA: Aromatic (15; 8.3%) BSLA: Aliphatic (79; 43.6%) BSLA: Polar (54; 29.8%) BSLA: Charged (33; 18.2%) 
 
  
+ 
(12) 
= 
(211) 
- 
(50) 
x 
(27) 
+ 
(69) 
= 
836) 
- 
362) 
x 
313) 
+ 
(62) 
= 
(751) 
- 
(190) 
x 
77) 
+ 
(38) 
= 
(479) 
- 
(62) 
x 
(81) 
T
F
E
 
Aromatic  8% 19% 6% 0% 23% 12% 17% 19% 18% 15% 14% 19% 16% 15% 16% 15% 
Aliphatic  0% 27% 28% 19% 14% 33% 20% 12% 19% 26% 28% 16% 16% 26% 23% 25% 
Polar 33% 34% 34% 44% 29% 38% 37% 27% 26% 38% 31% 29% 45% 33% 32% 43% 
Charged 58% 20% 32% 37% 33% 18% 26% 42% 37% 22% 28% 36% 24% 26% 29% 17% 
acidic 8% 8% 16% 15% 14% 6% 14% 15% 16% 9% 12% 10% 5% 10% 21% 6% 
basic 50% 12% 16% 22% 19% 11% 12% 27% 21% 13% 16% 26% 18% 16% 8% 11% 
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Table 7-15: Chemical diversity for improved variants in all three OS. The percentage values were calculated by addition 
of the values for the chemically different amino acids in each case. In case of DMSO for example, 93% (addition of values 
from aliphatic, polar, and charged) of the aromatic WT residues preferred substitutions with chemically different amino acid. 
Lowest and highest values are in bold. 
Amino acid types in BSLA WT 
 Aromatic [%] Aliphatic [%] Polar [%] Charged [%] 
DMSO 93  79  68  72  
1,4-dioxane 95  87  68  58  
TFE 92  86  74  76  
 
Table 7-16: Effect of amino acid location (buried, exposed) on OS resistance of BSLA when replacing each type of 
amino acid in BSLA WT. 16 patterns per OS are shown. The absolute number of BSLA variants per type is shown in 
bracket. Amino acids are grouped into: aromatic (F, Y, and W), aliphatic (A, V, L, I, and G), charged (D, E, H, K, and R), 
and polar (C, M, P, S, T, N, and Q). All SSM-BSLA variants were grouped as described in the text: “+” representing variants 
with improved resistance, “=” representing variants with unchanged resistance, “-” representing variants with decreased 
resistance and “x” representing inactive variants in buffer. 
 
The percentage values were given here for a better comparison among columns since the amino acid composition of BSLA is 
not equally distributed (43.6 % aliphatic, 29.8 % polar amino acids, 18.2 % charged, and, 8.3 % aromatic). Column “x” 
shows that the number of inactive variants resulted from amino acid substitutions. The activity was measured in a buffer plate 
which was used as reference (absence of OS) for comparison. Therefore, the number of inactive variants was the same for the 
three OS. 
  
  Location of amino acid positions in BSLA   
  Exposed positions (128; 71%) Buried positions (53; 29%) 
   
+ 
(275) 
= 
(1777) 
- 
(319) 
x 
(189) 
+ 
(96) 
= 
(435) 
- 
(220) 
x 
(309) 
D
M
S
O
 Aromatic  10% 15% 22% 15% 14% 12% 16% 19% 
Aliphatic  25% 27% 21% 17% 21% 36% 20% 14% 
Polar 31% 36% 33% 38% 44% 36% 41% 26% 
Charged 35% 23% 24% 30% 22% 15% 23% 41% 
 acidic 9% 9% 13% 11% 10% 6% 11% 9% 
 basic 26% 14% 11% 19% 11% 9% 12% 25% 
  
                
  
+ 
(138) 
= 
(1903) 
- 
(330) 
x 
(189) 
+ 
(21) 
= 
(385) 
- 
(345) 
x 
(309) 
1
,4
-d
io
x
a
n
e
 
Aromatic  16% 15% 17% 15% 10% 12% 15% 19% 
Aliphatic  17% 27% 19% 17% 14% 39% 20% 14% 
Polar 26% 35% 35% 38% 52% 40% 37% 26% 
Charged 41% 23% 28% 30% 24% 9% 28% 41% 
 acidic 6% 9% 19% 11% 10% 3% 14% 14% 
 basic 36% 14% 10% 19% 14% 6% 14% 27% 
  
                
  
+ 
(152) 
= 
(1883) 
- 
(336) 
x 
(189) 
+ 
(29) 
= 
(394) 
- 
(328) 
x 
(309) 
T
F
E
 
Aromatic  19% 15% 15% 15% 17% 12% 15% 19% 
Aliphatic  16% 27% 24% 17% 10% 37% 22% 14% 
Polar 30% 36% 32% 38% 38% 40% 38% 26% 
Charged 34% 23% 29% 30% 34% 11% 26% 41% 
 acidic 11% 9% 15% 11% 21% 3% 13% 14% 
 basic 23% 14% 14% 19% 14% 8% 13% 27% 
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Table 7-17: Overall number of amino acid substitutions on different secondary elements of BSLA (loop, helix and β-
sheet) contributing to increased/unchanged/decreased resistance towards all three OS and inactivation of BSLA. “+”: 
improved resistance; “=”: unchanged resistance; “-”: decreased resistance and “x” inactivated. 
 
 
 
 
 
 
 
 
 
 
 
 
 DMSO 
 
+ 
(107) 
= 
(181) 
- 
(118) 
x 
(99) 
Loops 44% 44% 41% 28% 
Sheets 22% 18% 16% 25% 
Helices 34% 39% 43% 46% 
Total 100% 100% 100% 100% 
 
 1,4-Dioxane  
 
+ 
(75) 
= 
(181) 
- 
(136) 
x 
(99) 
Loops 47% 44% 38% 28% 
Sheets 17% 18% 21% 25% 
Helices 36% 39% 42% 46% 
Total 100% 100% 100% 100% 
 
 TFE  
 
+ 
(74) 
= 
(181) 
- 
(120) 
x 
(99) 
Loops 43% 44% 41% 28% 
Sheets 14% 18% 21% 25% 
Helices 43% 39% 38% 46% 
Total 100% 100% 100% 100% 
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Figure 7-3: 3D model auf BSLA (Protein Database code: 1I6W) displaying regions which inactivated BSLA. These 
numbers are identical in all OS and ILs since inactivation resulted from the mutations and did not depend on the non-
conventional media used. Positions which did not habor inactive substitutions are colored grey. Positions with one 
substitution leading to inactivation are colored blue. Positions with two to seven substitutions leading to inactivation are 
colored purple (two positions) to magenta (seven positions). Red represents positions with eight or more substitutions leading 
to inactivation. The active site residue Ser 77 is colored green. A) Cartoon representation of BSLA, B) Van der Waals 
representation of surface residues of BSLA, C) Van der Waals representation of buried residues of BSLA. The two N-
terminal amino acids (Ala1 and Glu2) are also included. Yasara was used for visualization 
 
 
A front view (inactive substitutions) 
 
B surface front view 
 
C buried front view 
 
Back view (inactive substitutions) 
 
surface back view 
 
buried back view 
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